Pathway,Count
MP:0000003 abnormal adipose tissue morphology,16
MP:0000005 increased brown adipose tissue amount,30
MP:0000008 increased white adipose tissue amount,32
MP:0000010 abnormal abdominal fat pad morphology,18
MP:0000013 abnormal adipose tissue distribution,12
MP:0000015 abnormal ear pigmentation,8
MP:0000017 big ears,4
MP:0000018 small ears,19
MP:0000022 abnormal ear shape,5
MP:0000023 abnormal ear position,11
MP:0000024 lowered ear position,17
MP:0000026 abnormal inner ear morphology,43
MP:0000029 abnormal malleus morphology,23
MP:0000030 abnormal tympanic ring morphology,16
MP:0000031 abnormal cochlea morphology,51
MP:0000032 cochlear degeneration,5
MP:0000033 absent scala media,4
MP:0000034 abnormal inner ear vestibule morphology,24
MP:0000035 abnormal membranous labyrinth morphology,12
MP:0000036 absent semicircular canals,10
MP:0000037 abnormal lateral semicircular canal morphology,10
MP:0000039 abnormal otic capsule morphology,9
MP:0000040 absent middle ear ossicles,3
MP:0000041 absent endolymphatic duct,6
MP:0000042 abnormal organ of Corti morphology,41
MP:0000043 organ of Corti degeneration,45
MP:0000044 absent organ of Corti,4
MP:0000048 abnormal stria vascularis morphology,26
MP:0000049 abnormal middle ear morphology,28
MP:0000060 delayed bone ossification,76
MP:0000061 fragile skeleton,23
MP:0000062 increased bone mineral density,106
MP:0000063 decreased bone mineral density,244
MP:0000064 failure of secondary bone resorption,4
MP:0000065 abnormal bone marrow cavity morphology,18
MP:0000066 osteoporosis,42
MP:0000067 osteopetrosis,29
MP:0000069 kyphoscoliosis,17
MP:0000071 axial skeleton hypoplasia,3
MP:0000074 abnormal neurocranium morphology,75
MP:0000075 absent neurocranium,4
MP:0000077 abnormal interparietal bone morphology,14
MP:0000078 abnormal supraoccipital bone morphology,11
MP:0000079 abnormal basioccipital bone morphology,17
MP:0000080 abnormal exoccipital bone morphology,7
MP:0000081 premature suture closure,10
MP:0000084 abnormal fontanelle morphology,14
MP:0000085 large anterior fontanelle,5
MP:0000087 absent mandible,16
MP:0000088 short mandible,56
MP:0000091 short premaxilla,12
MP:0000097 short maxilla,35
MP:0000098 abnormal vomer bone morphology,4
MP:0000102 abnormal nasal bone morphology,24
MP:0000104 abnormal sphenoid bone morphology,8
MP:0000106 abnormal basisphenoid bone morphology,19
MP:0000107 abnormal frontal bone morphology,39
MP:0000108 midline facial cleft,13
MP:0000109 abnormal parietal bone morphology,28
MP:0000111 cleft palate,125
MP:0000116 abnormal tooth development,31
MP:0000118 arrest of tooth development,5
MP:0000119 abnormal tooth eruption,4
MP:0000120 malocclusion,35
MP:0000121 failure of tooth eruption,16
MP:0000124 absent teeth,11
MP:0000125 absent incisors,14
MP:0000126 brittle teeth,6
MP:0000128 growth retardation of molars,6
MP:0000129 ameloblast degeneration,3
MP:0000130 abnormal trabecular bone morphology,118
MP:0000131 abnormal long bone epiphysis morphology,19
MP:0000133 abnormal long bone metaphysis morphology,33
MP:0000135 decreased compact bone thickness,63
MP:0000136 abnormal microglial cell morphology,28
MP:0000137 abnormal vertebrae morphology,99
MP:0000138 absent vertebrae,3
MP:0000141 abnormal vertebral body morphology,25
MP:0000149 abnormal scapula morphology,18
MP:0000150 abnormal rib morphology,125
MP:0000151 absent ribs,3
MP:0000153 rib bifurcation,26
MP:0000154 rib fusion,65
MP:0000155 asymmetric rib joints,6
MP:0000157 abnormal sternum morphology,67
MP:0000159 abnormal xiphoid process morphology,25
MP:0000160 kyphosis,142
MP:0000161 scoliosis,29
MP:0000162 lordosis,28
MP:0000163 abnormal cartilage morphology,44
MP:0000164 abnormal cartilage development,47
MP:0000165 abnormal long bone hypertrophic chondrocyte zone,49
MP:0000166 abnormal chondrocyte morphology,54
MP:0000167 decreased chondrocyte number,14
MP:0000168 abnormal bone marrow development,7
MP:0000172 abnormal bone marrow cell number,14
MP:0000180 abnormal circulating cholesterol level,24
MP:0000181 abnormal circulating LDL cholesterol level,3
MP:0000182 increased circulating LDL cholesterol level,42
MP:0000183 decreased circulating LDL cholesterol level,60
MP:0000184 abnormal circulating HDL cholesterol level,4
MP:0000186 decreased circulating HDL cholesterol level,117
MP:0000187 abnormal triglyceride level,14
MP:0000188 abnormal circulating glucose level,24
MP:0000189 hypoglycemia,91
MP:0000192 abnormal mineral level,8
MP:0000194 increased circulating calcium level,50
MP:0000195 decreased circulating calcium level,52
MP:0000198 decreased circulating phosphate level,37
MP:0000199 abnormal circulating serum albumin level,4
MP:0000208 decreased hematocrit,149
MP:0000216 absent erythroid progenitor cell,3
MP:0000217 abnormal leukocyte cell number,22
MP:0000218 increased leukocyte cell number,130
MP:0000219 increased neutrophil cell number,135
MP:0000220 increased monocyte cell number,94
MP:0000221 decreased leukocyte cell number,124
MP:0000222 decreased neutrophil cell number,98
MP:0000223 decreased monocyte cell number,56
MP:0000228 abnormal thrombopoiesis,10
MP:0000229 abnormal megakaryocyte differentiation,14
MP:0000230 abnormal systemic arterial blood pressure,33
MP:0000231 hypertension,42
MP:0000233 abnormal blood flow velocity,12
MP:0000238 absent pre-B cells,8
MP:0000239 absent common myeloid progenitor cells,14
MP:0000240 extramedullary hematopoiesis,105
MP:0000242 impaired fertilization,54
MP:0000243 myoclonus,24
MP:0000245 abnormal erythropoiesis,107
MP:0000248 macrocytosis,14
MP:0000249 abnormal blood vessel physiology,23
MP:0000250 abnormal vasoconstriction,11
MP:0000255 vasculature congestion,16
MP:0000256 echinocytosis,6
MP:0000259 abnormal vascular development,68
MP:0000260 abnormal angiogenesis,75
MP:0000262 poor arterial differentiation,5
MP:0000263 absent organized vascular network,6
MP:0000264 failure of vascular branching,7
MP:0000266 abnormal heart morphology,224
MP:0000267 abnormal heart development,157
MP:0000269 abnormal heart looping,40
MP:0000270 abnormal heart tube morphology,29
MP:0000272 abnormal aorta morphology,30
MP:0000273 overriding aortic valve,38
MP:0000274 enlarged heart,216
MP:0000275 heart hyperplasia,9
MP:0000276 heart right ventricle hypertrophy,38
MP:0000277 abnormal heart shape,17
MP:0000278 abnormal myocardial fiber morphology,88
MP:0000279 ventricular hypoplasia,25
MP:0000280 thin ventricular wall,90
MP:0000281 abnormal interventricular septum morphology,50
MP:0000282 abnormal interatrial septum morphology,6
MP:0000284 double outlet right ventricle,90
MP:0000285 abnormal heart valve morphology,26
MP:0000286 abnormal mitral valve morphology,17
MP:0000288 abnormal pericardium morphology,20
MP:0000291 enlarged pericardium,32
MP:0000292 distended pericardium,51
MP:0000293 absent myocardial trabeculae,12
MP:0000295 trabecula carnea hypoplasia,43
MP:0000296 absent trabeculae carneae,12
MP:0000297 abnormal atrioventricular cushion morphology,20
MP:0000298 absent atrioventricular cushions,14
MP:0000299 failure of atrioventricular cushion closure,6
MP:0000301 decreased atrioventricular cushion size,10
MP:0000313 abnormal cell death,41
MP:0000314 schistocytosis,11
MP:0000315 hemoglobinuria,3
MP:0000316 cellular necrosis,5
MP:0000321 increased bone marrow cell number,39
MP:0000322 increased granulocyte number,73
MP:0000324 increased mast cell number,10
MP:0000333 decreased bone marrow cell number,70
MP:0000334 decreased granulocyte number,27
MP:0000336 decreased mast cell number,15
MP:0000343 altered response to myocardial infarction,45
MP:0000346 broad head,6
MP:0000350 abnormal cell proliferation,18
MP:0000351 increased cell proliferation,53
MP:0000352 decreased cell proliferation,166
MP:0000358 abnormal cell morphology,102
MP:0000359 abnormal mast cell morphology,11
MP:0000362 decreased mast cell histamine storage,4
MP:0000364 abnormal vascular regression,19
MP:0000367 abnormal coat/ hair morphology,50
MP:0000370 head blaze,4
MP:0000371 diluted coat color,47
MP:0000372 irregular coat pigmentation,15
MP:0000373 belly spot,33
MP:0000377 abnormal hair follicle morphology,60
MP:0000378 absent hair follicles,6
MP:0000379 decreased hair follicle number,34
MP:0000380 small hair follicles,4
MP:0000381 enlarged hair follicles,3
MP:0000382 underdeveloped hair follicles,16
MP:0000383 abnormal hair follicle orientation,15
MP:0000384 distorted hair follicle pattern,8
MP:0000392 accelerated hair follicle regression,3
MP:0000394 absent hair follicle melanin granules,4
MP:0000396 increased curvature of hairs,4
MP:0000397 abnormal guard hair morphology,5
MP:0000400 abnormal awl hair morphology,10
MP:0000402 abnormal zigzag hair morphology,13
MP:0000405 abnormal auchene hair morphology,9
MP:0000410 waved hair,17
MP:0000411 shiny fur,3
MP:0000413 polyphalangy,6
MP:0000414 alopecia,95
MP:0000416 sparse hair,74
MP:0000417 short hair,12
MP:0000418 focal hair loss,25
MP:0000420 ruffled hair,22
MP:0000421 mottled coat,6
MP:0000422 delayed hair appearance,16
MP:0000423 delayed hair regrowth,3
MP:0000424 retarded hair growth,9
MP:0000427 abnormal hair cycle,28
MP:0000428 abnormal craniofacial morphology,104
MP:0000430 absent maxillary shelf,9
MP:0000431 absent palatine bone horizontal plate,9
MP:0000432 abnormal head morphology,56
MP:0000433 microcephaly,67
MP:0000434 megacephaly,14
MP:0000435 shortened head,28
MP:0000436 abnormal head movements,9
MP:0000438 abnormal cranium morphology,133
MP:0000439 enlarged cranium,10
MP:0000440 domed cranium,64
MP:0000441 increased cranium width,9
MP:0000443 abnormal snout morphology,48
MP:0000445 short snout,103
MP:0000447 flattened snout,3
MP:0000448 pointed snout,8
MP:0000449 broad nasal bridge,3
MP:0000452 abnormal mouth morphology,14
MP:0000453 absent mouth,3
MP:0000454 abnormal jaw morphology,27
MP:0000455 abnormal maxilla morphology,54
MP:0000457 maxilla hypoplasia,6
MP:0000458 abnormal mandible morphology,54
MP:0000460 mandible hypoplasia,24
MP:0000462 abnormal digestive system morphology,24
MP:0000465 gastrointestinal hemorrhage,28
MP:0000466 esophageal epithelium hyperplasia,3
MP:0000467 abnormal esophagus morphology,10
MP:0000468 abnormal esophageal epithelium morphology,8
MP:0000469 abnormal esophageal squamous epithelium morphology,3
MP:0000470 abnormal stomach morphology,25
MP:0000471 abnormal stomach epithelium morphology,9
MP:0000473 abnormal stomach glandular epithelium morphology,15
MP:0000474 abnormal foregut morphology,24
MP:0000477 abnormal intestine morphology,72
MP:0000478 delayed intestine development,4
MP:0000479 abnormal enterocyte morphology,17
MP:0000480 increased rib number,65
MP:0000484 abnormal pulmonary artery morphology,22
MP:0000486 abnormal pulmonary trunk morphology,4
MP:0000488 abnormal intestinal epithelium morphology,43
MP:0000489 abnormal large intestine morphology,10
MP:0000490 abnormal crypts of Lieberkuhn morphology,30
MP:0000491 crypts of Lieberkuhn abscesses,6
MP:0000492 abnormal rectum morphology,11
MP:0000493 rectal prolapse,27
MP:0000494 abnormal cecum morphology,7
MP:0000495 abnormal colon morphology,53
MP:0000496 abnormal small intestine morphology,52
MP:0000501 abnormal digestive secretion,3
MP:0000505 decreased digestive secretion,11
MP:0000511 abnormal intestinal mucosa morphology,39
MP:0000512 intestinal ulcer,19
MP:0000516 abnormal renal/urinary system morphology,13
MP:0000519 hydronephrosis,86
MP:0000520 absent kidney,45
MP:0000521 abnormal kidney cortex morphology,25
MP:0000522 kidney cortex cysts,32
MP:0000523 cortical renal glomerulopathies,16
MP:0000525 renal tubular acidosis,8
MP:0000527 abnormal kidney development,59
MP:0000528 delayed kidney development,15
MP:0000530 abnormal kidney blood vessel morphology,13
MP:0000531 right pulmonary isomerism,16
MP:0000532 kidney vascular congestion,4
MP:0000533 kidney hemorrhage,9
MP:0000534 abnormal ureter morphology,21
MP:0000536 hydroureter,16
MP:0000537 abnormal urethra morphology,4
MP:0000538 abnormal urinary bladder morphology,15
MP:0000539 distended urinary bladder,16
MP:0000540 abnormal urinary bladder urothelium morphology,8
MP:0000542 left-sided isomerism,5
MP:0000547 short limbs,87
MP:0000549 absent limbs,5
MP:0000550 abnormal forelimb morphology,48
MP:0000552 abnormal radius morphology,18
MP:0000553 absent radius,7
MP:0000554 abnormal carpal bone morphology,22
MP:0000556 abnormal hindlimb morphology,53
MP:0000557 absent hindlimb,4
MP:0000558 abnormal tibia morphology,45
MP:0000559 abnormal femur morphology,61
MP:0000561 adactyly,3
MP:0000562 polydactyly,85
MP:0000564 syndactyly,57
MP:0000565 oligodactyly,46
MP:0000566 synostosis,7
MP:0000568 ectopic digits,5
MP:0000571 interdigital webbing,14
MP:0000572 abnormal autopod morphology,44
MP:0000574 abnormal foot pad morphology,7
MP:0000575 increased foot pad pigmentation,10
MP:0000576 clubfoot,7
MP:0000578 ulcerated paws,4
MP:0000579 abnormal nail morphology,16
MP:0000580 deformed nails,6
MP:0000583 long toenails,4
MP:0000585 kinked tail,99
MP:0000588 thick tail,8
MP:0000589 thin tail,5
MP:0000592 short tail,81
MP:0000596 abnormal liver development,35
MP:0000597 delayed hepatic development,9
MP:0000598 abnormal liver morphology,173
MP:0000599 enlarged liver,95
MP:0000600 liver hypoplasia,48
MP:0000601 small liver,78
MP:0000602 enlarged liver sinusoidal spaces,14
MP:0000603 pale liver,64
MP:0000604 amyloidosis,11
MP:0000606 decreased hepatocyte number,14
MP:0000607 abnormal hepatocyte morphology,101
MP:0000608 dissociated hepatocytes,4
MP:0000609 abnormal liver physiology,91
MP:0000611 jaundice,12
MP:0000613 abnormal salivary gland morphology,17
MP:0000623 decreased salivation,13
MP:0000627 abnormal mammary gland morphology,18
MP:0000628 abnormal mammary gland development,40
MP:0000629 absent mammary gland,6
MP:0000630 mammary gland hyperplasia,7
MP:0000633 abnormal pituitary gland morphology,15
MP:0000635 pituitary gland hyperplasia,5
MP:0000636 enlarged pituitary gland,7
MP:0000639 abnormal adrenal gland morphology,22
MP:0000640 adrenal gland hypoplasia,3
MP:0000642 enlarged adrenal glands,19
MP:0000644 dextrocardia,27
MP:0000646 enlarged adrenocortical cells,3
MP:0000647 abnormal sebaceous gland morphology,8
MP:0000650 mesocardia,12
MP:0000652 enlarged sebaceous gland,14
MP:0000653 abnormal sex gland morphology,3
MP:0000659 prostate gland hyperplasia,5
MP:0000661 small prostate gland ventral lobe,4
MP:0000662 abnormal branching of the mammary ductal tree,35
MP:0000664 small prostate gland anterior lobe,5
MP:0000666 decreased prostate gland duct number,3
MP:0000676 abnormal body water content,4
MP:0000680 absent parathyroid glands,8
MP:0000681 abnormal thyroid gland morphology,19
MP:0000685 abnormal immune system morphology,40
MP:0000688 lymphoid hyperplasia,21
MP:0000689 abnormal spleen morphology,164
MP:0000690 absent spleen,16
MP:0000691 enlarged spleen,273
MP:0000692 small spleen,85
MP:0000693 spleen hyperplasia,75
MP:0000694 spleen hypoplasia,93
MP:0000696 abnormal Peyer's patch morphology,23
MP:0000702 enlarged lymph nodes,106
MP:0000703 abnormal thymus morphology,50
MP:0000704 abnormal thymus development,13
MP:0000705 athymia,10
MP:0000706 small thymus,84
MP:0000708 thymus hyperplasia,25
MP:0000709 enlarged thymus,29
MP:0000711 thymus cortex hypoplasia,16
MP:0000714 increased thymocyte number,15
MP:0000715 decreased thymocyte number,101
MP:0000716 abnormal immune system cell morphology,35
MP:0000717 abnormal lymphocyte cell number,19
"MP:0000727 absent CD8-positive, alpha-beta T cells",8
MP:0000729 abnormal myogenesis,26
MP:0000730 increased satellite cell number,7
MP:0000733 abnormal muscle development,19
MP:0000734 muscle hypoplasia,7
MP:0000737 abnormal myotome development,11
MP:0000738 impaired muscle contractility,5
MP:0000740 impaired smooth muscle contractility,10
MP:0000743 muscle spasm,23
MP:0000745 tremors,232
MP:0000746 weakness,79
MP:0000747 muscle weakness,48
MP:0000748 progressive muscle weakness,24
MP:0000749 muscle degeneration,23
MP:0000750 abnormal muscle regeneration,26
MP:0000751 myopathy,40
MP:0000752 dystrophic muscle,26
MP:0000753 paralysis,33
MP:0000754 paresis,18
MP:0000755 hindlimb paralysis,61
MP:0000756 forelimb paralysis,8
MP:0000757 herniated abdominal wall,20
MP:0000759 abnormal skeletal muscle morphology,72
MP:0000761 thin diaphragm muscle,24
MP:0000762 abnormal tongue morphology,26
MP:0000763 abnormal filiform papillae morphology,4
MP:0000764 abnormal tongue epithelium morphology,13
MP:0000767 abnormal smooth muscle morphology,9
MP:0000771 abnormal brain size,6
MP:0000774 decreased brain size,103
MP:0000776 abnormal inferior colliculus morphology,5
MP:0000777 increased inferior colliculus size,3
MP:0000778 abnormal nervous system tract morphology,17
MP:0000780 abnormal corpus callosum morphology,53
MP:0000781 decreased corpus callosum size,30
MP:0000783 abnormal forebrain morphology,69
MP:0000784 forebrain hypoplasia,19
MP:0000785 telencephalon hypoplasia,6
MP:0000786 abnormal embryonic neuroepithelial layer differentiation,15
MP:0000787 abnormal telencephalon morphology,36
MP:0000788 abnormal cerebral cortex morphology,145
MP:0000789 thickened cerebral cortex,6
MP:0000790 abnormal stratification in cerebral cortex,29
MP:0000792 abnormal cortical marginal zone morphology,10
MP:0000794 abnormal parietal lobe morphology,4
MP:0000798 abnormal frontal lobe morphology,8
MP:0000805 abnormal visual cortex morphology,5
MP:0000807 abnormal hippocampus morphology,86
MP:0000808 abnormal hippocampus development,19
MP:0000811 hippocampal neuron degeneration,14
MP:0000812 abnormal dentate gyrus morphology,58
MP:0000813 abnormal hippocampus layer morphology,12
MP:0000814 absent dentate gyrus,4
MP:0000815 abnormal Ammon gyrus morphology,7
MP:0000818 abnormal amygdala morphology,10
MP:0000819 abnormal olfactory bulb morphology,48
MP:0000820 abnormal choroid plexus morphology,30
MP:0000822 abnormal brain ventricle morphology,17
MP:0000823 abnormal lateral ventricle morphology,18
MP:0000825 dilated lateral ventricles,42
MP:0000826 abnormal third ventricle morphology,12
MP:0000827 dilated third ventricle,24
MP:0000828 abnormal fourth ventricle morphology,9
MP:0000829 dilated fourth ventricle,6
MP:0000830 abnormal diencephalon morphology,33
MP:0000832 abnormal thalamus morphology,37
MP:0000836 abnormal substantia nigra morphology,9
MP:0000837 abnormal hypothalamus morphology,31
MP:0000841 abnormal hindbrain morphology,28
MP:0000846 abnormal medulla oblongata morphology,15
MP:0000847 abnormal metencephalon morphology,7
MP:0000848 abnormal pons morphology,17
MP:0000849 abnormal cerebellum morphology,92
MP:0000850 absent cerebellum,10
MP:0000851 cerebellum hypoplasia,15
MP:0000852 small cerebellum,66
MP:0000853 absent cerebellar foliation,6
MP:0000854 abnormal cerebellum development,26
MP:0000857 abnormal cerebellar foliation,35
MP:0000859 abnormal somatosensory cortex morphology,12
MP:0000861 disorganized barrel cortex,6
MP:0000864 abnormal cerebellum vermis morphology,15
MP:0000866 cerebellum vermis hypoplasia,7
MP:0000867 abnormal cerebellum anterior vermis morphology,5
MP:0000869 abnormal cerebellum posterior vermis morphology,3
MP:0000872 abnormal cerebellum external granule cell layer morphology,38
MP:0000873 thin external granule cell layer,11
MP:0000875 abnormal cerebellar Purkinje cell layer,27
MP:0000876 Purkinje cell degeneration,53
MP:0000877 abnormal Purkinje cell morphology,67
MP:0000880 decreased Purkinje cell number,42
MP:0000884 delaminated Purkinje cell layer,5
MP:0000885 ectopic Purkinje cell,25
MP:0000886 abnormal cerebellar granule layer morphology,38
MP:0000888 absent cerebellar granule layer,3
MP:0000889 abnormal cerebellar molecular layer,31
MP:0000890 thin cerebellar molecular layer,20
MP:0000897 abnormal midbrain morphology,34
MP:0000899 abnormal corpora quadrigemina morphology,3
MP:0000904 abnormal superior colliculus morphology,10
MP:0000906 abnormal trigeminal V mesencephalic nucleus morphology,3
MP:0000909 abnormal facial motor nucleus morphology,8
MP:0000910 small facial motor nucleus,4
MP:0000913 abnormal brain development,93
MP:0000914 exencephaly,182
MP:0000917 obstructive hydrocephaly,3
MP:0000919 cranioschisis,8
MP:0000920 abnormal myelination,84
MP:0000921 demyelination,64
MP:0000923 abnormal roof plate morphology,6
MP:0000925 abnormal floor plate morphology,16
MP:0000926 absent floor plate,16
MP:0000928 incomplete rostral neuropore closure,61
MP:0000929 open neural tube,137
MP:0000930 wavy neural tube,31
MP:0000932 absent notochord,16
MP:0000933 abnormal rhombomere morphology,7
MP:0000934 abnormal telencephalon development,47
MP:0000935 abnormal folding of telencephalic vesicles,3
MP:0000936 small embryonic telencephalon,14
MP:0000937 abnormal motor neuron morphology,49
MP:0000938 motor neuron degeneration,30
MP:0000939 decreased motor neuron number,46
MP:0000940 abnormal motor neuron innervation pattern,25
MP:0000947 convulsive seizures,43
MP:0000948 nonconvulsive seizures,6
MP:0000951 sporadic seizures,21
MP:0000952 abnormal CNS glial cell morphology,20
MP:0000953 abnormal oligodendrocyte morphology,20
MP:0000954 decreased oligodendrocyte progenitor number,6
MP:0000955 abnormal spinal cord morphology,73
MP:0000956 decreased spinal cord size,8
MP:0000958 peripheral nervous system degeneration,8
MP:0000959 abnormal somatic sensory system morphology,5
MP:0000961 abnormal dorsal root ganglion morphology,56
MP:0000962 disorganized dorsal root ganglion,6
MP:0000963 fused dorsal root ganglion,9
MP:0000964 small dorsal root ganglion,18
MP:0000965 abnormal sensory neuron morphology,14
MP:0000966 decreased sensory neuron number,14
MP:0000968 abnormal sensory neuron innervation pattern,51
MP:0000997 abnormal joint capsule morphology,3
MP:0001004 abnormal retinal photoreceptor morphology,30
MP:0001005 abnormal retinal rod cell morphology,17
MP:0001006 abnormal retinal cone cell morphology,19
MP:0001007 abnormal sympathetic system morphology,3
MP:0001008 abnormal sympathetic ganglion morphology,12
MP:0001011 abnormal superior cervical ganglion morphology,11
MP:0001015 small superior cervical ganglion,9
MP:0001017 abnormal stellate ganglion morphology,3
MP:0001021 small L4 dorsal root ganglion,6
MP:0001024 small L5 dorsal root ganglion,3
MP:0001025 abnormal sympathetic neuron morphology,8
MP:0001034 abnormal parasympathetic ganglion morphology,3
MP:0001038 abnormal cholinergic neuron morphology,8
MP:0001044 abnormal enteric nervous system morphology,11
MP:0001045 abnormal enteric ganglia morphology,9
MP:0001046 abnormal enteric neuron morphology,14
MP:0001048 absent enteric neurons,8
MP:0001052 abnormal innervation pattern to muscle,22
MP:0001053 abnormal neuromuscular synapse morphology,65
MP:0001054 failure of neuromuscular synapse presynaptic differentiation,3
MP:0001055 failure of neuromuscular synapse postsynaptic differentiation,3
MP:0001056 abnormal cranial nerve morphology,24
MP:0001059 optic nerve atrophy,4
MP:0001061 abnormal oculomotor nerve morphology,6
MP:0001063 abnormal trochlear nerve morphology,4
MP:0001065 abnormal trigeminal nerve morphology,27
MP:0001068 abnormal mandibular nerve branching,3
MP:0001071 abnormal facial nerve morphology,24
MP:0001072 abnormal vestibulocochlear nerve morphology,5
MP:0001073 abnormal glossopharyngeal nerve morphology,12
MP:0001074 abnormal vagus nerve morphology,16
MP:0001076 abnormal hypoglossal nerve morphology,8
MP:0001077 abnormal spinal nerve morphology,27
MP:0001078 abnormal phrenic nerve morphology,16
MP:0001081 abnormal cranial ganglia morphology,32
MP:0001082 abnormal geniculate ganglion morphology,8
MP:0001083 small geniculate ganglion,8
MP:0001084 abnormal petrosal ganglion morphology,3
MP:0001085 small petrosal ganglion,9
MP:0001088 small nodose ganglion,8
MP:0001092 abnormal trigeminal ganglion morphology,26
MP:0001093 small trigeminal ganglion,13
MP:0001096 abnormal glossopharyngeal ganglion morphology,11
MP:0001100 abnormal vagus ganglion morphology,8
MP:0001101 abnormal superior vagus ganglion morphology,3
MP:0001102 small superior vagus ganglion,21
MP:0001105 abnormal PNS glial cell morphology,3
MP:0001106 abnormal Schwann cell morphology,27
MP:0001107 decreased Schwann cell number,6
MP:0001116 small gonad,18
MP:0001119 abnormal female reproductive system morphology,36
MP:0001120 abnormal uterus morphology,33
MP:0001121 uterus hypoplasia,12
MP:0001123 dilated uterus,8
MP:0001125 abnormal oocyte morphology,33
MP:0001126 abnormal ovary morphology,61
MP:0001127 small ovary,87
MP:0001128 ovary hyperplasia,4
MP:0001129 impaired ovarian folliculogenesis,37
MP:0001130 abnormal ovarian folliculogenesis,30
MP:0001131 abnormal ovarian follicle morphology,40
MP:0001132 absent mature ovarian follicles,24
MP:0001134 absent corpus luteum,47
MP:0001140 abnormal vagina epithelium morphology,8
MP:0001142 abnormal vagina orifice morphology,8
MP:0001143 constricted vagina orifice,5
MP:0001144 vagina atresia,13
MP:0001145 abnormal male reproductive system morphology,40
MP:0001146 abnormal testis morphology,97
MP:0001147 small testis,247
MP:0001148 enlarged testis,11
MP:0001152 Leydig cell hyperplasia,41
MP:0001153 small seminiferous tubules,69
MP:0001154 seminiferous tubule degeneration,66
MP:0001155 arrest of spermatogenesis,71
MP:0001156 abnormal spermatogenesis,163
MP:0001157 small seminal vesicle,26
MP:0001158 abnormal prostate gland morphology,14
MP:0001159 absent prostate gland,4
MP:0001163 abnormal prostate gland anterior lobe morphology,3
MP:0001167 prostate gland epithelial hyperplasia,6
MP:0001168 abnormal prostate gland epithelium morphology,9
MP:0001175 abnormal lung morphology,121
MP:0001176 abnormal lung development,85
MP:0001177 atelectasis,67
MP:0001178 pulmonary hypoplasia,45
MP:0001179 thick pulmonary interalveolar septum,32
MP:0001181 absent lungs,4
MP:0001182 lung hemorrhage,32
MP:0001183 overexpanded pulmonary alveoli,30
MP:0001188 hyperpigmentation,14
MP:0001189 absent skin pigmentation,7
MP:0001190 reddish skin,26
MP:0001191 abnormal skin condition,49
MP:0001192 scaly skin,39
MP:0001193 psoriasis,5
MP:0001194 dermatitis,53
MP:0001195 flaky skin,13
MP:0001196 shiny skin,17
MP:0001198 tight skin,12
MP:0001199 thin skin,33
MP:0001200 thick skin,25
MP:0001201 translucent skin,13
MP:0001202 skin photosensitivity,6
MP:0001203 increased sensitivity to skin irradiation,5
MP:0001204 decreased sensitivity to skin irradiation,4
MP:0001208 blistering,22
MP:0001209 spontaneous skin ulceration,21
MP:0001211 wrinkled skin,24
MP:0001212 skin lesions,57
MP:0001214 skin hyperplasia,4
MP:0001216 abnormal epidermal layer morphology,61
MP:0001218 thin epidermis,25
MP:0001219 thick epidermis,63
MP:0001220 epidermal necrosis,4
MP:0001222 epidermal hyperplasia,53
MP:0001224 abnormal keratinocyte apoptosis,3
MP:0001230 epidermal desquamation,4
MP:0001231 abnormal epidermis stratum basale morphology,31
MP:0001233 abnormal epidermis suprabasal layer morphology,8
MP:0001236 abnormal epidermis stratum spinosum morphology,14
MP:0001239 abnormal epidermis stratum granulosum morphology,32
MP:0001240 abnormal epidermis stratum corneum morphology,45
MP:0001241 absent epidermis stratum corneum,7
MP:0001242 hyperkeratosis,60
MP:0001243 abnormal dermal layer morphology,33
MP:0001244 thin dermal layer,18
MP:0001245 thick dermal layer,15
MP:0001246 mixed cellular infiltration to dermis,12
MP:0001247 dermal cysts,6
MP:0001255 decreased body height,23
MP:0001257 increased body length,36
MP:0001258 decreased body length,260
MP:0001259 abnormal body weight,22
MP:0001260 increased body weight,201
MP:0001261 obese,64
MP:0001262 decreased body weight,1189
MP:0001263 weight loss,163
MP:0001264 increased body size,18
MP:0001265 decreased body size,774
MP:0001270 distended abdomen,50
MP:0001272 increased metastatic potential,26
MP:0001273 decreased metastatic potential,21
MP:0001274 curly vibrissae,21
MP:0001278 kinked vibrissae,4
MP:0001279 wavy vibrissae,8
MP:0001280 loss of vibrissae,3
MP:0001282 short vibrissae,18
MP:0001283 sparse vibrissae,5
MP:0001284 absent vibrissae,29
MP:0001286 abnormal eye development,55
MP:0001288 abnormal lens induction,6
MP:0001289 persistence of hyaloid vascular system,38
MP:0001290 delayed eyelid opening,30
MP:0001292 abnormal lens vesicle development,10
MP:0001293 anophthalmia,80
MP:0001296 macrophthalmia,3
MP:0001297 microphthalmia,150
MP:0001299 abnormal eye distance/ position,10
MP:0001300 ocular hypertelorism,22
MP:0001302 eyelids open at birth,52
MP:0001303 abnormal lens morphology,123
MP:0001304 cataract,118
MP:0001306 small lens,39
MP:0001307 fused cornea and lens,9
MP:0001310 abnormal conjunctiva morphology,3
MP:0001312 abnormal cornea morphology,71
MP:0001313 increased incidence of corneal inflammation,15
MP:0001314 corneal opacity,66
MP:0001316 corneal scarring,4
MP:0001317 abnormal pupil morphology,6
MP:0001319 irregularly shaped pupil,12
MP:0001320 small pupils,3
MP:0001322 abnormal iris morphology,38
MP:0001324 abnormal eye pigmentation,16
MP:0001325 abnormal retina morphology,202
MP:0001326 retinal degeneration,88
MP:0001327 decreased retinal photoreceptor cell number,24
MP:0001328 disorganized retinal layers,15
MP:0001329 retina hyperplasia,6
MP:0001330 abnormal optic nerve morphology,40
MP:0001332 abnormal optic nerve innervation,9
MP:0001333 absent optic nerve,10
MP:0001337 dry eyes,6
MP:0001340 abnormal eyelid morphology,29
MP:0001341 absent eyelids,8
MP:0001344 blepharoptosis,17
MP:0001346 abnormal lacrimal gland morphology,5
MP:0001347 absent lacrimal glands,4
MP:0001348 abnormal lacrimal gland physiology,4
MP:0001349 excessive tearing,6
MP:0001353 increased aggression towards mice,16
MP:0001354 increased aggression towards males,11
MP:0001356 increased aggression towards females,3
MP:0001360 abnormal social investigation,80
MP:0001361 social withdrawal,8
MP:0001362 abnormal anxiety-related response,19
MP:0001363 increased anxiety-related response,132
MP:0001364 decreased anxiety-related response,116
MP:0001376 abnormal mating receptivity,4
MP:0001377 abnormal mating frequency,12
MP:0001378 abnormal ejaculation,3
MP:0001379 abnormal penile erection,3
MP:0001380 reduced male mating frequency,15
MP:0001382 abnormal nursing,22
MP:0001384 abnormal pup retrieval,15
MP:0001385 pup cannibalization,13
MP:0001386 abnormal maternal nurturing,60
MP:0001388 abnormal stationary movement,17
MP:0001391 abnormal tail movements,18
MP:0001392 abnormal locomotor behavior,90
MP:0001393 ataxia,195
MP:0001394 circling,84
MP:0001395 bidirectional circling,21
MP:0001396 unidirectional circling,7
MP:0001399 hyperactivity,344
MP:0001400 hyperresponsive,5
MP:0001401 jumpy,5
MP:0001402 hypoactivity,353
MP:0001404 no spontaneous movement,24
MP:0001405 impaired coordination,332
MP:0001406 abnormal gait,302
MP:0001407 short stride length,47
MP:0001408 stereotypic behavior,19
MP:0001409 increased stereotypic behavior,20
MP:0001410 head bobbing,37
MP:0001411 spinning,7
MP:0001412 excessive scratching,12
MP:0001413 abnormal response to new environment,26
MP:0001415 increased exploration in new environment,66
MP:0001417 decreased exploration in new environment,82
MP:0001422 abnormal drinking behavior,5
MP:0001423 abnormal liquid preference,6
MP:0001426 polydipsia,27
MP:0001429 dehydration,71
MP:0001431 abnormal eating behavior,58
MP:0001432 abnormal food preference,8
MP:0001433 polyphagia,47
MP:0001435 no suckling reflex,14
MP:0001436 abnormal suckling behavior,83
MP:0001437 no swallowing reflex,3
MP:0001438 aphagia,29
MP:0001440 abnormal grooming behavior,10
MP:0001441 increased grooming behavior,36
MP:0001442 decreased grooming behavior,18
MP:0001443 poor grooming,7
MP:0001447 abnormal nest building behavior,23
MP:0001454 abnormal cued conditioning behavior,47
MP:0001458 abnormal object recognition memory,27
MP:0001460 abnormal olfactory -discrimination memory,4
MP:0001462 abnormal avoidance learning behavior,5
MP:0001463 abnormal spatial learning,162
MP:0001468 abnormal temporal memory,3
MP:0001469 abnormal contextual conditioning behavior,54
MP:0001473 reduced long term potentiation,106
MP:0001475 reduced long term depression,31
MP:0001485 abnormal pinna reflex,14
MP:0001486 abnormal startle reflex,21
MP:0001488 increased startle reflex,83
MP:0001489 decreased startle reflex,108
MP:0001491 unresponsive to tactile stimuli,19
MP:0001492 abnormal pilomotor reflex,11
MP:0001496 audiogenic seizures,13
MP:0001499 abnormal kindling response,8
MP:0001501 abnormal sleep pattern,43
MP:0001502 abnormal circadian rhythm,38
MP:0001504 abnormal posture,79
MP:0001505 hunched posture,79
MP:0001506 limp posture,6
MP:0001510 abnormal coat appearance,64
MP:0001511 disheveled coat,39
MP:0001512 trunk curl,22
MP:0001513 limb grasping,176
MP:0001515 abnormal grip strength,10
MP:0001516 abnormal motor coordination/ balance,94
MP:0001522 impaired swimming,63
MP:0001523 impaired righting response,95
MP:0001524 impaired limb coordination,53
MP:0001525 impaired balance,100
MP:0001526 abnormal placing response,12
MP:0001527 athetotic walking movements,5
MP:0001529 abnormal vocalization,39
MP:0001533 abnormal skeleton physiology,33
MP:0001539 decreased caudal vertebrae number,61
MP:0001541 abnormal osteoclast physiology,62
MP:0001544 abnormal cardiovascular system physiology,129
MP:0001545 abnormal hematopoietic system physiology,22
MP:0001547 abnormal lipid level,80
MP:0001548 hyperlipidemia,18
MP:0001552 increased circulating triglyceride level,130
MP:0001553 abnormal circulating free fatty acids level,6
MP:0001554 increased circulating free fatty acid level,62
MP:0001556 increased circulating HDL cholesterol level,90
MP:0001559 hyperglycemia,83
MP:0001560 abnormal circulating insulin level,19
MP:0001562 abnormal circulating calcium level,7
MP:0001565 abnormal circulating phosphate level,4
MP:0001566 increased circulating phosphate level,34
MP:0001570 abnormal circulating enzyme level,19
MP:0001573 abnormal circulating alanine transaminase level,6
MP:0001574 abnormal oxygen level,3
MP:0001575 cyanosis,192
MP:0001577 anemia,213
MP:0001585 hemolytic anemia,27
MP:0001586 abnormal erythrocyte cell number,7
MP:0001588 abnormal hemoglobin,15
MP:0001589 abnormal mean corpuscular hemoglobin,3
MP:0001596 hypotension,22
MP:0001601 abnormal myelopoiesis,45
MP:0001602 impaired myelopoiesis,11
MP:0001606 impaired hematopoiesis,48
MP:0001613 abnormal vasodilation,23
MP:0001614 abnormal blood vessel morphology,146
MP:0001619 abnormal vascular permeability,6
MP:0001622 abnormal vasculogenesis,43
MP:0001625 cardiac hypertrophy,95
MP:0001629 abnormal heart rate,15
MP:0001633 poor circulation,16
MP:0001634 internal hemorrhage,65
MP:0001636 irregular heartbeat,42
MP:0001648 abnormal apoptosis,49
MP:0001650 abnormal seizure response to electrical stimulation,13
MP:0001652 colonic necrosis,3
MP:0001654 hepatic necrosis,43
MP:0001655 multifocal hepatic necrosis,7
MP:0001656 focal hepatic necrosis,11
MP:0001658 increased mortality induced by gamma-irradiation,27
MP:0001661 extended life span,13
MP:0001663 abnormal digestive system physiology,47
MP:0001664 abnormal digestion,11
MP:0001665 chronic diarrhea,4
MP:0001666 abnormal intestinal absorption,12
MP:0001670 abnormal intestinal mineral absorption,3
MP:0001672 abnormal embryo development,134
MP:0001674 abnormal germ layer development,22
MP:0001675 abnormal ectoderm development,44
MP:0001676 abnormal apical ectodermal ridge morphology,14
MP:0001677 absent apical ectodermal ridge,3
MP:0001678 thick apical ectodermal ridge,3
MP:0001680 abnormal mesoderm development,54
MP:0001683 absent mesoderm,60
MP:0001684 abnormal axial mesoderm,6
MP:0001685 abnormal endoderm development,32
MP:0001688 abnormal somite development,84
MP:0001689 incomplete somite formation,38
MP:0001690 failure of somite differentiation,10
MP:0001691 abnormal somite shape,27
MP:0001693 failure of primitive streak formation,32
MP:0001694 absent egg cylinders,15
MP:0001695 abnormal gastrulation,51
MP:0001696 failure to gastrulate,45
MP:0001697 abnormal embryo size,99
MP:0001698 decreased embryo size,472
MP:0001699 increased embryo size,5
MP:0001700 abnormal embryo turning,59
MP:0001701 incomplete embryo turning,59
MP:0001704 abnormal dorsal-ventral axis patterning,19
MP:0001705 abnormal proximal-distal axis patterning,10
MP:0001706 abnormal left-right axis patterning,43
MP:0001710 absent amniotic folds,6
MP:0001711 abnormal placenta morphology,79
MP:0001712 abnormal placenta development,51
MP:0001713 decreased trophoblast giant cell number,29
MP:0001714 absent trophoblast giant cells,9
MP:0001715 placental labyrinth hypoplasia,15
MP:0001716 abnormal placenta labyrinth morphology,76
MP:0001717 absent ectoplacental cone,6
MP:0001718 abnormal visceral yolk sac morphology,80
MP:0001719 absent vitelline blood vessels,59
MP:0001721 absent visceral yolk sac blood islands,13
MP:0001722 pale yolk sac,82
MP:0001723 disorganized yolk sac vascular plexus,18
MP:0001724 abnormal extraembryonic endoderm formation,16
MP:0001726 abnormal allantois morphology,48
MP:0001727 abnormal embryo implantation,3
MP:0001728 failure of embryo implantation,23
MP:0001729 impaired embryo implantation,11
MP:0001730 embryonic growth arrest,228
MP:0001731 abnormal postnatal growth,22
MP:0001732 postnatal growth retardation,590
MP:0001739 abnormal adrenal gland secretion,14
MP:0001744 hypersecretion of corticosterone,3
MP:0001745 increased circulating corticosterone level,36
MP:0001746 abnormal pituitary secretion,8
MP:0001748 increased circulating adrenocorticotropin level,11
MP:0001750 increased circulating follicle stimulating hormone level,29
MP:0001751 increased circulating luteinizing hormone level,24
MP:0001752 abnormal hypothalamus secretion,10
MP:0001756 abnormal urination,7
MP:0001759 increased urine glucose level,19
MP:0001762 polyuria,72
MP:0001764 abnormal homeostasis,41
MP:0001765 abnormal ion homeostasis,8
MP:0001770 abnormal iron level,15
MP:0001775 abnormal selenium level,3
MP:0001777 abnormal body temperature homeostasis,25
MP:0001780 decreased brown adipose tissue amount,34
MP:0001783 decreased white adipose tissue amount,64
MP:0001784 abnormal fluid regulation,13
MP:0001785 edema,169
MP:0001786 skin edema,45
MP:0001787 pericardial edema,72
MP:0001788 periorbital edema,3
MP:0001790 abnormal immune system physiology,109
MP:0001792 impaired wound healing,31
MP:0001793 altered susceptibility to infection,16
MP:0001798 impaired macrophage phagocytosis,36
MP:0001800 abnormal humoral immune response,92
MP:0001802 arrested B cell differentiation,40
MP:0001805 decreased IgG level,100
MP:0001806 decreased IgM level,85
MP:0001807 decreased IgA level,47
MP:0001819 abnormal immune cell physiology,10
MP:0001823 thymus hypoplasia,132
MP:0001824 abnormal thymus involution,11
MP:0001825 arrested T cell differentiation,29
MP:0001828 abnormal T cell activation,62
MP:0001829 increased activated T cell number,18
MP:0001830 decreased activated T cell number,6
MP:0001835 abnormal antigen presentation,12
MP:0001837 defective assembly of class I molecules,3
MP:0001841 decreased level of surface class I molecules,8
MP:0001844 autoimmune response,26
MP:0001845 abnormal inflammatory response,66
MP:0001846 increased inflammatory response,84
MP:0001847 brain inflammation,15
MP:0001849 ear inflammation,9
MP:0001850 increased susceptibility to otitis media,24
MP:0001851 eye inflammation,18
MP:0001852 conjunctivitis,21
MP:0001853 heart inflammation,23
MP:0001855 abnormal atrial thrombosis,8
MP:0001856 myocarditis,8
MP:0001858 intestinal inflammation,17
MP:0001859 kidney inflammation,45
MP:0001860 liver inflammation,108
MP:0001861 lung inflammation,121
MP:0001862 interstitial pneumonia,11
MP:0001863 vascular inflammation,4
MP:0001864 vasculitis,8
MP:0001867 rhinitis,7
MP:0001869 pancreas inflammation,17
MP:0001870 salivary gland inflammation,26
MP:0001872 sinus inflammation,3
MP:0001873 stomach inflammation,25
MP:0001874 acanthosis,32
MP:0001876 decreased inflammatory response,78
MP:0001879 abnormal lymphatic vessel morphology,24
MP:0001881 abnormal mammary gland physiology,9
MP:0001882 abnormal lactation,29
MP:0001883 increased mammary adenocarcinoma incidence,20
MP:0001885 mammary gland duct hyperplasia,3
MP:0001889 delayed brain development,5
MP:0001890 anencephaly,19
MP:0001891 hydroencephaly,99
MP:0001893 non-obstructive hydrocephaly,5
MP:0001898 abnormal long term depression,17
MP:0001899 absent long term depression,26
MP:0001900 impaired synaptic plasticity,31
MP:0001902 reduced NMDA-mediated synaptic currents,5
MP:0001905 abnormal dopamine level,18
MP:0001906 increased dopamine level,29
MP:0001914 hemorrhage,230
MP:0001915 intracranial hemorrhage,62
MP:0001916 intracerebral hemorrhage,19
MP:0001917 intraventricular hemorrhage,14
MP:0001919 abnormal reproductive system physiology,36
MP:0001921 reduced fertility,134
MP:0001922 reduced male fertility,212
MP:0001923 reduced female fertility,227
MP:0001924 infertility,98
MP:0001925 male infertility,444
MP:0001926 female infertility,257
MP:0001927 abnormal estrous cycle,28
MP:0001928 abnormal ovulation,26
MP:0001929 abnormal gametogenesis,41
MP:0001930 abnormal meiosis,12
MP:0001931 abnormal oogenesis,18
MP:0001932 abnormal spermiogenesis,46
MP:0001934 increased litter size,8
MP:0001935 decreased litter size,272
MP:0001938 delayed sexual maturation,18
MP:0001939 secondary sex reversal,10
MP:0001940 testis hypoplasia,19
MP:0001942 abnormal lung volume,9
MP:0001943 abnormal respiration,29
MP:0001944 abnormal pancreas morphology,39
MP:0001951 abnormal breathing pattern,35
MP:0001952 increased airway responsiveness,14
MP:0001953 respiratory failure,147
MP:0001954 respiratory distress,174
MP:0001957 apnea,23
MP:0001958 emphysema,30
MP:0001961 abnormal reflex,33
MP:0001963 abnormal hearing physiology,21
MP:0001967 deafness,94
MP:0001968 abnormal touch/ nociception,14
MP:0001970 abnormal pain threshold,29
MP:0001973 increased thermal nociceptive threshold,87
MP:0001980 abnormal chemically-elicited antinociception,5
MP:0001981 increased chemically-elicited antinociception,5
MP:0001982 decreased chemically-elicited antinociception,17
MP:0001983 abnormal olfactory system physiology,12
MP:0001984 abnormal olfaction,16
MP:0001985 abnormal gustatory system physiology,4
MP:0001986 abnormal taste sensitivity,7
MP:0001987 alcohol preference,9
MP:0001999 photosensitivity,4
MP:0002001 blindness,22
MP:0002007 increased cellular sensitivity to gamma-irradiation,41
MP:0002009 preneoplasia,6
MP:0002014 increased papilloma incidence,10
MP:0002016 ovary cysts,29
MP:0002018 increased malignant tumor incidence,19
MP:0002019 abnormal tumor incidence,6
MP:0002020 increased tumor incidence,113
MP:0002021 increased incidence of induced tumors,19
MP:0002023 increased B cell derived lymphoma incidence,47
MP:0002024 increased T cell derived lymphoma incidence,46
MP:0002026 increased leukemia incidence,27
MP:0002027 increased lung adenocarcinoma incidence,41
MP:0002031 increased adrenal gland tumor incidence,3
MP:0002032 increased sarcoma incidence,43
MP:0002035 increased leiomyosarcoma incidence,3
MP:0002038 increased carcinoma incidence,31
MP:0002041 increased pituitary adenoma incidence,11
MP:0002044 increased colonic adenoma incidence,5
MP:0002047 increased hepatic hemangioma incidence,4
MP:0002048 increased lung adenoma incidence,23
MP:0002050 increased pheochromocytoma incidence,8
MP:0002051 increased skin papilloma incidence,19
MP:0002052 decreased tumor incidence,17
MP:0002053 decreased incidence of induced tumors,9
MP:0002058 neonatal lethality,28
MP:0002059 abnormal seminal vesicle morphology,46
MP:0002060 abnormal skin morphology,57
MP:0002061 abnormal aggression-related behavior,3
MP:0002062 abnormal associative learning,20
MP:0002063 abnormal learning/memory/conditioning,49
MP:0002064 seizures,110
MP:0002065 abnormal fear/anxiety-related behavior,9
MP:0002066 abnormal motor capabilities/coordination/movement,128
MP:0002067 abnormal sensory capabilities/reflexes/nociception,24
MP:0002068 abnormal parental behavior,7
MP:0002073 abnormal hair growth,47
MP:0002074 abnormal hair texture,20
MP:0002075 abnormal coat/hair pigmentation,98
MP:0002078 abnormal glucose homeostasis,172
MP:0002079 increased circulating insulin level,142
MP:0002080 prenatal lethality,66
MP:0002081 perinatal lethality,40
MP:0002082 postnatal lethality,165
MP:0002083 premature death,834
MP:0002084 abnormal developmental patterning,84
MP:0002085 abnormal embryonic tissue morphology,149
MP:0002086 abnormal extraembryonic tissue morphology,103
MP:0002088 abnormal embryonic growth/weight/body size,11
MP:0002089 abnormal postnatal growth/weight/body size,29
MP:0002090 abnormal vision,35
MP:0002092 abnormal eye morphology,132
MP:0002095 abnormal skin pigmentation,36
MP:0002098 abnormal vibrissa morphology,41
MP:0002100 abnormal tooth morphology,59
MP:0002102 abnormal ear morphology,18
MP:0002106 abnormal muscle physiology,84
MP:0002108 abnormal muscle morphology,41
MP:0002109 abnormal limb morphology,75
MP:0002110 abnormal digit morphology,69
MP:0002111 abnormal tail morphology,64
MP:0002113 abnormal skeleton development,79
MP:0002114 abnormal axial skeleton morphology,74
MP:0002115 abnormal limb bone morphology,34
MP:0002116 abnormal craniofacial bone morphology,56
MP:0002118 abnormal lipid homeostasis,121
MP:0002123 abnormal definitive hematopoiesis,94
MP:0002127 abnormal cardiovascular system morphology,45
MP:0002128 abnormal blood circulation,42
MP:0002132 abnormal respiratory system morphology,14
MP:0002133 abnormal respiratory system physiology,53
MP:0002135 abnormal kidney morphology,167
MP:0002136 abnormal kidney physiology,44
MP:0002138 abnormal hepatobiliary system morphology,6
MP:0002139 abnormal hepatobiliary system physiology,5
MP:0002144 abnormal B cell differentiation,87
MP:0002145 abnormal T cell differentiation,93
MP:0002148 abnormal hypersensitivity reaction,6
MP:0002151 abnormal neural tube morphology,159
MP:0002152 abnormal brain morphology,152
MP:0002160 abnormal reproductive system morphology,41
MP:0002161 abnormal fertility/fecundity,71
MP:0002163 abnormal gland morphology,9
MP:0002164 abnormal gland physiology,5
MP:0002166 altered tumor susceptibility,10
MP:0002169 no abnormal phenotype detected,1674
MP:0002174 abnormal gastrulation movements,7
MP:0002175 decreased brain weight,55
MP:0002176 increased brain weight,24
MP:0002177 abnormal outer ear morphology,26
MP:0002182 abnormal astrocyte morphology,38
MP:0002183 gliosis,54
MP:0002184 abnormal innervation,47
MP:0002187 abnormal fibula morphology,20
MP:0002188 small heart,44
MP:0002189 abnormal myocardial trabeculae morphology,47
MP:0002190 disorganized myocardium,30
MP:0002191 abnormal artery morphology,32
MP:0002192 hydrops fetalis,68
MP:0002194 maximal tonic hindlimb extension seizures,3
MP:0002196 absent corpus callosum,30
MP:0002199 abnormal brain commissure morphology,25
MP:0002200 abnormal brain ventricular system morphology,6
MP:0002204 abnormal neurotransmitter level,19
MP:0002206 abnormal CNS synaptic transmission,90
MP:0002207 abnormal long term potentiation,31
MP:0002208 abnormal germ cell morphology,7
MP:0002209 decreased germ cell number,18
MP:0002211 abnormal primary sex determination,10
MP:0002212 abnormal secondary sex determination,7
MP:0002216 abnormal seminiferous tubule morphology,130
MP:0002217 small lymph nodes,20
MP:0002219 decreased lymph node number,3
MP:0002221 abnormal lymph organ size,5
MP:0002223 lymphoid hypoplasia,10
MP:0002229 neurodegeneration,48
MP:0002230 abnormal primitive streak formation,23
MP:0002231 abnormal primitive streak morphology,27
MP:0002233 abnormal nose morphology,30
MP:0002236 abnormal internal nares morphology,3
MP:0002237 abnormal nasal cavity morphology,17
MP:0002238 abnormal nasal mucosa morphology,4
MP:0002239 abnormal nasal septum morphology,14
MP:0002243 abnormal vomeronasal organ morphology,6
MP:0002244 abnormal turbinate morphology,3
MP:0002247 abnormal maxillary sinus morphology,3
MP:0002249 abnormal larynx morphology,6
MP:0002251 abnormal nasopharynx morphology,4
MP:0002252 abnormal oropharynx morphology,4
MP:0002256 abnormal laryngeal cartilage morphology,8
MP:0002258 abnormal cricoid cartilage morphology,14
MP:0002260 abnormal thyroid cartilage morphology,17
MP:0002264 abnormal bronchus morphology,14
MP:0002267 abnormal bronchiole morphology,9
MP:0002269 muscular atrophy,37
MP:0002270 abnormal pulmonary alveolus morphology,103
MP:0002271 abnormal pulmonary alveolar duct morphology,5
MP:0002272 abnormal nervous system electrophysiology,85
MP:0002273 abnormal pulmonary alveolus epithelial cell morphology,11
MP:0002274 abnormal type I pneumocyte morphology,4
MP:0002275 abnormal type II pneumocyte morphology,26
MP:0002276 abnormal lung interstitium morphology,13
MP:0002277 abnormal respiratory mucosa morphology,3
MP:0002279 abnormal diaphragm morphology,31
MP:0002280 abnormal intercostal muscle morphology,11
MP:0002281 abnormal respiratory mucosa goblet cell morphology,5
MP:0002282 abnormal trachea morphology,16
MP:0002285 abnormal tracheal ciliated epithelium morphology,9
MP:0002286 cryptorchism,25
MP:0002293 long gestation period,8
MP:0002295 abnormal pulmonary circulation,7
MP:0002309 abnormal vital capacity,3
MP:0002310 decreased susceptibility to hepatic steatosis,55
MP:0002314 abnormal respiratory mechanics,10
MP:0002316 anoxia,4
MP:0002318 hypercapnia,4
MP:0002319 hyperoxia,3
MP:0002321 hypoventilation,3
MP:0002327 abnormal respiratory function,11
MP:0002329 abnormal blood gas level,5
MP:0002332 abnormal exercise endurance,3
MP:0002333 abnormal lung compliance,4
MP:0002334 abnormal airway responsiveness,9
MP:0002335 decreased airway responsiveness,17
MP:0002338 abnormal pulmonary ventilation,5
MP:0002339 abnormal lymph node morphology,41
MP:0002343 abnormal lymph node cortex morphology,5
MP:0002344 abnormal lymph node B cell domain morphology,12
MP:0002345 abnormal lymph node primary follicle morphology,6
MP:0002346 abnormal lymph node secondary follicle morphology,3
MP:0002347 abnormal lymph node T cell domain morphology,4
MP:0002351 abnormal cervical lymph node morphology,6
MP:0002356 abnormal spleen red pulp morphology,33
MP:0002357 abnormal spleen white pulp morphology,40
MP:0002358 abnormal spleen periarteriolar lymphoid sheath morphology,12
MP:0002359 abnormal spleen germinal center morphology,22
MP:0002362 abnormal spleen marginal zone morphology,27
MP:0002363 abnormal spleen marginal sinus morphology,3
MP:0002364 abnormal thymus size,3
MP:0002367 abnormal thymus lobule morphology,8
MP:0002371 abnormal thymus cortex morphology,17
MP:0002375 abnormal thymus medulla morphology,16
MP:0002376 abnormal dendritic cell physiology,93
MP:0002378 abnormal gut-associated lymphoid tissue morphology,8
MP:0002389 abnormal Peyer's patch follicle morphology,11
MP:0002391 abnormal Peyer's patch germinal center morphology,16
MP:0002392 abnormal Peyer's patch T cell area morphology,6
MP:0002396 abnormal hematopoietic system morphology/development,28
MP:0002397 abnormal bone marrow morphology,36
MP:0002398 abnormal bone marrow cell morphology/development,60
MP:0002399 abnormal pluripotent precursor cell morphology,4
MP:0002401 abnormal lymphopoiesis,41
MP:0002403 abnormal pre-B cell morphology,5
MP:0002404 increased intestinal adenoma incidence,16
MP:0002405 respiratory system inflammation,14
MP:0002406 increased susceptibility to infection,17
MP:0002407 abnormal double-negative T cell morphology,23
MP:0002408 abnormal double-positive T cell morphology,20
MP:0002410 decreased susceptibility to viral infection,39
MP:0002411 decreased susceptibility to bacterial infection,56
MP:0002412 increased susceptibility to bacterial infection,192
MP:0002413 abnormal megakaryocyte progenitor cell morphology,20
MP:0002414 abnormal myeloblast morphology/development,9
MP:0002415 abnormal neutrophil differentiation,8
MP:0002416 abnormal proerythroblast morphology,28
MP:0002417 abnormal megakaryocyte morphology,28
MP:0002418 increased susceptibility to viral infection,88
MP:0002419 abnormal innate immunity,12
MP:0002420 abnormal adaptive immunity,13
MP:0002421 abnormal cell-mediated immunity,16
MP:0002423 abnormal mast cell physiology,38
MP:0002424 abnormal reticulocyte morphology,10
MP:0002425 altered susceptibility to autoimmune disorder,3
MP:0002427 disproportionate dwarf,46
MP:0002428 abnormal semicircular canal morphology,29
MP:0002429 abnormal blood cell morphology/development,21
"MP:0002432 abnormal CD4-positive, alpha beta T cell morphology",28
MP:0002433 abnormal T-helper 1 cell morphology,6
MP:0002434 abnormal T-helper 2 cell morphology,5
MP:0002435 abnormal effector T cell morphology,7
"MP:0002436 abnormal CD8-positive, alpha-beta cytotoxic T cell morphology",6
MP:0002439 abnormal plasma cell morphology,7
MP:0002441 abnormal granulocyte morphology,10
MP:0002442 abnormal leukocyte physiology,45
MP:0002444 abnormal T cell physiology,104
MP:0002446 abnormal macrophage morphology,26
MP:0002447 abnormal erythrocyte morphology,81
MP:0002450 abnormal lymph organ development,9
MP:0002451 abnormal macrophage physiology,161
MP:0002452 abnormal professional antigen presenting cell physiology,12
MP:0002455 abnormal dendritic cell antigen presentation,28
MP:0002458 abnormal B cell number,25
MP:0002459 abnormal B cell physiology,91
MP:0002460 decreased immunoglobulin level,48
MP:0002461 increased immunoglobulin level,35
MP:0002462 abnormal granulocyte physiology,9
MP:0002463 abnormal neutrophil physiology,89
MP:0002465 abnormal eosinophil physiology,9
MP:0002467 impaired neutrophil phagocytosis,11
MP:0002471 abnormal complement pathway,8
MP:0002472 impaired complement alternative pathway,6
MP:0002473 impaired complement classical pathway,5
MP:0002490 abnormal immunoglobulin level,50
MP:0002491 decreased IgD level,4
MP:0002492 decreased IgE level,50
MP:0002493 increased IgG level,56
MP:0002494 increased IgM level,91
MP:0002495 increased IgA level,52
MP:0002497 increased IgE level,58
MP:0002498 abnormal acute inflammation,8
MP:0002499 chronic inflammation,21
MP:0002500 granulomatous inflammation,22
MP:0002503 abnormal histamine physiology,4
MP:0002531 abnormal type I hypersensitivity reaction,4
MP:0002534 abnormal type IV hypersensitivity reaction,6
MP:0002543 brachyphalangia,17
MP:0002544 brachydactyly,25
MP:0002546 mydriasis,18
MP:0002551 abnormal blood coagulation,63
MP:0002557 abnormal social/conspecific interaction,28
MP:0002558 abnormal circadian period,3
MP:0002560 arrhythmic circadian persistence,8
MP:0002561 abnormal circadian phase,13
MP:0002562 prolonged circadian period,7
MP:0002563 shortened circadian period,20
MP:0002564 advanced circadian phase,6
MP:0002565 delayed circadian phase,8
MP:0002566 abnormal sexual interaction,45
MP:0002570 alcohol aversion,6
MP:0002572 abnormal emotion/affect behavior,24
MP:0002573 behavioral despair,27
MP:0002574 increased vertical activity,66
MP:0002575 increased circulating ketone body level,29
MP:0002576 abnormal enamel morphology,19
MP:0002577 reduced enamel thickness,8
MP:0002578 impaired ability to fire action potentials,10
MP:0002579 disorganized secondary lens fibers,8
MP:0002581 abnormal ileum morphology,9
MP:0002582 disorganized extraembryonic tissue,19
MP:0002583 absent extraembryonic ectoderm,7
MP:0002584 small ectoplacental cone,12
MP:0002590 increased mean corpuscular volume,114
MP:0002591 decreased mean corpuscular volume,89
MP:0002594 low mean erythrocyte cell number,11
MP:0002599 increased mean platelet volume,34
MP:0002606 increased basophil cell number,8
MP:0002607 decreased basophil cell number,16
MP:0002608 increased hematocrit,63
MP:0002619 abnormal lymphocyte morphology,32
MP:0002620 abnormal monocyte morphology,6
MP:0002621 delayed neural tube closure,25
MP:0002622 abnormal cochlear hair cell morphology,29
MP:0002623 abnormal vestibular hair cell morphology,5
MP:0002624 abnormal tricuspid valve morphology,11
MP:0002625 heart left ventricle hypertrophy,54
MP:0002626 increased heart rate,59
MP:0002627 increased teratoma incidence,3
MP:0002628 hepatic steatosis,168
MP:0002629 hyperactivity elicited by ethanol administration,4
MP:0002631 abnormal epididymis morphology,61
MP:0002632 vestigial tail,6
MP:0002633 persistent truncus arteriosis,46
MP:0002635 reduced sensorimotor gating,8
MP:0002636 delayed vaginal opening,17
MP:0002637 small uterus,23
MP:0002638 abnormal pupillary reflex,6
MP:0002639 micrognathia,55
MP:0002640 reticulocytosis,72
MP:0002641 anisopoikilocytosis,19
MP:0002642 anisocytosis,41
MP:0002643 poikilocytosis,29
MP:0002644 decreased circulating triglyceride level,169
MP:0002647 decreased intestinal cholesterol absorption,9
MP:0002649 abnormal enamel rod pattern,4
MP:0002650 abnormal ameloblast morphology,11
MP:0002651 abnormal sciatic nerve morphology,31
MP:0002652 thin myocardium,72
MP:0002653 abnormal ependyma morphology,3
MP:0002654 spongiform encephalopathy,13
MP:0002655 abnormal keratinocyte morphology,20
MP:0002656 abnormal keratinocyte differentiation,28
MP:0002657 chondrodystrophy,14
MP:0002658 abnormal liver regeneration,4
MP:0002659 pituitary gland hypoplasia,7
MP:0002660 abnormal caput epididymis morphology,9
MP:0002661 abnormal corpus epididymis morphology,3
MP:0002662 abnormal cauda epididymis morphology,9
MP:0002663 absent blastocoele,24
MP:0002664 decreased circulating adrenocorticotropin level,10
MP:0002665 decreased circulating corticosterone level,32
MP:0002666 increased circulating aldosterone level,21
MP:0002667 decreased circulating aldosterone level,12
MP:0002670 absent scrotum,3
MP:0002672 abnormal pharyngeal arch artery morphology,20
MP:0002673 abnormal sperm number,14
MP:0002674 abnormal sperm motility,21
MP:0002675 asthenozoospermia,119
MP:0002679 abnormal corpus luteum morphology,13
MP:0002680 decreased corpora lutea number,21
MP:0002682 decreased mature ovarian follicle number,26
MP:0002685 abnormal spermatogonia proliferation,16
MP:0002686 globozoospermia,23
MP:0002687 oligozoospermia,168
MP:0002689 abnormal molar morphology,23
MP:0002690 akinesia,15
MP:0002691 small stomach,18
MP:0002693 abnormal pancreas physiology,17
MP:0002694 abnormal pancreas secretion,7
MP:0002696 decreased circulating glucagon level,15
MP:0002697 abnormal eye size,18
MP:0002698 abnormal sclera morphology,6
MP:0002699 abnormal vitreous body morphology,20
MP:0002700 opacity of vitreous body,3
MP:0002702 decreased circulating free fatty acid level,81
MP:0002703 abnormal renal tubule morphology,52
MP:0002704 tubular nephritis,5
MP:0002705 dilated renal tubules,72
MP:0002708 nephrolithiasis,3
MP:0002710 increased glucagon secretion,7
MP:0002711 decreased glucagon secretion,8
MP:0002712 increased circulating glucagon level,16
MP:0002715 decreased glycogen catabolism rate,5
MP:0002716 small male preputial glands,6
MP:0002717 abnormal male preputial gland morphology,5
MP:0002718 abnormal inner cell mass morphology,38
MP:0002722 abnormal immune system organ morphology,59
MP:0002723 abnormal immune serum protein physiology,16
MP:0002724 enhanced wound healing,20
MP:0002725 abnormal vein morphology,15
MP:0002726 abnormal pulmonary vein morphology,4
MP:0002727 decreased circulating insulin level,240
MP:0002728 absent tibia,5
MP:0002729 abnormal inner ear canal morphology,5
MP:0002730 head shaking,19
MP:0002731 megacolon,13
MP:0002733 abnormal thermal nociception,14
MP:0002734 abnormal mechanical nociception,18
MP:0002735 abnormal chemical nociception,6
MP:0002736 abnormal nociception after inflammation,36
MP:0002738 hyperresponsive to tactile stimuli,10
MP:0002739 abnormal olfactory bulb development,16
MP:0002740 heart hypoplasia,16
MP:0002741 small olfactory bulb,39
MP:0002742 enlarged submandibular lymph nodes,3
MP:0002743 glomerulonephritis,77
MP:0002745 abnormal atrioventricular valve morphology,13
MP:0002746 abnormal semilunar valve morphology,19
MP:0002747 abnormal aortic valve morphology,17
MP:0002748 abnormal pulmonary valve morphology,8
MP:0002750 exophthalmos,11
MP:0002752 abnormal somatic nervous system morphology,14
MP:0002753 dilated heart left ventricle,71
MP:0002754 dilated heart right ventricle,42
MP:0002757 decreased vertical activity,127
MP:0002758 long tail,3
MP:0002759 abnormal caudal vertebrae morphology,29
MP:0002761 abnormal hippocampal mossy fiber morphology,24
MP:0002762 ectopic cerebellar granule cells,12
MP:0002764 short tibia,137
MP:0002765 short fibula,18
MP:0002766 situs inversus,25
MP:0002767 situs ambiguus,5
MP:0002768 small adrenal glands,25
MP:0002769 abnormal vas deferens morphology,12
MP:0002772 brachypodia,4
MP:0002773 decreased circulating luteinizing hormone level,17
MP:0002774 small prostate gland,10
MP:0002776 Sertoli cell hyperplasia,4
MP:0002777 absent ovarian follicles,33
MP:0002780 decreased circulating testosterone level,43
MP:0002781 increased circulating testosterone level,19
MP:0002782 abnormal testes secretion,10
MP:0002783 abnormal ovarian secretion,6
MP:0002784 abnormal Sertoli cell morphology,44
MP:0002785 absent Leydig cells,3
MP:0002786 abnormal Leydig cell morphology,11
MP:0002789 male pseudohermaphroditism,5
MP:0002790 decreased circulating follicle stimulating hormone level,22
MP:0002791 steatorrhea,5
MP:0002792 abnormal retinal vasculature morphology,76
MP:0002795 dilated cardiomyopathy,44
MP:0002796 impaired skin barrier function,51
MP:0002797 increased thigmotaxis,42
MP:0002798 abnormal active avoidance behavior,9
MP:0002799 abnormal passive avoidance behavior,14
MP:0002800 abnormal short term object recognition memory,7
MP:0002801 abnormal long term object recognition memory,29
MP:0002802 abnormal discrimination learning,8
MP:0002803 abnormal operant conditioning behavior,9
MP:0002804 abnormal motor learning,40
MP:0002805 abnormal conditioned taste aversion behavior,16
MP:0002807 abnormal eye blink conditioning behavior,8
MP:0002809 increased spinal cord size,3
MP:0002810 microcytic anemia,17
MP:0002811 macrocytic anemia,10
MP:0002812 spherocytosis,13
MP:0002813 microcytosis,20
MP:0002814 hyperchromasia,4
MP:0002816 colitis,29
MP:0002817 abnormal tooth mineralization,8
MP:0002818 abnormal dentin morphology,18
MP:0002819 abnormal pulp cavity morphology,5
MP:0002820 abnormal premaxilla morphology,11
MP:0002822 catalepsy,6
MP:0002823 abnormal rib development,15
MP:0002824 abnormal chorioallantoic fusion,12
MP:0002825 abnormal notochord morphology,32
MP:0002826 tonic seizures,22
MP:0002828 abnormal renal glomerular capsule morphology,12
MP:0002829 abnormal juxtaglomerular apparatus morphology,5
MP:0002830 gallstones,9
MP:0002831 absent Peyer's patches,19
MP:0002832 coarse hair,7
MP:0002833 increased heart weight,132
MP:0002834 decreased heart weight,76
MP:0002835 abnormal cranial suture morphology,28
MP:0002836 abnormal chorion morphology,21
MP:0002837 dystrophic cardiac calcinosis,11
MP:0002840 abnormal lens fiber morphology,36
MP:0002841 impaired skeletal muscle contractility,32
MP:0002842 increased systemic arterial blood pressure,44
MP:0002843 decreased systemic arterial blood pressure,33
MP:0002844 aortic hypertrophy,3
MP:0002855 abnormal cochlear ganglion morphology,23
MP:0002856 abnormal vestibular ganglion morphology,11
MP:0002857 cochlear ganglion degeneration,53
MP:0002858 abnormal posterior semicircular canal morphology,6
MP:0002861 abnormal tail bud morphology,12
MP:0002862 altered righting response,14
MP:0002863 improved righting response,4
MP:0002864 abnormal ocular fundus morphology,22
MP:0002865 increased growth rate,11
MP:0002869 increased anti-insulin autoantibody level,3
MP:0002871 albuminuria,40
MP:0002872 polycythemia,9
MP:0002874 decreased hemoglobin content,137
MP:0002875 decreased erythrocyte cell number,153
MP:0002876 abnormal thyroid physiology,7
MP:0002877 abnormal melanocyte morphology,5
MP:0002878 abnormal corticospinal tract morphology,10
MP:0002880 opisthotonus,4
MP:0002882 abnormal neuron morphology,90
MP:0002883 chromatolysis,4
MP:0002884 abnormal pharyngeal arch morphology,34
MP:0002885 abnormal AMPA-mediated synaptic currents,10
MP:0002886 abnormal glutamate-mediated receptor currents,15
MP:0002887 decreased susceptibility to pharmacologically induced seizures,25
MP:0002888 abnormal NMDA-mediated synaptic currents,8
MP:0002891 increased insulin sensitivity,130
MP:0002892 decreased superior colliculus size,4
MP:0002893 ketoaciduria,9
MP:0002894 abnormal otolith morphology,13
MP:0002895 abnormal otolithic membrane morphology,6
MP:0002896 abnormal bone mineralization,115
MP:0002899 fatigue,10
MP:0002901 increased urine phosphate level,11
MP:0002904 increased circulating parathyroid hormone level,12
MP:0002905 decreased circulating parathyroid hormone level,9
MP:0002906 increased susceptibility to pharmacologically induced seizures,90
MP:0002907 abnormal parturition,7
MP:0002908 delayed wound healing,44
MP:0002909 abnormal adrenal gland physiology,6
MP:0002910 abnormal excitatory postsynaptic currents,73
MP:0002911 abnormal inhibitory postsynaptic potential,6
MP:0002912 abnormal excitatory postsynaptic potential,72
MP:0002913 abnormal PNS synaptic transmission,9
MP:0002914 abnormal endplate potential,14
MP:0002915 abnormal synaptic depression,3
MP:0002916 increased synaptic depression,12
MP:0002917 decreased synaptic depression,11
MP:0002918 abnormal paired-pulse facilitation,3
MP:0002919 enhanced paired-pulse facilitation,26
MP:0002920 decreased paired-pulse facilitation,17
MP:0002922 decreased post-tetanic potentiation,10
MP:0002923 increased post-tetanic potentiation,5
MP:0002925 abnormal cardiovascular development,21
MP:0002926 aganglionic megacolon,5
MP:0002928 abnormal bile duct morphology,14
MP:0002929 abnormal bile duct development,10
MP:0002932 abnormal joint morphology,55
MP:0002933 joint inflammation,11
MP:0002936 joint swelling,7
MP:0002938 white spotting,14
MP:0002939 head spot,7
MP:0002940 variable body spotting,10
MP:0002941 increased circulating alanine transaminase level,68
MP:0002942 decreased circulating alanine transaminase level,69
MP:0002944 increased lactate dehydrogenase level,12
MP:0002945 abnormal inhibitory postsynaptic currents,59
MP:0002946 delayed axon extension,3
MP:0002947 increased hemangioma incidence,11
MP:0002948 abnormal neuron specification,9
MP:0002950 abnormal neural crest cell migration,16
MP:0002951 small thyroid gland,7
MP:0002952 ventricular cardiomyopathy,3
MP:0002953 thick ventricular wall,39
MP:0002957 increased intestinal adenocarcinoma incidence,15
MP:0002958 cerebral aqueductal stenosis,4
MP:0002959 increased urine microalbumin level,4
MP:0002961 abnormal axon guidance,42
MP:0002962 increased urine protein level,74
MP:0002963 decreased urine protein level,3
MP:0002965 increased circulating serum albumin level,24
MP:0002966 decreased circulating alkaline phosphatase level,49
MP:0002968 increased circulating alkaline phosphatase level,150
MP:0002969 impaired social transmission of food preference,10
MP:0002970 abnormal white adipose tissue morphology,12
MP:0002971 abnormal brown adipose tissue morphology,29
MP:0002972 abnormal cardiac muscle contractility,24
MP:0002975 vascular smooth muscle hypertrophy,7
MP:0002978 absent otoliths,13
MP:0002980 abnormal postural reflex,8
MP:0002981 increased liver weight,86
MP:0002982 abnormal primordial germ cell migration,9
MP:0002983 increased retinal ganglion cell number,6
MP:0002984 retina hypoplasia,5
MP:0002986 decreased urine calcium level,7
MP:0002987 abnormal urine osmolality,4
MP:0002988 decreased urine osmolality,46
MP:0002989 small kidney,82
MP:0002990 short ureter,7
MP:0002991 abnormal sebaceous gland physiology,3
MP:0002992 abnormal sebaceous lipid secretion,4
MP:0002993 arthritis,14
MP:0002995 primary sex reversal,8
MP:0002996 ovotestis,3
MP:0002997 enlarged seminal vesicle,3
MP:0002998 abnormal bone remodeling,32
MP:0002999 abnormal bone healing,8
MP:0003005 abnormal hippocampal fimbria morphology,5
MP:0003007 ectopic thymus,5
MP:0003008 enhanced long term potentiation,51
MP:0003009 abnormal cytokine secretion,130
MP:0003010 decreased mortality induced by ionizing radiation,6
MP:0003011 delayed dark adaptation,8
MP:0003014 abnormal kidney medulla morphology,12
MP:0003017 decreased circulating bicarbonate level,8
MP:0003019 increased circulating chloride level,46
MP:0003020 decreased circulating chloride level,29
MP:0003023 decreased coronary flow rate,3
MP:0003025 increased vasoconstriction,18
MP:0003026 decreased vasoconstriction,17
MP:0003027 abnormal blood pH regulation,3
MP:0003028 alkalosis,4
MP:0003030 acidemia,5
MP:0003031 acidosis,17
MP:0003036 vertebral transformation,44
MP:0003037 increased myocardial infarction size,21
MP:0003038 decreased myocardial infarction size,19
MP:0003043 hypoalgesia,18
MP:0003044 impaired basement membrane formation,9
MP:0003046 liver cirrhosis,5
MP:0003047 abnormal thoracic vertebrae morphology,54
MP:0003048 abnormal cervical vertebrae morphology,50
MP:0003049 abnormal lumbar vertebrae morphology,28
MP:0003050 abnormal sacral vertebrae morphology,22
MP:0003051 curly tail,46
MP:0003052 omphalocele,43
MP:0003053 delayed tooth eruption,5
MP:0003054 spina bifida,43
MP:0003055 abnormal long bone epiphyseal plate morphology,58
MP:0003056 abnormal hyoid bone morphology,18
MP:0003057 abnormal epicardium morphology,15
MP:0003058 increased insulin secretion,35
MP:0003059 decreased insulin secretion,84
MP:0003060 increased aerobic running capacity,3
MP:0003061 decreased aerobic running capacity,7
MP:0003062 abnormal coping response,11
MP:0003063 increased coping response,21
MP:0003064 decreased coping response,12
MP:0003068 enlarged kidney,49
MP:0003069 abnormal superior semicircular canal morphology,6
MP:0003070 increased vascular permeability,37
MP:0003071 decreased vascular permeability,13
MP:0003072 abnormal metatarsal bone morphology,19
MP:0003073 abnormal metacarpal bone morphology,19
MP:0003075 altered response to CNS ischemic injury,7
MP:0003076 increased susceptibility to ischemic brain injury,15
MP:0003077 abnormal cell cycle,105
MP:0003078 aphakia,16
MP:0003080 increased natural killer cell mediated cytotoxicity,4
MP:0003081 abnormal soleus morphology,13
MP:0003082 abnormal gastrocnemius morphology,10
MP:0003083 abnormal tibialis anterior morphology,8
MP:0003084 abnormal skeletal muscle fiber morphology,66
MP:0003085 abnormal egg cylinder morphology,23
MP:0003087 absent allantois,19
MP:0003088 abnormal prepulse inhibition,12
MP:0003089 decreased skin tensile strength,18
MP:0003090 abnormal muscle precursor cell migration,7
MP:0003091 abnormal cell migration,41
MP:0003092 decreased corneal stroma thickness,7
MP:0003098 decreased tendon stiffness,4
MP:0003099 retinal detachment,10
MP:0003103 liver degeneration,20
MP:0003104 acrania,10
MP:0003105 abnormal heart atrium morphology,30
MP:0003107 abnormal response to novelty,17
MP:0003108 short zygomatic bone,3
MP:0003109 short femur,87
MP:0003110 absent malleus processus brevis,4
MP:0003111 abnormal cell nucleus morphology,42
MP:0003112 enlarged parathyroid gland,4
MP:0003116 rickets,9
MP:0003119 abnormal digestive system development,18
MP:0003120 abnormal tracheal cartilage morphology,21
MP:0003121 genetic imprinting,8
MP:0003122 maternal imprinting,20
MP:0003123 paternal imprinting,14
MP:0003124 hypospadia,7
MP:0003125 abnormal septation of the cloaca,3
MP:0003126 abnormal external female genitalia morphology,3
MP:0003130 anal atresia,11
MP:0003131 increased erythrocyte cell number,57
MP:0003132 increased pre-B cell number,25
MP:0003135 increased erythroid progenitor cell number,42
MP:0003136 yellow coat color,8
MP:0003137 abnormal impulse conducting system conduction,20
MP:0003138 absent tympanic ring,8
MP:0003139 patent ductus arteriosus,11
MP:0003140 dilated heart atrium,32
MP:0003141 cardiac fibrosis,81
MP:0003143 enlarged otoliths,8
MP:0003144 decreased otolith number,5
MP:0003146 absent cochlear ganglion,4
MP:0003147 absent cochlea,5
MP:0003148 decreased cochlear coiling,15
MP:0003149 abnormal tectorial membrane morphology,25
MP:0003150 detached tectorial membrane,5
MP:0003151 absent tunnel of Corti,5
MP:0003153 early eyelid opening,7
MP:0003154 abnormal soft palate morphology,7
MP:0003155 abnormal telomere length,10
MP:0003156 abnormal leukocyte migration,46
MP:0003157 impaired muscle relaxation,15
MP:0003159 abnormal esophageal smooth muscle morphology,4
MP:0003160 abnormal esophagus development,4
MP:0003161 absent lateral semicircular canal,12
MP:0003162 decreased lateral semicircular canal size,6
MP:0003163 absent posterior semicircular canal,8
MP:0003164 decreased posterior semicircular canal size,5
MP:0003165 absent superior semicircular canal,4
MP:0003168 abnormal scala vestibuli morphology,3
MP:0003169 abnormal scala media morphology,8
MP:0003171 phenotypic reversion,5
MP:0003172 abnormal lysosome physiology,16
MP:0003174 increased lysosomal enzyme secretion,3
MP:0003177 allodynia,10
MP:0003178 left pulmonary isomerism,19
MP:0003179 thrombocytopenia,133
MP:0003186 abnormal redox activity,13
MP:0003189 fused joints,10
MP:0003191 abnormal cellular cholesterol metabolism,5
MP:0003193 decreased cholesterol efflux,6
MP:0003194 abnormal frequency of paradoxical sleep,10
MP:0003195 calcinosis,6
MP:0003196 calcified skin,3
MP:0003197 nephrocalcinosis,15
MP:0003199 calcified muscle,7
MP:0003200 calcified joint,5
MP:0003201 extremity edema,5
MP:0003202 abnormal neuron apoptosis,7
MP:0003203 increased neuron apoptosis,77
MP:0003204 decreased neuron apoptosis,35
MP:0003205 testicular atrophy,45
MP:0003207 decreased cellular sensitivity to gamma-irradiation,17
MP:0003209 abnormal pulmonary elastic fiber morphology,15
MP:0003211 abnormal aorta elastic fiber morphology,11
MP:0003212 increased susceptibility to age related obesity,22
MP:0003213 decreased susceptibility to age related obesity,7
MP:0003215 renal interstitial fibrosis,37
MP:0003216 absence seizures,14
MP:0003222 increased cardiomyocyte apoptosis,32
MP:0003223 decreased cardiomyocyte apoptosis,6
MP:0003224 neuron degeneration,41
MP:0003225 axonal dystrophy,14
MP:0003227 abnormal vascular branching morphogenesis,22
MP:0003228 abnormal sinus venosus morphology,6
MP:0003229 abnormal vitelline vasculature morphology,117
MP:0003230 abnormal umbilical artery morphology,6
MP:0003231 abnormal placenta vasculature,51
MP:0003232 abnormal forebrain development,70
MP:0003233 prolonged QT interval,21
MP:0003234 enhanced NMDA-mediated synaptic currents,3
MP:0003235 abnormal alisphenoid bone morphology,11
MP:0003236 abnormal lens capsule morphology,8
MP:0003237 abnormal lens epithelium morphology,18
MP:0003240 loss of hippocampal neurons,5
MP:0003241 loss of cortex neurons,9
MP:0003243 abnormal dopaminergic neuron morphology,10
MP:0003244 loss of dopaminergic neurons,9
MP:0003245 abnormal GABAergic neuron morphology,11
MP:0003246 loss of GABAergic neurons,8
MP:0003247 abnormal glutaminergic neuron morphology,5
MP:0003253 dilated bile duct,6
MP:0003254 bile duct inflammation,5
MP:0003255 bile duct proliferation,3
MP:0003257 abnormal abdominal wall morphology,9
MP:0003266 biliary cyst,4
MP:0003269 colon polyps,7
MP:0003270 intestinal obstruction,13
MP:0003271 abnormal duodenum morphology,16
MP:0003276 esophageal atresia,5
MP:0003279 aneurysm,9
MP:0003280 urinary incontinence,7
MP:0003282 gastric ulcer,4
MP:0003283 abnormal digestive organ placement,3
MP:0003288 intestinal edema,9
MP:0003289 abnormal intestinal peristalsis,5
MP:0003290 intestinal hypoperistalsis,9
MP:0003292 melena,3
MP:0003293 rectal hemorrhage,10
MP:0003299 gastric polyps,4
MP:0003300 gastrointestinal ulcer,3
MP:0003303 peritoneal inflammation,9
MP:0003304 large intestinal inflammation,14
MP:0003306 small intestinal inflammation,10
MP:0003307 pyloric stenosis,3
MP:0003308 abnormal cochlear sensory epithelium morphology,22
MP:0003311 aminoaciduria,16
MP:0003312 abnormal locomotor coordination,32
MP:0003313 abnormal locomotor activation,86
MP:0003315 abnormal perineum morphology,6
MP:0003321 tracheoesophageal fistula,12
MP:0003324 increased liver adenoma incidence,18
MP:0003325 decreased liver function,5
MP:0003326 liver failure,6
MP:0003327 liver cysts,6
MP:0003329 amyloid beta deposits,13
MP:0003330 abnormal auditory tube,3
MP:0003331 increased hepatocellular carcinoma incidence,57
MP:0003332 liver abscess,3
MP:0003333 liver fibrosis,42
MP:0003334 pancreas fibrosis,5
MP:0003335 exocrine pancreatic insufficiency,3
MP:0003336 pancreas cysts,8
MP:0003339 decreased pancreatic beta cell number,30
MP:0003342 accessory spleen,3
MP:0003345 decreased rib number,81
MP:0003351 decreased circulating levels of thyroid hormone,3
MP:0003352 increased circulating renin level,17
MP:0003353 decreased circulating renin level,6
MP:0003354 astrocytosis,68
MP:0003355 decreased ovulation rate,22
MP:0003356 impaired luteinization,10
MP:0003357 impaired granulosa cell differentiation,5
MP:0003358 abnormal hypaxial muscle morphology,8
MP:0003360 abnormal depression-related behavior,30
MP:0003378 early sexual maturation,5
MP:0003381 vitreal fibroplasia,3
MP:0003382 straub tail,28
MP:0003383 abnormal gluconeogenesis,44
MP:0003384 abnormal ventral body wall morphology,15
MP:0003385 abnormal body wall morphology,15
MP:0003387 aorta coarctation,3
MP:0003390 lymphedema,9
MP:0003393 decreased cardiac output,19
MP:0003394 increased cardiac output,7
MP:0003396 abnormal embryonic hematopoiesis,31
MP:0003397 increased muscle weight,4
MP:0003400 kinked neural tube,51
MP:0003402 decreased liver weight,72
MP:0003403 absent placental labyrinth,20
MP:0003404 absent enamel,6
MP:0003405 abnormal platelet shape,3
MP:0003406 failure of zygotic cell division,14
MP:0003407 abnormal central nervous system regeneration,8
MP:0003408 increased width of hypertrophic chondrocyte zone,33
MP:0003409 decreased width of hypertrophic chondrocyte zone,35
MP:0003410 abnormal artery development,8
MP:0003412 abnormal afterhyperpolarization,10
MP:0003413 hair follicle degeneration,7
MP:0003414 epidermal cyst,4
MP:0003415 priapism,8
MP:0003416 premature bone ossification,8
MP:0003417 premature endochondral bone ossification,4
MP:0003419 delayed endochondral bone ossification,42
MP:0003420 delayed intramembranous bone ossification,16
MP:0003421 abnormal thyroid gland development,6
MP:0003422 abnormal thrombolysis,3
MP:0003424 premature neuronal precursor differentiation,7
MP:0003425 abnormal optic vesicle formation,19
MP:0003426 pulmonary interstitial fibrosis,7
MP:0003427 parakeratosis,18
MP:0003432 increased activity of parathyroid,4
MP:0003434 decreased susceptibility to induced choroidal neovascularization,8
MP:0003436 decreased susceptibility to induced arthritis,48
MP:0003441 increased glycerol level,5
MP:0003442 decreased circulating glycerol level,23
MP:0003443 increased circulating glycerol level,16
MP:0003444 abnormal neurotransmitter uptake,6
MP:0003445 sirenomelia,4
MP:0003446 renal hypoplasia,35
MP:0003447 decreased tumor growth/size,49
MP:0003448 abnormal tumor morphology,20
MP:0003449 abnormal intestinal goblet cell morphology,31
MP:0003450 enlarged pancreas,5
MP:0003451 absent olfactory bulb,11
MP:0003453 abnormal keratinocyte physiology,23
MP:0003454 erythroderma,3
MP:0003456 absent tail,10
MP:0003458 decreased circulating ketone body level,10
MP:0003459 increased fear-related response,11
MP:0003460 decreased fear-related response,8
MP:0003461 abnormal response to novel object,47
MP:0003462 abnormal response to novel odor,6
MP:0003463 abnormal single cell response,25
MP:0003477 abnormal nerve fiber response,10
MP:0003484 abnormal channel response,20
MP:0003488 decreased channel response intensity,3
MP:0003491 abnormal voluntary movement,14
MP:0003492 abnormal involuntary movement,16
MP:0003494 parathyroid hypoplasia,3
MP:0003496 increased thyroid adenoma incidence,4
MP:0003498 thyroid gland hyperplasia,3
MP:0003499 thyroid hypoplasia,4
MP:0003503 decreased activity of thyroid,15
MP:0003507 abnormal ovary physiology,8
MP:0003529 enlarged clitoris,3
MP:0003537 hydrometrocolpos,3
MP:0003542 abnormal vascular endothelial cell development,11
MP:0003543 abnormal vascular endothelial cell differentiation,4
MP:0003544 abnormal vascular endothelial cell migration,12
MP:0003545 increased alcohol consumption,13
MP:0003546 decreased alcohol consumption,12
MP:0003548 pulmonary hypertension,11
MP:0003550 short perineum,5
MP:0003557 absent vas deferens,4
MP:0003558 absent uterus,4
MP:0003560 osteoarthritis,18
MP:0003561 rheumatoid arthritis,4
MP:0003562 abnormal pancreatic beta cell physiology,33
MP:0003564 abnormal insulin secretion,11
MP:0003566 abnormal cell adhesion,49
MP:0003567 abnormal fetal cardiomyocyte proliferation,26
MP:0003572 abnormal uterus development,13
MP:0003578 absent ovary,11
MP:0003582 abnormal ovary development,6
MP:0003584 bifid ureter,3
MP:0003585 large ureter,4
MP:0003586 dilated ureter,9
MP:0003587 ureter obstruction,5
MP:0003596 epididymal inflammation,4
MP:0003604 single kidney,33
MP:0003605 fused kidneys,3
MP:0003606 kidney failure,39
MP:0003607 abnormal prostate gland physiology,6
MP:0003608 prostate gland inflammation,4
MP:0003620 oliguria,18
MP:0003622 ischuria,3
MP:0003624 anuria,6
MP:0003627 abnormal leukocyte tethering or rolling,5
MP:0003628 abnormal leukocyte adhesion,38
MP:0003630 abnormal urothelium morphology,3
MP:0003632 abnormal nervous system morphology,73
MP:0003633 abnormal nervous system physiology,106
MP:0003634 abnormal glial cell morphology,13
MP:0003635 abnormal synaptic transmission,27
MP:0003637 cochlear ganglion hypoplasia,8
MP:0003638 abnormal response/metabolism to endogenous compounds,77
MP:0003639 abnormal response to vitamins,3
MP:0003641 small lung,50
MP:0003642 absent seminal vesicle,9
MP:0003643 spleen atrophy,17
MP:0003644 thymus atrophy,39
MP:0003645 increased pancreatic beta cell number,16
MP:0003646 muscle fatigue,11
MP:0003648 abnormal radial glial cell morphology,10
MP:0003649 decreased heart right ventricle size,6
MP:0003651 abnormal axon extension,48
MP:0003653 decreased skin turgor,4
MP:0003655 absent pancreas,4
MP:0003656 abnormal erythrocyte physiology,21
MP:0003657 abnormal erythrocyte osmotic lysis,28
MP:0003658 abnormal capillary morphology,30
MP:0003659 abnormal lymph circulation,10
MP:0003660 chylothorax,3
MP:0003661 abnormal locus ceruleus morphology,5
MP:0003662 abnormal long bone epiphyseal plate proliferative zone,50
MP:0003663 abnormal thermosensation,7
MP:0003666 impaired sperm capacitation,9
MP:0003667 increased hemangiosarcoma incidence,22
MP:0003668 abnormal periodontal ligament morphology,4
MP:0003670 dilated renal glomerular capsule,11
MP:0003671 abnormal eyelid aperture,6
MP:0003672 abnormal ureter development,10
MP:0003674 oxidative stress,80
MP:0003675 kidney cysts,72
MP:0003684 abnormal inferior olivary complex morphology,3
MP:0003690 abnormal glial cell physiology,9
MP:0003691 abnormal microglial cell physiology,28
MP:0003694 failure of blastocyst to hatch from the zona pellucida,27
MP:0003695 delayed blastocyst hatching from the zona pellucida,3
MP:0003696 abnormal zona pellucida morphology,5
MP:0003697 absent zona pellucida,3
MP:0003698 abnormal male reproductive system physiology,18
MP:0003699 abnormal female reproductive system physiology,18
MP:0003701 elevated level of mitotic sister chromatid exchange,5
MP:0003702 abnormal chromosome morphology,30
MP:0003703 abnormal vestibulocochlear ganglion morphology,12
MP:0003704 abnormal hair follicle development,36
MP:0003705 abnormal hypodermis morphology,3
MP:0003707 increased cell nucleus count,4
MP:0003708 binucleate,6
MP:0003710 abnormal physiological neovascularization,19
MP:0003711 pathological neovascularization,9
MP:0003717 pallor,180
MP:0003718 maternal effect,63
MP:0003719 abnormal pericyte morphology,14
MP:0003720 abnormal neural tube closure,81
MP:0003721 increased tumor growth/size,34
MP:0003722 absent ureter,15
MP:0003723 abnormal long bone morphology,60
MP:0003724 increased susceptibility to induced arthritis,27
MP:0003725 increased autoantibody level,29
MP:0003726 decreased autoantibody level,3
MP:0003727 abnormal retinal layer morphology,23
MP:0003728 abnormal retinal photoreceptor layer morphology,30
MP:0003729 abnormal photoreceptor outer segment morphology,36
MP:0003730 abnormal photoreceptor inner segment morphology,16
MP:0003731 abnormal retinal outer nuclear layer morphology,32
MP:0003732 abnormal retinal outer plexiform layer morphology,20
MP:0003733 abnormal retinal inner nuclear layer morphology,26
MP:0003734 abnormal retinal inner plexiform layer morphology,12
MP:0003740 fusion of middle ear ossicles,5
MP:0003743 abnormal facial morphology,58
MP:0003755 abnormal palate morphology,25
MP:0003756 abnormal hard palate morphology,6
MP:0003763 abnormal thymus physiology,7
MP:0003786 premature aging,25
MP:0003787 abnormal imprinting,14
MP:0003789 increased osteosarcoma incidence,10
"MP:0003790 absent CD4-positive, alpha beta T cells",8
MP:0003793 abnormal submandibular gland morphology,9
MP:0003794 delayed somite formation,11
MP:0003795 abnormal bone structure,173
MP:0003797 abnormal compact bone morphology,38
MP:0003799 impaired macrophage chemotaxis,35
MP:0003806 abnormal nucleotide metabolism,10
MP:0003807 camptodactyly,3
MP:0003808 increased atrioventricular cushion size,9
MP:0003809 abnormal hair shaft morphology,43
MP:0003810 abnormal hair cuticle,13
MP:0003811 abnormal hair cortex morphology,3
MP:0003812 abnormal hair medulla,10
MP:0003813 abnormal hair follicle dermal papilla morphology,3
MP:0003814 vascular smooth muscle hypoplasia,13
MP:0003815 hairless,5
MP:0003816 abnormal pituitary gland development,10
MP:0003819 increased left ventricle diastolic pressure,9
MP:0003820 increased left ventricle systolic pressure,7
MP:0003822 decreased left ventricle systolic pressure,11
MP:0003824 decreased left ventricle developed pressure,3
MP:0003825 abnormal pillar cell morphology,9
MP:0003826 abnormal Mullerian duct morphology,4
MP:0003827 abnormal Wolffian duct morphology,11
MP:0003828 pulmonary edema,24
MP:0003829 impaired febrile response,8
MP:0003830 abnormal testis development,16
MP:0003838 abnormal milk ejection,4
MP:0003840 abnormal coronal suture morphology,11
MP:0003841 abnormal lambdoidal suture morphology,5
MP:0003842 abnormal metopic suture morphology,4
MP:0003843 abnormal sagittal suture morphology,13
MP:0003845 abnormal decidualization,13
MP:0003846 matted coat,5
MP:0003848 brittle hair,7
MP:0003849 greasy coat,12
MP:0003850 abnormal thymocyte activation,18
MP:0003851 skeletal muscle interstitial fibrosis,6
MP:0003852 skeletal muscle necrosis,9
MP:0003853 dry skin,19
MP:0003855 abnormal forelimb zeugopod morphology,7
MP:0003857 abnormal hindlimb zeugopod morphology,9
MP:0003858 enhanced coordination,24
MP:0003861 abnormal nervous system development,32
MP:0003862 decreased aggression towards males,13
MP:0003863 decreased aggression towards mice,15
MP:0003864 abnormal midbrain development,33
MP:0003865 lymph node inflammation,5
MP:0003866 abnormal defecation,11
MP:0003867 increased defecation amount,8
MP:0003868 abnormal feces composition,22
MP:0003869 ectopic cartilage,3
MP:0003871 abnormal myelin sheath morphology,46
MP:0003872 absent heart right ventricle,4
MP:0003873 pharyngeal arch hypoplasia,10
MP:0003874 absent pharyngeal arches,9
MP:0003877 abnormal serotonergic neuron morphology,6
MP:0003878 abnormal ear physiology,9
MP:0003880 abnormal central pattern generator function,6
MP:0003881 abnormal nephron morphology,6
MP:0003883 enlarged stomach,11
MP:0003884 decreased macrophage cell number,42
MP:0003885 abnormal rostral-caudal body axis extension,12
MP:0003886 abnormal embryonic epiblast morphology,34
MP:0003887 increased hepatocyte apoptosis,40
MP:0003888 liver hemorrhage,27
MP:0003889 enhanced sensorimotor gating,3
MP:0003890 abnormal embryonic-extraembryonic boundary morphology,17
MP:0003891 increased allantois apoptosis,4
MP:0003892 abnormal gastric gland morphology,7
MP:0003893 increased hepatocyte proliferation,11
MP:0003894 abnormal Purkinje cell innervation,6
MP:0003895 increased ectoderm apoptosis,5
MP:0003896 prolonged PR interval,21
MP:0003897 abnormal ST segment,5
MP:0003898 abnormal QRS complex,27
MP:0003900 shortened QT interval,4
MP:0003913 increased heart right ventricle weight,5
MP:0003915 increased left ventricle weight,17
MP:0003916 decreased heart left ventricle weight,5
MP:0003917 increased kidney weight,47
MP:0003918 decreased kidney weight,51
MP:0003920 abnormal heart right ventricle morphology,19
MP:0003921 abnormal heart left ventricle morphology,67
MP:0003923 abnormal heart left atrium morphology,5
MP:0003924 diaphragmatic hernia,23
MP:0003928 increased heart rate variability,9
MP:0003929 decreased heart rate variability,15
MP:0003930 abnormal tooth hard tissue morphology,4
MP:0003931 absent molars,4
MP:0003932 abnormal molar crown morphology,16
MP:0003934 abnormal pancreas development,12
MP:0003935 abnormal craniofacial development,49
MP:0003936 abnormal reproductive system development,8
MP:0003938 abnormal ear development,15
MP:0003939 abnormal myotome morphology,3
MP:0003941 abnormal skin development,7
MP:0003942 abnormal urinary system development,4
MP:0003944 abnormal T cell subpopulation ratio,32
MP:0003945 abnormal lymphocyte physiology,41
MP:0003946 renal necrosis,5
MP:0003947 abnormal cholesterol level,5
MP:0003948 abnormal gas homeostasis,9
MP:0003949 abnormal circulating lipid level,21
MP:0003950 abnormal plasma membrane morphology,9
MP:0003952 abnormal copper level,3
MP:0003953 abnormal hormone level,24
MP:0003954 abnormal Reichert's membrane morphology,11
MP:0003956 abnormal body size,4
MP:0003957 abnormal nitric oxide homeostasis,27
MP:0003958 heart valve hyperplasia,3
MP:0003960 increased lean body mass,123
MP:0003961 decreased lean body mass,216
MP:0003962 abnormal adrenaline level,11
MP:0003963 abnormal corticosterone level,11
MP:0003964 abnormal noradrenaline level,30
MP:0003965 abnormal pituitary hormone level,4
MP:0003966 abnormal adrenocorticotropin level,3
MP:0003974 abnormal endocardium morphology,23
MP:0003975 increased circulating VLDL triglyceride level,11
MP:0003976 decreased circulating VLDL triglyceride level,10
MP:0003978 decreased circulating carnitine level,5
MP:0003979 increased circulating carnitine level,8
MP:0003980 increased circulating phospholipid level,6
MP:0003982 increased cholesterol level,25
MP:0003983 decreased cholesterol level,18
MP:0003984 embryonic growth retardation,435
MP:0003985 renal fibrosis,14
MP:0003986 small cochlear ganglion,6
MP:0003987 small vestibular ganglion,9
MP:0003988 disorganized embryonic tissue,29
MP:0003989 abnormal barrel cortex morphology,6
MP:0003990 decreased neurotransmitter release,12
MP:0003991 arteriosclerosis,3
MP:0003992 increased mortality induced by ionizing radiation,13
MP:0003993 abnormal ventral spinal root morphology,17
MP:0003994 abnormal dorsal spinal root morphology,7
MP:0003996 clonic seizures,12
MP:0003997 tonic-clonic seizures,51
MP:0003998 decreased thermal nociceptive threshold,38
MP:0004000 impaired passive avoidance behavior,20
MP:0004001 decreased hepatocyte proliferation,20
MP:0004002 abnormal jejunum morphology,10
MP:0004003 abnormal vascular endothelial cell physiology,25
MP:0004007 abnormal lung vasculature morphology,45
MP:0004008 abnormal GABA-mediated receptor currents,13
MP:0004014 abnormal uterine environment,12
MP:0004016 decreased bone mass,35
MP:0004017 duplex kidney,13
MP:0004019 abnormal vitamin homeostasis,3
MP:0004021 abnormal rod electrophysiology,80
MP:0004022 abnormal cone electrophysiology,67
MP:0004023 abnormal chromosome number,7
MP:0004024 aneuploidy,39
MP:0004025 polyploidy,19
MP:0004028 chromosome breakage,21
MP:0004029 spontaneous chromosome breakage,21
MP:0004030 induced chromosome breakage,16
MP:0004031 insulitis,19
MP:0004032 abnormal interventricular groove morphology,6
MP:0004033 supernumerary teeth,9
MP:0004035 abnormal sublingual gland morphology,3
MP:0004036 abnormal muscle relaxation,5
MP:0004037 increased muscle relaxation,3
MP:0004038 lymphangiectasis,9
MP:0004039 abnormal cardiac cell glucose uptake,5
MP:0004041 increased susceptibility to kidney reperfusion injury,4
MP:0004042 decreased susceptibility to kidney reperfusion injury,15
MP:0004043 abnormal pH regulation,3
MP:0004044 aortic dissection,7
MP:0004045 abnormal cell cycle checkpoint function,38
MP:0004046 abnormal mitosis,59
MP:0004047 abnormal milk composition,18
MP:0004053 abnormal synchondrosis,3
MP:0004055 atrium hypoplasia,6
MP:0004056 abnormal myocardium compact layer morphology,19
MP:0004057 thin myocardium compact layer,23
MP:0004062 dilated heart right atrium,7
MP:0004066 abnormal primitive node morphology,16
MP:0004067 abnormal trabecula carnea morphology,12
MP:0004068 dilated dorsal aorta,17
MP:0004069 abnormal muscle spindle morphology,8
MP:0004070 abnormal P wave,5
MP:0004071 prolonged P wave,9
MP:0004073 caudal body truncation,41
MP:0004076 abnormal vitelline vascular remodeling,60
MP:0004077 abnormal striatum morphology,29
MP:0004081 abnormal globus pallidus morphology,6
MP:0004082 abnormal habenula morphology,3
MP:0004083 polysyndactyly,11
MP:0004084 abnormal cardiac muscle relaxation,22
MP:0004085 abnormal heartbeat,3
MP:0004086 absent heartbeat,26
MP:0004087 abnormal muscle fiber morphology,25
MP:0004088 abnormal sarcoplasmic reticulum morphology,11
MP:0004089 dilated sarcoplasmic reticulum,5
MP:0004090 abnormal sarcomere morphology,37
MP:0004091 abnormal Z lines,19
MP:0004096 abnormal midbrain-hindbrain boundary development,8
MP:0004097 abnormal cerebellar cortex morphology,19
MP:0004098 abnormal cerebellar granule cell morphology,18
MP:0004100 abnormal spinal cord interneuron morphology,24
MP:0004101 abnormal brain interneuron morphology,25
MP:0004102 abnormal dorsal striatum morphology,8
MP:0004103 abnormal ventral striatum morphology,5
MP:0004106 lymphatic vessel hyperplasia,4
MP:0004109 abnormal Sertoli cell development,6
MP:0004110 transposition of great arteries,27
MP:0004111 abnormal coronary artery morphology,17
MP:0004112 abnormal arteriole morphology,4
MP:0004113 abnormal aortic arch morphology,28
MP:0004115 abnormal sinoatrial node morphology,4
MP:0004119 hypokalemia,8
MP:0004121 abnormal sarcolemma morphology,11
MP:0004122 abnormal sinus arrhythmia,6
MP:0004125 abnormal venule morphology,4
MP:0004126 thin hypodermis,3
MP:0004129 abnormal respiratory quotient,7
MP:0004130 abnormal muscle cell glucose uptake,36
MP:0004131 abnormal motile primary cilium morphology,11
MP:0004132 absent embryonic cilia,17
MP:0004133 heterotaxia,25
MP:0004134 abnormal chest morphology,7
MP:0004136 abnormal tongue muscle morphology,11
MP:0004138 abnormal mucous neck cell morphology,3
MP:0004139 abnormal gastric parietal cell morphology,22
MP:0004140 abnormal gastric chief cell morphology,17
MP:0004142 abnormal muscle tone,9
MP:0004143 muscle hypertonia,9
MP:0004144 hypotonia,19
MP:0004145 abnormal muscle electrophysiology,24
MP:0004147 increased porphyrin level,3
MP:0004148 increased compact bone thickness,28
MP:0004149 increased bone strength,8
MP:0004151 decreased circulating iron level,28
MP:0004153 increased renal tubule apoptosis,11
MP:0004154 renal tubular necrosis,15
MP:0004155 decreased susceptibility to induced pancreatitis,3
MP:0004157 interrupted aortic arch,32
MP:0004158 right aortic arch,41
MP:0004159 double aortic arch,11
MP:0004160 retroesophageal right subclavian artery,10
MP:0004163 abnormal adenohypophysis morphology,14
MP:0004164 abnormal neurohypophysis morphology,3
MP:0004165 abnormal lateral geniculate nucleus morphology,5
MP:0004166 abnormal limbic system morphology,3
MP:0004167 abnormal cingulate gyrus morphology,4
MP:0004171 abnormal pallium development,3
MP:0004173 abnormal intervertebral disk morphology,15
MP:0004174 abnormal spine curvature,47
MP:0004179 transmission ratio distortion,27
MP:0004180 failure of initiation of embryo turning,46
MP:0004181 abnormal carotid artery morphology,10
MP:0004182 abnormal spermiation,15
MP:0004183 abnormal sympathetic nervous system physiology,10
MP:0004184 abnormal baroreceptor physiology,9
MP:0004185 abnormal adipocyte glucose uptake,25
MP:0004187 cardia bifida,16
MP:0004188 delayed embryo turning,17
MP:0004189 abnormal alveolar process morphology,15
MP:0004190 abnormal direction of embryo turning,10
MP:0004191 neuronal intranuclear inclusions,7
MP:0004193 abnormal kidney papilla morphology,7
MP:0004194 abnormal kidney pelvis morphology,10
MP:0004197 abnormal fetal growth/weight/body size,4
MP:0004199 increased fetal size,4
MP:0004200 decreased fetal size,126
MP:0004201 fetal growth retardation,80
MP:0004202 pulmonary hyperplasia,4
MP:0004203 abnormal cranial flexure morphology,6
MP:0004204 absent stapes,10
MP:0004206 abnormal dermomyotome development,8
MP:0004207 increased squamous cell carcinoma incidence,23
MP:0004209 abnormal sweet taste sensitivity,5
MP:0004210 abnormal bitter taste sensitivity,4
MP:0004213 abnormal umami taste sensitivity,3
MP:0004214 abnormal long bone diaphysis morphology,17
MP:0004215 abnormal myocardial fiber physiology,60
MP:0004217 salt-sensitive hypertension,7
MP:0004220 abnormal peripheral nervous system regeneration,9
MP:0004221 abnormal iridocorneal angle,16
MP:0004223 hypoplastic trabecular meshwork,5
MP:0004225 patent foramen ovale,4
MP:0004226 absent Schlemm's canal,4
MP:0004227 increased cellular sensitivity to ionizing radiation,20
MP:0004228 decreased cellular sensitivity to ionizing radiation,6
MP:0004229 abnormal embryonic erythropoiesis,27
MP:0004230 abnormal embryonic erythrocyte morphology,8
MP:0004231 abnormal calcium ion homeostasis,36
MP:0004232 decreased muscle weight,8
MP:0004243 abnormal motor nerve collateral sprouting,4
MP:0004244 abnormal miscarriage rate,6
MP:0004246 abnormal extensor digitorum longus morphology,4
MP:0004247 small pancreas,15
MP:0004249 abnormal crista ampullaris morphology,22
MP:0004250 tau protein deposits,6
MP:0004251 failure of heart looping,37
MP:0004252 abnormal direction of heart looping,30
MP:0004255 abnormal spongiotrophoblast layer morphology,30
MP:0004256 abnormal maternal decidual layer morphology,12
MP:0004258 abnormal placenta size,13
MP:0004259 small placenta,44
MP:0004260 enlarged placenta,9
MP:0004261 abnormal embryonic neuroepithelium morphology,59
MP:0004262 abnormal physical strength,4
MP:0004263 abnormal limb posture,24
MP:0004264 abnormal extraembryonic tissue physiology,8
MP:0004265 abnormal placental transport,9
MP:0004266 pale placenta,10
MP:0004267 abnormal optic tract morphology,5
MP:0004268 abnormal optic stalk morphology,10
MP:0004269 abnormal optic cup morphology,12
MP:0004270 analgesia,3
MP:0004272 abnormal basement membrane morphology,21
MP:0004273 abnormal basal lamina morphology,4
MP:0004274 abnormal embryonic/fetal subventricular zone morphology,23
MP:0004275 abnormal postnatal subventricular zone morphology,19
MP:0004276 abnormal medial ganglionic eminence morphology,3
MP:0004277 abnormal lateral ganglionic eminence morphology,7
MP:0004279 abnormal rostral migratory stream morphology,14
MP:0004282 retrognathia,3
MP:0004283 absent corneal endothelium,3
MP:0004284 abnormal Descemet membrane,4
MP:0004287 abnormal spiral limbus morphology,3
MP:0004289 abnormal bony labyrinth,7
MP:0004297 abnormal proprioceptive neuron morphology,8
MP:0004298 vestibular ganglion degeneration,3
MP:0004300 abnormal organ of Corti supporting cell morphology,6
MP:0004301 absent organ of Corti supporting cells,4
MP:0004302 abnormal Deiters cell morphology,4
MP:0004310 small otic vesicle,12
MP:0004312 absent pillar cells,3
MP:0004314 absent inner ear vestibule,4
MP:0004315 absent vestibular saccule,6
MP:0004317 small vestibular saccule,3
MP:0004318 absent incus,5
MP:0004320 split sternum,12
MP:0004321 short sternum,28
MP:0004322 abnormal sternebra morphology,16
MP:0004324 vestibular hair cell degeneration,12
MP:0004325 absent vestibular hair cells,6
MP:0004328 decreased vestibular hair cell number,8
MP:0004329 vestibular saccular degeneration,5
MP:0004330 abnormal vestibular saccular macula morphology,6
MP:0004331 vestibular saccular macula degeneration,10
MP:0004333 abnormal utricular macula morphology,9
MP:0004334 utricular macular degeneration,6
MP:0004338 small clavicle,5
MP:0004340 short scapula,6
MP:0004342 scapular bone foramen,4
MP:0004343 small scapula,8
MP:0004347 abnormal scapular spine morphology,3
MP:0004348 long femur,6
MP:0004351 short humerus,41
MP:0004353 abnormal deltoid tuberosity morphology,11
MP:0004354 absent deltoid tuberosity,8
MP:0004355 short radius,37
MP:0004357 long tibia,15
MP:0004358 bowed tibia,16
MP:0004359 short ulna,42
MP:0004360 absent ulna,6
MP:0004361 bowed ulna,12
MP:0004362 cochlear hair cell degeneration,41
MP:0004363 stria vascularis degeneration,10
MP:0004364 thin stria vascularis,7
MP:0004366 abnormal strial marginal cell morphology,6
MP:0004367 abnormal strial intermediate cell morphology,5
MP:0004368 abnormal stria vascularis vasculature morphology,8
MP:0004369 absent utricle,4
MP:0004372 bowed fibula,7
MP:0004373 bowed humerus,5
MP:0004374 bowed radius,16
MP:0004376 absent frontal bone,4
MP:0004377 small frontal bone,8
MP:0004380 short frontal bone,7
MP:0004381 abnormal hair follicle melanocyte morphology,6
MP:0004382 abnormal hair follicle melanogenesis,3
MP:0004383 absent interparietal bone,8
MP:0004384 small interparietal bone,12
MP:0004385 interparietal bone hypoplasia,3
MP:0004386 enlarged interparietal bone,5
MP:0004387 abnormal prechordal plate morphology,4
MP:0004388 absent prechordal plate,3
MP:0004391 abnormal respiratory conducting tube morphology,10
"MP:0004392 abnormal CD8-positive, alpha-beta T cell physiology",27
MP:0004393 abnormal cochlear inner hair cell morphology,18
MP:0004395 increased cochlear inner hair cell number,12
MP:0004396 decreased cochlear inner hair cell number,9
MP:0004397 absent cochlear inner hair cells,4
MP:0004398 cochlear inner hair cell degeneration,48
MP:0004399 abnormal cochlear outer hair cell morphology,24
MP:0004401 increased cochlear outer hair cell number,15
MP:0004402 decreased cochlear outer hair cell number,20
MP:0004403 absent cochlear outer hair cells,7
MP:0004404 cochlear outer hair cell degeneration,69
MP:0004405 absent cochlear hair cells,11
MP:0004407 increased cochlear hair cell number,3
MP:0004408 decreased cochlear hair cell number,8
MP:0004409 abnormal crista ampullaris neuroepithelium morphology,10
MP:0004410 absent endocochlear potential,6
MP:0004411 decreased endocochlear potential,12
MP:0004413 absent cochlear microphonics,7
MP:0004414 decreased cochlear microphonics,3
MP:0004415 abnormal cochlear nerve compound action potential,5
MP:0004416 absent cochlear nerve compound action potential,5
MP:0004417 decreased cochlear nerve compound action potential,11
MP:0004418 small parietal bone,11
MP:0004419 absent parietal bone,7
MP:0004420 parietal bone hypoplasia,3
MP:0004423 abnormal squamosal bone morphology,13
MP:0004427 abnormal vestibular labyrinth morphology,7
MP:0004428 abnormal type I vestibular cell,3
MP:0004431 abnormal hair cell mechanoelectric transduction,8
MP:0004432 abnormal cochlear hair cell physiology,4
MP:0004433 abnormal cochlear inner hair cell physiology,7
MP:0004434 abnormal cochlear outer hair cell physiology,9
MP:0004438 abnormal vestibular hair cell physiology,3
MP:0004439 absent Meckel's cartilage,3
MP:0004443 absent supraoccipital bone,9
MP:0004444 small supraoccipital bone,5
MP:0004445 small exoccipital bone,3
MP:0004447 small basioccipital bone,6
MP:0004448 abnormal presphenoid bone morphology,18
MP:0004449 absent presphenoid bone,8
MP:0004450 presphenoid bone hypoplasia,3
MP:0004452 abnormal pterygoid process morphology,10
MP:0004453 abnormal pterygoid bone morphology,6
MP:0004458 absent alisphenoid bone,3
MP:0004460 alisphenoid bone hypoplasia,3
MP:0004462 small basisphenoid bone,12
MP:0004463 basisphenoid bone foramen,6
MP:0004465 degeneration of organ of Corti supporting cells,9
MP:0004466 short cochlear outer hair cells,4
MP:0004467 absent zygomatic bone,3
MP:0004469 abnormal zygomatic arch morphology,9
MP:0004470 small nasal bone,4
MP:0004471 short nasal bone,30
MP:0004472 broad nasal bone,3
MP:0004476 absent palatine bone,3
MP:0004478 increased testicular teratoma incidence,3
MP:0004480 abnormal round window morphology,3
MP:0004484 altered response of heart to induced stress,19
MP:0004485 increased response of heart to induced stress,31
MP:0004486 decreased response of heart to induced stress,25
MP:0004490 type IV spiral ligament fibrocyte degeneration,3
MP:0004491 abnormal orientation of outer hair cell stereociliary bundles,20
MP:0004492 abnormal orientation of inner hair cell stereociliary bundles,11
MP:0004494 abnormal synaptic glutamate release,5
MP:0004495 decreased synaptic glutamate release,7
MP:0004499 increased incidence of tumors by chemical induction,85
MP:0004500 increased incidence of tumors by ionizing radiation induction,14
MP:0004501 increased incidence of tumors by UV-induction,5
MP:0004502 decreased incidence of tumors by chemical induction,63
MP:0004505 decreased renal glomerulus number,27
MP:0004506 abnormal pubis morphology,6
MP:0004507 abnormal ischium morphology,6
MP:0004508 abnormal pectoral girdle bone morphology,8
MP:0004509 abnormal pelvic girdle bone morphology,39
MP:0004510 myositis,17
MP:0004512 anosmia,4
MP:0004514 dystocia,3
MP:0004515 abnormal vestibular hair cell stereociliary bundle morphology,9
MP:0004517 decreased vestibular hair cell stereocilia number,4
MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology,25
MP:0004522 abnormal orientation of cochlear hair cell stereociliary bundles,12
MP:0004524 short cochlear hair cell stereocilia,6
MP:0004527 abnormal outer hair cell stereociliary bundle morphology,27
MP:0004528 fused outer hair cell stereocilia,5
MP:0004529 decreased outer hair cell stereocilia number,10
MP:0004530 absent outer hair cell stereocilia,7
MP:0004531 short outer hair cell stereocilia,3
MP:0004532 abnormal inner hair cell stereociliary bundle morphology,15
MP:0004533 fused inner hair cell stereocilia,6
MP:0004534 decreased inner hair cell stereocilia number,8
MP:0004536 short inner hair cell stereocilia,5
MP:0004537 abnormal palatine bone horizontal plate morphology,5
MP:0004538 abnormal maxillary shelf morphology,7
MP:0004539 absent maxilla,5
MP:0004540 small maxilla,4
MP:0004542 impaired acrosome reaction,21
MP:0004543 abnormal sperm physiology,38
MP:0004545 enlarged esophagus,5
MP:0004548 dilated esophagus,3
MP:0004551 decreased tracheal cartilage ring number,4
MP:0004556 enlarged allantois,14
MP:0004557 dilated allantois,7
MP:0004558 delayed allantois development,4
MP:0004559 small allantois,11
MP:0004560 abnormal chorionic plate morphology,12
MP:0004561 absent facial nerve,3
MP:0004562 abnormal inner hair cell synaptic ribbon morphology,4
MP:0004564 enlarged myocardial fiber,32
MP:0004565 small myocardial fiber,8
MP:0004566 myocardial fiber degeneration,21
MP:0004567 decreased myocardial fiber number,12
MP:0004568 fusion of glossopharyngeal and vagus nerve,11
MP:0004573 absent limb buds,5
MP:0004574 broad limb buds,6
MP:0004575 small limb buds,4
MP:0004576 abnormal foot plate morphology,5
MP:0004577 abnormal cochlear hair cell inter-stereocilial links morphology,5
MP:0004578 abnormal cochlear hair bundle tip links morphology,3
MP:0004586 pillar cell degeneration,6
MP:0004589 abnormal cochlear hair cell development,7
MP:0004591 enlarged tectorial membrane,7
MP:0004592 small mandible,18
MP:0004594 abnormal mandibular coronoid process morphology,8
MP:0004595 abnormal mandibular condyloid process morphology,10
MP:0004596 abnormal mandibular angle morphology,4
MP:0004597 increased susceptibility to noise-induced hearing loss,12
MP:0004599 abnormal vertebral arch morphology,38
MP:0004600 abnormal vertebral transverse process morphology,6
MP:0004601 abnormal vertebral spinous process morphology,10
MP:0004604 abnormal vertebral pedicle morphology,6
MP:0004605 abnormal vertebral lamina morphology,3
MP:0004607 abnormal cervical atlas morphology,28
MP:0004608 abnormal cervical axis morphology,19
MP:0004609 vertebral fusion,40
MP:0004610 small vertebrae,11
MP:0004612 fusion of vertebral bodies,7
MP:0004613 fusion of vertebral arches,22
MP:0004614 caudal vertebral transformation,6
MP:0004615 cervical vertebral transformation,37
MP:0004616 lumbar vertebral transformation,38
MP:0004617 sacral vertebral transformation,15
MP:0004618 thoracic vertebral transformation,46
MP:0004619 caudal vertebral fusion,10
MP:0004620 cervical vertebral fusion,31
MP:0004621 lumbar vertebral fusion,8
MP:0004622 sacral vertebral fusion,11
MP:0004623 thoracic vertebral fusion,9
MP:0004624 abnormal thoracic cage morphology,27
MP:0004626 vertebral compression,3
MP:0004627 abnormal trochanter morphology,5
MP:0004628 Deiters cell degeneration,3
MP:0004631 abnormal auditory cortex morphology,4
MP:0004632 abnormal cochlear OHC efferent innervation pattern,7
MP:0004633 abnormal cochlear IHC efferent innervation pattern,4
MP:0004634 short metacarpal bones,12
MP:0004635 short metatarsal bones,9
MP:0004639 fused metacarpal bones,4
MP:0004642 fused metatarsal bones,6
MP:0004646 decreased cervical vertebrae number,8
MP:0004647 decreased lumbar vertebrae number,69
MP:0004648 decreased thoracic vertebrae number,7
MP:0004650 increased lumbar vertebrae number,3
MP:0004651 increased thoracic vertebrae number,12
MP:0004652 small caudal vertebrae,6
MP:0004653 absent caudal vertebrae,7
MP:0004656 absent sacral vertebrae,3
MP:0004657 small sacral vertebrae,3
MP:0004659 abnormal odontoid process morphology,6
MP:0004664 delayed inner ear development,5
MP:0004666 absent stapedial artery,4
MP:0004667 vertebral body hypoplasia,3
MP:0004669 enlarged vertebral body,3
MP:0004670 small vertebral body,7
MP:0004672 short ribs,27
MP:0004673 splayed ribs,4
MP:0004674 thin ribs,8
MP:0004675 rib fractures,3
MP:0004677 truncated ribs,3
MP:0004678 split xiphoid process,14
MP:0004679 xiphoid process foramen,4
MP:0004683 absent intervertebral disk,7
MP:0004685 calcified intervertebral disk,3
MP:0004686 decreased length of long bones,82
MP:0004687 split vertebrae,3
MP:0004692 small pubis,3
MP:0004694 absent patella,4
MP:0004695 increased length of long bones,4
MP:0004696 abnormal thyroid follicle morphology,17
MP:0004697 abnormal thyroid follicular cell morphology,4
MP:0004701 decreased circulating insulin-like growth factor I level,46
MP:0004702 increased circulating insulin-like growth factor I level,6
MP:0004703 abnormal vertebral column morphology,36
MP:0004704 short vertebral column,13
MP:0004706 short vertebral body,5
MP:0004708 short lumbar vertebrae,4
MP:0004711 persistence of notochord tissue,3
MP:0004712 notochord degeneration,5
MP:0004713 split notochord,6
MP:0004714 truncated notochord,4
MP:0004716 abnormal cochlear nerve morphology,8
MP:0004718 abnormal vestibular nerve morphology,3
MP:0004720 abnormal platelet morphology,13
MP:0004721 abnormal platelet dense granule morphology,3
MP:0004722 abnormal platelet dense granule number,5
MP:0004725 decreased platelet serotonin level,8
MP:0004726 abnormal nasal capsule morphology,17
MP:0004727 absent epididymis,6
MP:0004728 abnormal efferent ductules of testis morphology,3
MP:0004731 increased circulating gastrin level,7
MP:0004733 abnormal thoracic cavity morphology,9
MP:0004734 small thoracic cavity,11
MP:0004736 abnormal distortion product otoacoustic emission,33
MP:0004737 absent distortion product otoacoustic emissions,28
MP:0004738 abnormal auditory brainstem response,25
MP:0004739 conductive hearing loss,13
MP:0004740 sensorineural hearing loss,30
MP:0004742 abnormal vestibular system physiology,17
MP:0004746 abnormal cochlear IHC afferent innervation pattern,8
MP:0004748 increased susceptibility to age-related hearing loss,20
MP:0004749 nonsyndromic hearing loss,4
MP:0004750 syndromic hearing loss,4
MP:0004751 increased length of allograft survival,17
MP:0004752 decreased length of allograft survival,3
MP:0004753 abnormal miniature excitatory postsynaptic currents,70
MP:0004754 abnormal kidney collecting duct morphology,15
MP:0004756 abnormal proximal convoluted tubule morphology,42
MP:0004757 abnormal distal convoluted tubule morphology,6
MP:0004759 decreased mitotic index,7
MP:0004760 increased mitotic index,7
MP:0004761 increased susceptibility to induced pancreatitis,6
MP:0004762 increased anti-double stranded DNA antibody level,51
MP:0004768 abnormal axonal transport,18
MP:0004769 abnormal synaptic vesicle morphology,17
MP:0004770 abnormal synaptic vesicle recycling,14
MP:0004771 increased anti-single stranded DNA antibody level,16
MP:0004772 abnormal bile secretion,10
MP:0004773 abnormal bile composition,17
MP:0004774 abnormal bile salt level,13
MP:0004777 abnormal phospholipid level,28
MP:0004778 increased macrophage derived foam cell number,6
MP:0004780 abnormal surfactant secretion,18
MP:0004781 abnormal surfactant composition,6
MP:0004782 abnormal surfactant physiology,11
MP:0004783 abnormal cardinal vein morphology,16
MP:0004784 abnormal anterior cardinal vein morphology,10
MP:0004787 abnormal dorsal aorta morphology,55
MP:0004789 increased bile salt level,12
MP:0004790 absent upper incisors,3
MP:0004791 absent lower incisors,4
MP:0004792 abnormal synaptic vesicle number,30
MP:0004793 abnormal synaptic vesicle clustering,6
MP:0004794 increased anti-nuclear antigen antibody level,40
MP:0004796 increased anti-histone antibody level,9
MP:0004799 increased susceptibility to experimental autoimmune encephalomyelitis,42
MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis,56
MP:0004801 increased susceptibility to systemic lupus erythematosus,12
MP:0004803 increased susceptibility to autoimmune diabetes,14
MP:0004804 decreased susceptibility to autoimmune diabetes,31
MP:0004805 absent oocytes,18
MP:0004806 absent germ cells,8
MP:0004807 abnormal paired-pulse inhibition,7
MP:0004808 abnormal hematopoietic stem cell morphology,24
MP:0004809 increased hematopoietic stem cell number,30
MP:0004810 decreased hematopoietic stem cell number,46
MP:0004811 abnormal neuron physiology,90
MP:0004812 abnormal linear vestibular evoked potential,3
MP:0004813 absent linear vestibular evoked potential,18
MP:0004814 reduced linear vestibular evoked potential,12
MP:0004815 abnormal somatic hypermutation frequency,11
MP:0004816 abnormal class switch recombination,58
MP:0004818 increased skeletal muscle mass,7
MP:0004819 decreased skeletal muscle mass,52
MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis,3
MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis,3
MP:0004824 decreased susceptibility to experimental autoimmune myasthenia gravis,3
MP:0004829 increased anti-chromatin antibody level,8
MP:0004830 short incisors,15
MP:0004831 long incisors,6
MP:0004832 enlarged ovary,8
MP:0004833 ovary atrophy,14
MP:0004834 ovary hemorrhage,8
MP:0004835 abnormal miniature endplate potential,22
MP:0004836 abnormal synaptic acetylcholine release,5
MP:0004837 abnormal neural fold formation,18
MP:0004838 abnormal neural fold elevation formation,9
MP:0004839 bile duct hyperplasia,5
MP:0004841 abnormal small intestine crypts of Lieberkuhn morphology,11
MP:0004842 abnormal large intestine crypts of Lieberkuhn morphology,25
MP:0004843 abnormal Paneth cell morphology,4
MP:0004846 absent skeletal muscle,3
MP:0004848 abnormal liver size,4
MP:0004851 increased testis weight,16
MP:0004852 decreased testis weight,192
MP:0004855 increased ovary weight,3
MP:0004856 decreased ovary weight,27
MP:0004859 abnormal synaptic plasticity,19
MP:0004860 dilated kidney collecting duct,16
MP:0004867 decreased platelet calcium level,3
MP:0004871 premaxilla hypoplasia,5
MP:0004872 absent nasal septum,4
MP:0004875 increased mean systemic arterial blood pressure,34
MP:0004876 decreased mean systemic arterial blood pressure,23
MP:0004880 lung cysts,3
MP:0004882 enlarged lung,7
MP:0004883 abnormal vascular wound healing,57
MP:0004884 abnormal testis physiology,9
MP:0004889 increased energy expenditure,42
MP:0004890 decreased energy expenditure,22
MP:0004892 increased adiponectin level,24
MP:0004893 decreased adiponectin level,25
MP:0004894 uterus atrophy,8
MP:0004896 abnormal endometrium morphology,6
MP:0004898 uterine hemorrhage,5
MP:0004899 absent squamosal bone,3
MP:0004901 decreased male germ cell number,79
MP:0004904 increased uterus weight,9
MP:0004905 decreased uterus weight,16
MP:0004906 enlarged uterus,13
MP:0004909 increased seminal vesicle weight,7
MP:0004910 decreased seminal vesicle weight,22
MP:0004912 absent mandibular coronoid process,5
MP:0004917 abnormal T cell selection,3
MP:0004918 abnormal negative T cell selection,5
MP:0004919 abnormal positive T cell selection,12
MP:0004920 increased placenta weight,11
MP:0004921 decreased placenta weight,24
MP:0004922 abnormal common crus morphology,5
MP:0004923 absent common crus,3
MP:0004924 abnormal behavior,262
MP:0004928 increased epididymis weight,7
MP:0004929 decreased epididymis weight,22
MP:0004930 small epididymis,14
MP:0004931 enlarged epididymis,20
MP:0004933 abnormal epididymis epithelium morphology,14
MP:0004936 impaired branching involved in ureteric bud morphogenesis,36
MP:0004937 dilated heart,23
MP:0004938 dilated vasculature,18
MP:0004939 abnormal B cell morphology,21
MP:0004940 abnormal B-1 B cell morphology,3
MP:0004946 abnormal regulatory T cell physiology,20
MP:0004947 skin inflammation,30
MP:0004948 abnormal neuronal precursor proliferation,51
MP:0004950 abnormal brain vasculature morphology,31
MP:0004952 increased spleen weight,110
MP:0004953 decreased spleen weight,71
MP:0004955 increased thymus weight,15
MP:0004956 decreased thymus weight,28
MP:0004957 abnormal blastocyst morphology,20
MP:0004958 enlarged prostate gland,3
MP:0004961 increased prostate gland weight,6
MP:0004962 decreased prostate gland weight,5
MP:0004963 abnormal blastocoele morphology,5
MP:0004964 absent inner cell mass,18
MP:0004965 inner cell mass degeneration,32
MP:0004966 abnormal inner cell mass proliferation,4
MP:0004967 abnormal kidney epithelium morphology,7
MP:0004969 pale kidney,28
MP:0004970 kidney atrophy,17
MP:0004971 dermal hyperplasia,3
MP:0004973 increased regulatory T cell number,13
MP:0004974 decreased regulatory T cell number,32
MP:0004977 increased B-1 B cell number,15
MP:0004978 decreased B-1 B cell number,35
MP:0004980 increased neuronal precursor cell number,9
MP:0004981 decreased neuronal precursor cell number,29
MP:0004982 abnormal osteoclast morphology,46
MP:0004983 abnormal osteoclast cell number,3
MP:0004984 increased osteoclast cell number,58
MP:0004985 decreased osteoclast cell number,41
MP:0004986 abnormal osteoblast morphology,23
MP:0004988 increased osteoblast cell number,31
MP:0004989 decreased osteoblast cell number,32
MP:0004991 decreased bone strength,26
MP:0004992 increased bone resorption,27
MP:0004993 decreased bone resorption,23
MP:0004994 abnormal brain wave pattern,46
MP:0004996 abnormal CNS synapse formation,8
MP:0004998 decreased CNS synapse formation,12
MP:0005000 abnormal immune tolerance,5
MP:0005002 abnormal T cell clonal deletion,5
MP:0005006 abnormal osteoblast physiology,52
"MP:0005010 abnormal CD8-positive, alpha beta T cell morphology",28
MP:0005011 increased eosinophil cell number,58
MP:0005012 decreased eosinophil cell number,55
MP:0005013 increased lymphocyte cell number,65
MP:0005014 increased B cell number,102
MP:0005015 increased T cell number,78
MP:0005016 decreased lymphocyte cell number,110
MP:0005017 decreased B cell number,190
MP:0005018 decreased T cell number,153
MP:0005022 abnormal immature B cell morphology,5
MP:0005023 abnormal wound healing,14
MP:0005025 abnormal response to infection,66
MP:0005026 decreased susceptibility to parasitic infection,28
MP:0005027 increased susceptibility to parasitic infection,80
MP:0005028 abnormal trophectoderm morphology,16
MP:0005029 abnormal amnion morphology,16
MP:0005030 absent amnion,18
MP:0005031 abnormal trophoblast layer morphology,51
MP:0005032 abnormal ectoplacental cone morphology,16
MP:0005033 abnormal trophoblast giant cell morphology,35
MP:0005034 abnormal anus morphology,5
MP:0005036 diarrhea,31
MP:0005039 hypoxia,26
MP:0005040 abnormal MHC II cell surface expression on macrophages,6
MP:0005042 abnormal level of surface class II molecules,15
MP:0005044 sepsis,16
MP:0005046 absent spleen white pulp,4
MP:0005048 abnormal thrombosis,49
MP:0005058 abnormal lysosome morphology,30
MP:0005059 lysosomal protein accumulation,13
MP:0005060 accumulation of giant lysosomes in kidney/renal tubule cells,6
MP:0005061 abnormal eosinophil morphology,4
MP:0005065 abnormal neutrophil morphology,17
MP:0005068 abnormal NK cell morphology,7
MP:0005070 impaired natural killer cell mediated cytotoxicity,45
MP:0005074 impaired granulocyte bactericidal activity,6
MP:0005075 abnormal melanosome morphology,12
MP:0005076 abnormal cell differentiation,37
MP:0005078 abnormal cytotoxic T cell physiology,33
MP:0005079 decreased cytotoxic T cell cytolysis,29
MP:0005083 abnormal biliary tract morphology,3
MP:0005084 abnormal gallbladder morphology,5
MP:0005085 abnormal gallbladder physiology,8
MP:0005087 decreased acute inflammation,22
MP:0005088 increased acute inflammation,16
MP:0005089 decreased double-negative T cell number,31
MP:0005090 increased double-negative T cell number,57
MP:0005091 increased double-positive T cell number,28
MP:0005092 decreased double-positive T cell number,97
MP:0005093 decreased B cell proliferation,70
MP:0005094 abnormal T cell proliferation,28
MP:0005095 decreased T cell proliferation,134
MP:0005096 erythroblastosis,4
MP:0005097 polychromatophilia,29
MP:0005098 abnormal optic choroid morphology,7
MP:0005099 abnormal ciliary body morphology,6
MP:0005100 abnormal choroid pigmentation,4
MP:0005102 abnormal iris pigmentation,12
MP:0005103 abnormal retinal pigmentation,78
MP:0005104 abnormal tarsal bone morphology,16
MP:0005105 abnormal middle ear ossicle morphology,31
MP:0005106 abnormal incus morphology,19
MP:0005107 abnormal stapes morphology,19
MP:0005108 abnormal ulna morphology,23
MP:0005109 abnormal talus morphology,6
MP:0005112 abnormal spinal cord ventral horn morphology,9
MP:0005114 premature hair loss,12
MP:0005119 decreased circulating thyroid-stimulating hormone level,4
MP:0005120 decreased circulating growth hormone level,14
MP:0005121 decreased circulating prolactin level,16
MP:0005122 increased circulating thyroid-stimulating hormone level,12
MP:0005123 increased circulating growth hormone level,13
MP:0005124 increased circulating prolactin level,7
MP:0005128 decreased adrenocorticotropin level,6
MP:0005129 increased adrenocorticotropin level,6
MP:0005130 decreased follicle stimulating hormone level,11
MP:0005132 decreased luteinizing hormone level,11
MP:0005133 increased luteinizing hormone level,3
MP:0005134 decreased thyroid-stimulating hormone level,8
MP:0005135 increased thyroid-stimulating hormone level,6
MP:0005136 decreased growth hormone level,16
MP:0005137 increased growth hormone level,3
MP:0005138 decreased prolactin level,9
MP:0005140 decreased cardiac muscle contractility,98
MP:0005141 liver hyperplasia,8
MP:0005145 increased circulating VLDL cholesterol level,17
MP:0005146 decreased circulating VLDL cholesterol level,19
MP:0005148 seminal vesicle hypoplasia,4
MP:0005150 cachexia,97
MP:0005152 pancytopenia,16
MP:0005153 abnormal B cell proliferation,7
MP:0005154 increased B cell proliferation,52
MP:0005155 herniated intestine,3
MP:0005156 bradykinesia,27
MP:0005157 holoprosencephaly,30
MP:0005159 azoospermia,139
MP:0005161 hematuria,9
MP:0005162 carpoptosis,3
MP:0005163 cyclopia,10
MP:0005164 abnormal response to injury,35
MP:0005165 increased susceptibility to injury,43
MP:0005166 decreased susceptibility to injury,60
MP:0005167 abnormal blood-brain barrier function,21
MP:0005168 abnormal female meiosis,50
MP:0005169 abnormal male meiosis,58
MP:0005170 cleft upper lip,20
MP:0005171 absent coat pigmentation,9
MP:0005172 decreased eye pigmentation,14
MP:0005174 abnormal tail pigmentation,3
MP:0005175 non-pigmented tail tip,8
MP:0005176 eyelids fail to open,19
MP:0005178 increased circulating cholesterol level,153
MP:0005179 decreased circulating cholesterol level,173
MP:0005181 decreased circulating estradiol level,21
MP:0005182 increased circulating estradiol level,14
MP:0005185 decreased circulating progesterone level,27
MP:0005186 increased circulating progesterone level,7
MP:0005188 small penis,6
MP:0005189 abnormal anogenital distance,11
MP:0005190 osteomyelitis,4
MP:0005191 head tilt,34
MP:0005192 increased motor neuron number,11
MP:0005193 abnormal anterior eye segment morphology,19
MP:0005195 abnormal posterior eye segment morphology,8
MP:0005199 abnormal iris pigment epithelium,4
MP:0005201 abnormal retinal pigment epithelium morphology,75
MP:0005202 lethargy,86
MP:0005203 abnormal trabecular meshwork morphology,3
MP:0005204 abnormal canal of Schlemm morphology,7
MP:0005205 abnormal eye anterior chamber morphology,17
MP:0005208 abnormal iris stroma morphology,4
MP:0005211 increased stomach mucosa thickness,8
MP:0005215 abnormal pancreatic islet morphology,49
MP:0005216 abnormal pancreatic alpha cell morphology,14
MP:0005217 abnormal pancreatic beta cell morphology,38
MP:0005218 abnormal pancreatic delta cell morphology,5
MP:0005220 abnormal exocrine pancreas morphology,12
MP:0005221 abnormal rostral-caudal axis patterning,57
MP:0005222 abnormal somite size,7
MP:0005223 abnormal dorsal-ventral polarity of the somites,9
MP:0005224 abnormal left-right axis symmetry of the somites,5
MP:0005225 abnormal vertebrae development,23
MP:0005226 abnormal vertebral arch development,12
MP:0005227 abnormal vertebral body development,7
MP:0005229 abnormal intervertebral disk development,8
MP:0005230 ectrodactyly,7
MP:0005232 abnormal mesenteric lymph node morphology,20
MP:0005236 abnormal olfactory nerve morphology,11
MP:0005237 abnormal olfactory tract morphology,7
MP:0005238 increased brain size,14
MP:0005239 abnormal Bruch membrane morphology,9
MP:0005240 abnormal amacrine cell morphology,11
MP:0005241 abnormal retinal ganglion layer morphology,24
MP:0005243 hemothorax,8
MP:0005244 hemopericardium,34
MP:0005247 abnormal extraocular muscle morphology,3
MP:0005249 abnormal palatine bone morphology,11
MP:0005250 Sertoli cell hypoplasia,6
MP:0005251 blepharitis,15
MP:0005253 abnormal eye physiology,59
MP:0005258 ocular hypertension,8
MP:0005261 aniridia,3
MP:0005262 coloboma,16
MP:0005264 glomerulosclerosis,50
MP:0005265 abnormal blood urea nitrogen level,3
MP:0005266 abnormal metabolism,36
MP:0005267 abnormal olfactory cortex morphology,5
MP:0005269 abnormal occipital bone morphology,21
MP:0005270 abnormal zygomatic bone morphology,15
MP:0005272 abnormal temporal bone morphology,21
MP:0005274 abnormal viscerocranium morphology,13
MP:0005275 abnormal skin tensile strength,3
MP:0005277 abnormal brainstem morphology,27
MP:0005278 abnormal cholesterol homeostasis,33
MP:0005280 abnormal fatty acid level,10
MP:0005281 increased fatty acid level,28
MP:0005282 decreased fatty acid level,22
MP:0005283 increased unsaturated fatty acid level,4
MP:0005285 decreased unsaturated fatty acid level,4
MP:0005287 narrow eye opening,31
MP:0005288 abnormal oxygen consumption,8
MP:0005289 increased oxygen consumption,76
MP:0005290 decreased oxygen consumption,38
MP:0005291 abnormal glucose tolerance,11
MP:0005292 improved glucose tolerance,177
MP:0005293 impaired glucose tolerance,230
MP:0005294 abnormal heart ventricle morphology,77
MP:0005296 abnormal humerus morphology,33
MP:0005297 spina bifida occulta,13
MP:0005298 abnormal clavicle morphology,20
MP:0005300 abnormal corneal stroma morphology,23
MP:0005301 abnormal corneal endothelium morphology,9
MP:0005306 abnormal phalanx morphology,47
MP:0005307 head tossing,31
MP:0005309 increased circulating ammonia level,12
MP:0005310 abnormal salivary gland physiology,4
MP:0005311 abnormal circulating amino acid level,56
MP:0005312 pericardial effusion,63
MP:0005313 absent adrenal gland,8
MP:0005314 absent thyroid gland,6
MP:0005315 absent pituitary gland,4
MP:0005316 abnormal response to tactile stimuli,18
MP:0005317 increased triglyceride level,22
MP:0005318 decreased triglyceride level,28
MP:0005319 abnormal enzyme/coenzyme level,50
MP:0005322 abnormal serotonin level,32
MP:0005323 dystonia,15
MP:0005324 ascites,8
MP:0005325 abnormal renal glomerulus morphology,101
MP:0005326 abnormal podocyte morphology,27
MP:0005327 abnormal mesangial cell morphology,4
MP:0005328 abnormal circulating creatinine level,3
MP:0005329 abnormal myocardium layer morphology,78
MP:0005330 cardiomyopathy,39
MP:0005331 insulin resistance,117
MP:0005332 abnormal amino acid level,41
MP:0005333 decreased heart rate,91
MP:0005334 abnormal fat pad morphology,29
MP:0005335 abnormal gonadal fat pad morphology,8
MP:0005336 abnormal inguinal fat pad morphology,7
MP:0005338 atherosclerotic lesions,6
MP:0005339 increased susceptibility to atherosclerosis,8
MP:0005341 decreased susceptibility to atherosclerosis,7
MP:0005342 abnormal intestinal lipid absorption,10
MP:0005343 increased circulating aspartate transaminase level,56
MP:0005344 increased circulating bilirubin level,54
MP:0005345 abnormal circulating corticosterone level,6
MP:0005348 increased T cell proliferation,85
MP:0005350 increased susceptibility to autoimmune disorder,17
MP:0005351 decreased susceptibility to autoimmune disorder,6
MP:0005352 small cranium,30
MP:0005353 abnormal patella morphology,11
MP:0005354 abnormal ilium morphology,7
MP:0005356 positive geotaxis,8
MP:0005357 novel environmental response-related retropulsion,3
MP:0005358 abnormal incisor morphology,57
MP:0005359 growth retardation of incisors,4
MP:0005360 urolithiasis,7
MP:0005361 small pituitary gland,12
MP:0005362 abnormal Langerhans cell physiology,13
MP:0005365 abnormal bile salt homeostasis,18
MP:0005366 variegated coat color,5
MP:0005382 craniofacial phenotype,6
MP:0005385 cardiovascular system phenotype,29
MP:0005387 immune system phenotype,14
MP:0005398 decreased susceptibility to fungal infection,4
MP:0005399 increased susceptibility to fungal infection,17
MP:0005402 abnormal action potential,61
MP:0005403 abnormal nerve conduction,25
MP:0005404 abnormal axon morphology,107
MP:0005405 axon degeneration,52
MP:0005406 abnormal heart size,4
MP:0005407 hyperalgesia,12
MP:0005408 hypopigmentation,21
MP:0005409 darkened coat color,16
MP:0005410 abnormal fertilization,13
MP:0005412 vascular stenosis,3
MP:0005415 intrahepatic cholestasis,4
MP:0005416 abnormal circulating protein level,48
MP:0005418 abnormal circulating hormone level,33
MP:0005419 decreased circulating serum albumin level,80
MP:0005421 loose skin,14
MP:0005422 osteosclerosis,10
MP:0005423 abnormal somatic nervous system physiology,9
MP:0005424 jerky movement,17
MP:0005425 increased macrophage cell number,54
MP:0005426 tachypnea,10
MP:0005430 absent fibula,7
MP:0005431 decreased oocyte number,47
MP:0005435 hemoperitoneum,9
MP:0005438 abnormal glycogen homeostasis,16
MP:0005439 decreased glycogen level,30
MP:0005440 increased glycogen level,7
MP:0005441 increased urine calcium level,19
MP:0005444 abnormal retinol metabolism,4
MP:0005445 abnormal neurotransmitter secretion,14
MP:0005448 abnormal energy homeostasis,13
MP:0005449 abnormal food intake,66
MP:0005450 abnormal energy expenditure,22
MP:0005451 abnormal body composition,3
MP:0005452 abnormal adipose tissue amount,6
MP:0005455 increased susceptibility to weight gain,29
MP:0005458 increased percent body fat/body weight,45
MP:0005459 decreased percent body fat/body weight,72
MP:0005460 abnormal leukopoiesis,9
MP:0005461 abnormal dendritic cell morphology,14
MP:0005462 abnormal mast cell differentiation,6
"MP:0005463 abnormal CD4-positive, alpha-beta T cell physiology",56
MP:0005464 abnormal platelet physiology,51
MP:0005465 abnormal T-helper 1 physiology,39
MP:0005466 abnormal T-helper 2 physiology,49
MP:0005468 abnormal thyroid hormone level,6
MP:0005471 decreased thyroxine level,9
MP:0005472 abnormal triiodothyronine level,3
MP:0005473 decreased triiodothyronine level,5
MP:0005474 increased triiodothyronine level,5
MP:0005477 increased circulating thyroxine level,11
MP:0005478 decreased circulating thyroxine level,28
MP:0005479 decreased circulating triiodothyronine level,14
MP:0005480 increased circulating triiodothyronine level,10
MP:0005481 increased chronic myelocytic leukemia incidence,6
MP:0005488 bronchial epithelial hyperplasia,4
MP:0005489 vascular smooth muscle hyperplasia,9
MP:0005491 pancreatic islet hyperplasia,28
MP:0005493 stomach epithelial hyperplasia,7
MP:0005498 hyporesponsive to tactile stimuli,39
MP:0005501 abnormal skin physiology,31
MP:0005502 abnormal renal/urinary system physiology,5
MP:0005503 abnormal tendon morphology,17
MP:0005504 abnormal ligament morphology,5
MP:0005505 thrombocytosis,54
MP:0005507 tail dragging,3
MP:0005508 abnormal skeleton morphology,115
MP:0005517 decreased liver regeneration,15
MP:0005522 increased circulating atrial natriuretic factor,4
MP:0005525 increased renal plasma flow rate,3
MP:0005526 decreased renal plasma flow rate,4
MP:0005527 increased renal glomerular filtration rate,5
MP:0005528 decreased renal glomerular filtration rate,11
MP:0005531 increased renal vascular resistance,3
MP:0005533 increased body temperature,22
MP:0005534 decreased body temperature,45
MP:0005535 abnormal body temperature,6
MP:0005536 Leydig cell hypoplasia,17
MP:0005537 abnormal cerebral aqueduct morphology,13
MP:0005542 corneal vascularization,26
MP:0005543 decreased cornea thickness,12
MP:0005545 abnormal lens development,23
MP:0005546 choroidal neovascularization,7
MP:0005547 abnormal Muller cell morphology,12
MP:0005548 retinal pigment epithelium atrophy,5
MP:0005551 abnormal eye electrophysiology,117
MP:0005553 increased circulating creatinine level,79
MP:0005554 decreased circulating creatinine level,45
MP:0005556 abnormal renal filtration rate,5
MP:0005558 decreased creatinine clearance,15
MP:0005559 increased circulating glucose level,127
MP:0005560 decreased circulating glucose level,260
MP:0005561 increased mean corpuscular hemoglobin,94
MP:0005562 decreased mean corpuscular hemoglobin,72
MP:0005563 abnormal hemoglobin content,5
MP:0005564 increased hemoglobin content,57
MP:0005565 increased blood urea nitrogen level,133
MP:0005566 decreased blood urea nitrogen level,36
MP:0005567 decreased circulating total protein level,47
MP:0005568 increased circulating total protein level,19
MP:0005571 decreased lactate dehydrogenase level,15
MP:0005572 abnormal pulmonary respiratory rate,4
MP:0005573 increased pulmonary respiratory rate,13
MP:0005574 decreased pulmonary respiratory rate,17
MP:0005575 increased pulmonary ventilation,7
MP:0005576 decreased pulmonary ventilation,9
MP:0005578 teratozoospermia,66
MP:0005579 absent outer ear,8
MP:0005581 abnormal renin activity,3
MP:0005582 increased renin activity,12
MP:0005584 abnormal enzyme/coenzyme activity,145
MP:0005585 increased tidal volume,8
MP:0005586 decreased tidal volume,6
MP:0005587 abnormal Meckel's cartilage morphology,30
MP:0005590 increased vasodilation,16
MP:0005591 decreased vasodilation,24
MP:0005592 abnormal vascular smooth muscle morphology,43
MP:0005595 abnormal vascular smooth muscle physiology,34
MP:0005596 increased susceptibility to type I hypersensitivity reaction,28
MP:0005597 decreased susceptibility to type I hypersensitivity reaction,29
MP:0005598 decreased ventricle muscle contractility,66
MP:0005599 increased cardiac muscle contractility,25
MP:0005600 increased ventricle muscle contractility,10
MP:0005601 increased angiogenesis,22
MP:0005602 decreased angiogenesis,64
MP:0005604 hyperekplexia,4
MP:0005605 increased bone mass,32
MP:0005606 increased bleeding time,62
MP:0005607 decreased bleeding time,9
MP:0005608 cardiac interstitial fibrosis,38
MP:0005610 increased circulating antidiuretic hormone level,4
MP:0005616 decreased susceptibility to type IV hypersensitivity reaction,51
MP:0005617 increased susceptibility to type IV hypersensitivity reaction,20
MP:0005618 decreased urine potassium level,12
MP:0005619 increased urine potassium level,12
MP:0005620 abnormal muscle contractility,24
MP:0005621 abnormal cell physiology,233
MP:0005627 increased circulating potassium level,40
MP:0005628 decreased circulating potassium level,18
MP:0005630 increased lung weight,19
MP:0005631 decreased lung weight,20
MP:0005632 decreased circulating aspartate transaminase level,32
MP:0005633 increased circulating sodium level,70
MP:0005634 decreased circulating sodium level,19
MP:0005635 decreased circulating bilirubin level,11
MP:0005637 abnormal iron homeostasis,24
MP:0005638 hemochromatosis,6
MP:0005639 hemosiderosis,10
MP:0005641 increased mean corpuscular hemoglobin concentration,31
MP:0005642 decreased mean corpuscular hemoglobin concentration,39
MP:0005643 decreased dopamine level,31
MP:0005644 agonadal,6
MP:0005645 abnormal hypothalamus physiology,6
MP:0005646 abnormal pituitary gland physiology,7
MP:0005650 abnormal limb bud morphology,39
MP:0005654 porphyria,4
MP:0005655 increased aggression,5
MP:0005656 decreased aggression,16
MP:0005657 abnormal neural plate morphology,24
MP:0005658 increased susceptibility to diet-induced obesity,45
MP:0005659 decreased susceptibility to diet-induced obesity,99
MP:0005661 decreased circulating adrenaline level,7
MP:0005662 increased circulating adrenaline level,6
MP:0005664 decreased circulating noradrenaline level,6
MP:0005665 increased circulating noradrenaline level,7
MP:0005666 abnormal adipose tissue physiology,15
MP:0005667 abnormal circulating leptin level,3
MP:0005668 decreased circulating leptin level,89
MP:0005669 increased circulating leptin level,76
MP:0005670 abnormal white adipose tissue physiology,16
MP:0005671 abnormal response to transplant,24
MP:0005673 decreased susceptibility to graft versus host disease,4
MP:0006000 abnormal corneal epithelium morphology,35
MP:0006001 abnormal intestinal transit time,8
MP:0006007 abnormal basal ganglion morphology,14
MP:0006009 abnormal neuronal migration,76
MP:0006011 abnormal endolymphatic duct morphology,12
MP:0006012 dilated endolymphatic duct,9
MP:0006014 dilated endolymphatic sac,4
MP:0006018 abnormal tympanic membrane morphology,8
MP:0006020 decreased tympanic ring size,13
MP:0006021 abnormal Reissner membrane morphology,4
MP:0006024 collapsed Reissner membrane,3
MP:0006025 distended Reissner membrane,3
MP:0006026 dilated terminal bronchiole tubes,3
MP:0006027 impaired lung alveolus development,35
MP:0006029 abnormal sclerotome morphology,14
MP:0006030 abnormal otic vesicle development,19
MP:0006031 abnormal pharyngeal pouch morphology,5
MP:0006032 abnormal ureteric bud morphology,15
MP:0006033 abnormal external auditory canal morphology,12
MP:0006035 abnormal mitochondrion morphology,53
MP:0006036 abnormal mitochondrial physiology,53
MP:0006038 increased mitochondrial fission,3
MP:0006042 increased apoptosis,126
MP:0006043 decreased apoptosis,40
MP:0006045 mitral valve regurgitation,3
MP:0006046 atrioventricular valve regurgitation,4
MP:0006047 aortic valve regurgitation,4
MP:0006049 semilunar valve regurgitation,3
MP:0006050 pulmonary fibrosis,24
MP:0006054 spinal hemorrhage,11
MP:0006055 abnormal vascular endothelial cell morphology,41
MP:0006056 increased vascular endothelial cell number,5
MP:0006057 decreased vascular endothelial cell number,5
MP:0006058 decreased cerebral infarction size,26
MP:0006059 decreased susceptibility to ischemic brain injury,16
MP:0006060 increased cerebral infarction size,19
MP:0006061 right atrial isomerism,5
MP:0006062 abnormal vena cava morphology,4
MP:0006063 abnormal inferior vena cava morphology,13
MP:0006065 abnormal heart position or orientation,18
MP:0006068 abnormal horizontal cell morphology,9
MP:0006069 abnormal retinal neuronal layer morphology,39
MP:0006071 abnormal retinal progenitor cell morphology,8
MP:0006072 abnormal retinal apoptosis,41
MP:0006073 abnormal retinal bipolar cell morphology,11
MP:0006074 abnormal retinal rod bipolar cell morphology,15
MP:0006075 abnormal retinal cone bipolar cell morphology,6
MP:0006076 abnormal circulating homocysteine level,7
MP:0006080 CNS ischemia,4
MP:0006082 CNS inflammation,16
MP:0006083 abnormal blood vessel elastic tissue morphology,5
MP:0006084 abnormal circulating phospholipid level,4
MP:0006085 myocardial necrosis,20
MP:0006086 decreased body mass index,16
MP:0006087 increased body mass index,11
MP:0006089 abnormal vestibular saccule morphology,22
MP:0006090 abnormal utricle morphology,17
MP:0006092 abnormal olfactory sensory neuron morphology,20
MP:0006093 arteriovenous malformation,6
MP:0006094 increased fat cell size,28
MP:0006097 abnormal cerebellar lobule formation,9
MP:0006098 absent cerebellar lobules,3
MP:0006099 thin cerebellar granule layer,10
MP:0006107 abnormal fetal atrioventricular canal morphology,10
MP:0006108 abnormal hindbrain development,42
MP:0006113 abnormal heart septum morphology,16
MP:0006116 calcified aortic valve,3
MP:0006117 aortic valve stenosis,11
MP:0006123 tricuspid valve atresia,6
MP:0006126 abnormal cardiac outflow tract development,46
MP:0006128 pulmonary valve stenosis,10
MP:0006130 pulmonary valve atresia,3
MP:0006133 calcified artery,7
MP:0006135 artery stenosis,5
MP:0006137 venoocclusion,5
MP:0006138 congestive heart failure,48
MP:0006141 abnormal atrioventricular node conduction,5
MP:0006142 abnormal sinoatrial node conduction,14
MP:0006143 increased systemic arterial diastolic blood pressure,35
MP:0006144 increased systemic arterial systolic blood pressure,60
MP:0006149 decreased visual acuity,5
MP:0006159 ocular albinism,4
MP:0006162 thick eyelids,3
MP:0006185 retinal hemorrhage,4
MP:0006187 retinal deposits,3
MP:0006197 ocular hypotelorism,6
MP:0006198 enophthalmos,7
MP:0006200 vitreous body deposition,5
MP:0006203 eye hemorrhage,5
MP:0006204 embryonic lethality before implantation,8
MP:0006205 embryonic lethality between implantation and somite formation,5
MP:0006207 embryonic lethality during organogenesis,15
MP:0006219 optic nerve degeneration,8
MP:0006221 optic nerve hypoplasia,10
MP:0006226 iris hypoplasia,7
MP:0006230 iris stroma hypoplasia,3
MP:0006236 absent Meibomian glands,7
MP:0006238 abnormal choriocapillaris morphology,3
MP:0006241 abnormal placement of pupils,6
MP:0006243 impaired pupillary reflex,14
MP:0006253 clinodactyly,5
MP:0006254 thin cerebral cortex,62
MP:0006258 abnormal circumvallate papillae morphology,3
MP:0006260 abnormal gustatory papillae taste bud morphology,3
MP:0006262 increased testis tumor incidence,9
MP:0006263 decreased systemic arterial diastolic blood pressure,6
MP:0006264 decreased systemic arterial systolic blood pressure,33
MP:0006267 abnormal intercalated disc morphology,13
MP:0006269 abnormal mammary gland growth during pregnancy,26
MP:0006270 abnormal mammary gland growth during lactation,20
MP:0006271 abnormal involution of the mammary gland,20
MP:0006272 abnormal urine organic anion level,3
MP:0006278 aortic aneurysm,9
MP:0006279 abnormal limb development,39
MP:0006280 abnormal digit development,16
MP:0006281 abnormal tail development,9
MP:0006282 abnormal spinal cord dorsal horn morphology,7
MP:0006283 increased medulloblastoma incidence,4
MP:0006285 absent inner ear,4
MP:0006286 inner ear hypoplasia,3
MP:0006287 inner ear cysts,4
MP:0006288 small otic capsule,4
MP:0006290 proboscis,5
MP:0006292 abnormal nasal placode morphology,5
MP:0006293 absent nasal placodes,5
MP:0006294 absent optic vesicle,6
MP:0006298 abnormal platelet activation,18
MP:0006299 abnormal latent inhibition of conditioning behavior,5
MP:0006300 abnormal entorhinal cortex morphology,5
MP:0006301 abnormal mesenchyme morphology,11
MP:0006303 abnormal retinal nerve fiber layer morphology,13
MP:0006306 abnormal nasal pit morphology,6
MP:0006308 enlarged seminiferous tubules,4
MP:0006309 decreased retinal ganglion cell number,22
MP:0006316 increased urine sodium level,20
MP:0006317 decreased urine sodium level,24
MP:0006319 abnormal epididymal fat pad morphology,27
MP:0006320 abnormal interscapular fat pad morphology,4
MP:0006321 increased myocardial fiber number,3
MP:0006323 abnormal extraembryonic mesoderm development,12
MP:0006325 impaired hearing,86
MP:0006335 abnormal hearing electrophysiology,7
MP:0006336 abnormal otoacoustic response,4
MP:0006337 abnormal first pharyngeal arch morphology,21
MP:0006338 abnormal second pharyngeal arch morphology,3
MP:0006339 abnormal third pharyngeal arch morphology,5
MP:0006340 abnormal fourth pharyngeal arch morphology,4
MP:0006341 small first pharyngeal arch,10
MP:0006344 small second pharyngeal arch,10
MP:0006345 absent second pharyngeal arch,9
MP:0006346 small pharyngeal arch,12
MP:0006353 increased glycosylated hemoglobin level,4
MP:0006354 abnormal fourth pharyngeal arch artery morphology,15
MP:0006355 abnormal sixth pharyngeal arch artery morphology,11
MP:0006356 abnormal third pharyngeal arch artery morphology,11
MP:0006357 abnormal circulating mineral level,6
MP:0006358 absent pinna reflex,51
MP:0006359 absent startle reflex,33
MP:0006361 abnormal female germ cell morphology,6
MP:0006362 abnormal male germ cell morphology,40
MP:0006365 absent guard hair,6
MP:0006366 absent zigzag hairs,3
MP:0006372 impaired placental function,5
MP:0006375 increased circulating angiotensinogen level,4
MP:0006376 decreased circulating angiotensinogen level,3
MP:0006378 abnormal spermatogonia morphology,25
MP:0006379 abnormal spermatocyte morphology,49
MP:0006380 abnormal spermatid morphology,93
MP:0006382 abnormal lung epithelium morphology,18
MP:0006386 absent somites,34
MP:0006387 abnormal T cell number,20
MP:0006394 abnormal vertebral epiphyseal plate morphology,6
MP:0006395 abnormal epiphyseal plate morphology,23
MP:0006396 decreased long bone epiphyseal plate size,28
MP:0006397 disorganized long bone epiphyseal plate,19
MP:0006398 increased long bone epiphyseal plate size,24
MP:0006399 abnormal long bone epiphyseal ossification zone morphology,6
MP:0006400 decreased molar number,7
MP:0006401 absent male preputial gland,3
MP:0006402 small molars,11
MP:0006410 abnormal common myeloid progenitor cell morphology,52
MP:0006413 increased T cell apoptosis,22
MP:0006414 decreased T cell apoptosis,15
MP:0006415 absent testes,7
MP:0006418 abnormal testis cord formation,6
MP:0006419 disorganized testis cords,4
MP:0006423 dilated rete testis,5
MP:0006429 abnormal hyaline cartilage morphology,6
MP:0006432 abnormal costal cartilage morphology,6
MP:0006433 abnormal articular cartilage morphology,10
MP:0008000 increased ovary tumor incidence,18
MP:0008001 hypochlorhydria,3
MP:0008003 achlorhydria,3
MP:0008006 increased stomach pH,11
MP:0008008 early cellular replicative senescence,41
MP:0008009 delayed cellular replicative senescence,8
MP:0008011 intestine polyps,9
MP:0008014 increased lung tumor incidence,26
MP:0008019 increased liver tumor incidence,25
MP:0008022 dilated heart ventricle,22
MP:0008023 abnormal styloid process morphology,9
MP:0008024 absent lymph nodes,15
MP:0008025 brain vacuoles,21
MP:0008026 abnormal brain white matter morphology,31
MP:0008027 abnormal spinal cord white matter morphology,13
MP:0008028 pregnancy-related premature death,13
MP:0008029 abnormal paraxial mesoderm morphology,19
MP:0008031 decreased Cajal-Retzius cell number,4
MP:0008033 impaired lipolysis,11
MP:0008034 enhanced lipolysis,16
MP:0008035 behavioral arrest,4
MP:0008036 abnormal NK T cell morphology,3
MP:0008037 abnormal T cell morphology,30
MP:0008039 increased NK T cell number,17
MP:0008040 decreased NK T cell number,48
MP:0008042 abnormal NK T cell physiology,9
MP:0008044 increased NK cell number,36
MP:0008045 decreased NK cell number,58
MP:0008046 absent NK cells,4
MP:0008049 increased memory T cell number,23
MP:0008050 decreased memory T cell number,15
MP:0008051 abnormal memory T cell physiology,10
MP:0008053 abnormal NK cell differentiation,9
MP:0008054 abnormal uterine NK cell morphology,4
MP:0008055 increased urine osmolality,9
MP:0008056 abnormal retinal ganglion cell morphology,26
MP:0008057 abnormal DNA replication,15
MP:0008058 abnormal DNA repair,27
MP:0008059 abnormal podocyte foot process morphology,10
MP:0008060 abnormal podocyte slit diaphragm morphology,3
MP:0008061 absent podocyte slit diaphragm,5
MP:0008065 short endolymphatic duct,5
MP:0008067 retinal ganglion cell degeneration,11
MP:0008069 abnormal joint mobility,11
MP:0008070 absent T cells,12
MP:0008071 absent B cells,9
"MP:0008073 abnormal CD4-positive, alpha beta T cell number",4
"MP:0008074 increased CD4-positive, alpha beta T cell number",87
"MP:0008075 decreased CD4-positive, alpha beta T cell number",130
MP:0008076 abnormal CD4-positive T cell differentiation,25
"MP:0008078 increased CD8-positive, alpha-beta T cell number",82
"MP:0008079 decreased CD8-positive, alpha-beta T cell number",134
"MP:0008080 abnormal CD8-positive, alpha-beta T cell differentiation",14
MP:0008082 increased single-positive T cell number,28
MP:0008083 decreased single-positive T cell number,38
MP:0008086 increased T-helper 1 cell number,10
MP:0008088 abnormal T-helper 1 cell differentiation,17
MP:0008090 increased T-helper 2 cell number,10
MP:0008091 decreased T-helper 2 cell number,5
MP:0008092 abnormal T-helper 2 cell differentiation,11
MP:0008097 increased plasma cell number,29
MP:0008098 decreased plasma cell number,11
MP:0008099 abnormal plasma cell differentiation,5
MP:0008101 lymph node hypoplasia,29
MP:0008102 lymph node hyperplasia,23
MP:0008105 increased amacrine cell number,4
MP:0008106 decreased amacrine cell number,6
MP:0008107 absent horizontal cells,3
MP:0008108 abnormal small intestinal villus morphology,21
MP:0008109 abnormal small intestinal microvillus morphology,6
MP:0008111 abnormal granulocyte differentiation,19
MP:0008112 abnormal monocyte differentiation,7
MP:0008113 abnormal macrophage differentiation,3
MP:0008114 abnormal Kupffer cell morphology,18
MP:0008115 abnormal dendritic cell differentiation,10
MP:0008118 absent Langerhans cell,5
MP:0008119 decreased Langerhans cell number,4
MP:0008122 decreased myeloid dendritic cell number,8
MP:0008124 decreased plasmacytoid dendritic cell number,7
MP:0008126 increased dendritic cell number,23
MP:0008127 decreased dendritic cell number,36
MP:0008128 abnormal brain internal capsule morphology,13
MP:0008129 absent brain internal capsule,4
MP:0008133 decreased Peyer's patch number,23
MP:0008135 small Peyer's patches,26
MP:0008136 enlarged Peyer's patches,5
MP:0008138 absent podocyte foot process,5
MP:0008139 fused podocyte foot processes,8
MP:0008140 podocyte foot process effacement,22
MP:0008141 decreased small intestinal microvillus size,3
MP:0008142 decreased small intestinal villus size,4
MP:0008143 abnormal dendrite morphology,57
MP:0008146 asymmetric sternocostal joints,30
MP:0008148 abnormal sternocostal joint morphology,32
MP:0008149 abnormal costovertebral joint morphology,6
MP:0008150 decreased diameter of long bones,3
MP:0008151 increased diameter of long bones,18
MP:0008152 decreased diameter of femur,9
MP:0008156 decreased diameter of tibia,4
MP:0008158 increased diameter of femur,9
MP:0008160 increased diameter of humerus,6
MP:0008161 increased diameter of radius,4
MP:0008162 increased diameter of tibia,5
MP:0008163 increased diameter of ulna,4
MP:0008167 increased B-1a cell number,9
MP:0008168 decreased B-1a cell number,24
MP:0008169 increased B-1b cell number,9
MP:0008170 decreased B-1b cell number,3
MP:0008171 abnormal mature B cell morphology,4
MP:0008173 increased follicular B cell number,13
MP:0008174 decreased follicular B cell number,42
MP:0008177 increased germinal center B cell number,14
MP:0008178 decreased germinal center B cell number,8
MP:0008179 absent germinal center B cells,4
MP:0008180 abnormal marginal zone B cell morphology,7
MP:0008181 increased marginal zone B cell number,28
MP:0008182 decreased marginal zone B cell number,45
MP:0008183 absent marginal zone B cells,5
MP:0008186 increased pro-B cell number,28
MP:0008189 increased transitional stage B cell number,13
MP:0008190 decreased transitional stage B cell number,22
MP:0008191 abnormal follicular B cell physiology,4
MP:0008192 abnormal germinal center B cell physiology,3
MP:0008193 abnormal marginal zone B cell physiology,4
MP:0008201 absent follicular dendritic cells,7
MP:0008203 absent B-1a cells,4
MP:0008207 decreased B-2 B cell number,17
MP:0008208 decreased pro-B cell number,34
MP:0008209 decreased pre-B cell number,50
MP:0008210 increased mature B cell number,29
MP:0008211 decreased mature B cell number,89
MP:0008212 absent mature B cells,11
MP:0008214 increased immature B cell number,23
MP:0008215 decreased immature B cell number,47
MP:0008217 abnormal B cell activation,29
MP:0008221 abnormal hippocampal commissure morphology,8
MP:0008222 decreased hippocampal commissure size,5
MP:0008223 absent hippocampal commissure,11
MP:0008225 abnormal anterior commissure morphology,16
MP:0008226 decreased anterior commissure size,8
MP:0008227 absent anterior commissure,13
MP:0008234 absent spleen marginal zone,9
MP:0008235 increased susceptibility to neuronal excitotoxicity,17
MP:0008236 decreased susceptibility to neuronal excitotoxicity,17
MP:0008237 abnormal ventral coat pigmentation,4
MP:0008240 abnormal spleen marginal zone macrophage morphology,3
MP:0008241 abnormal metallophilic macrophage morphology,5
MP:0008245 abnormal alveolar macrophage morphology,10
MP:0008246 abnormal leukocyte morphology,21
MP:0008247 abnormal mononuclear cell morphology,5
MP:0008249 abnormal common lymphocyte progenitor cell morphology,11
MP:0008250 abnormal myeloid leukocyte morphology,11
MP:0008253 absent megakaryocytes,4
MP:0008254 increased megakaryocyte cell number,36
MP:0008255 decreased megakaryocyte cell number,13
MP:0008257 thin myometrium,8
MP:0008258 thin endometrium,8
MP:0008259 abnormal optic disc morphology,12
MP:0008260 abnormal autophagy,41
MP:0008261 arrest of male meiosis,90
MP:0008263 abnormal hippocampus CA1 region morphology,23
MP:0008265 abnormal hippocampus CA2 region morphology,5
MP:0008267 abnormal hippocampus CA3 region morphology,16
MP:0008271 abnormal bone ossification,81
MP:0008272 abnormal endochondral bone ossification,21
MP:0008273 abnormal intramembranous bone ossification,8
MP:0008274 failure of bone ossification,4
MP:0008277 abnormal sternum ossification,35
MP:0008278 failure of sternum ossification,3
MP:0008279 arrest of spermiogenesis,13
MP:0008280 abnormal male germ cell apoptosis,107
MP:0008282 enlarged hippocampus,5
MP:0008283 small hippocampus,27
MP:0008284 abnormal hippocampus pyramidal cell layer,22
MP:0008285 abnormal hippocampus granule cell layer,6
MP:0008288 abnormal adrenal cortex morphology,13
MP:0008289 abnormal adrenal medulla morphology,5
MP:0008291 abnormal adrenocortical cell morphology,5
MP:0008294 abnormal adrenal gland zona fasciculata morphology,13
MP:0008295 abnormal adrenal gland zona reticularis morphology,5
MP:0008297 retention of the adrenal gland x-zone,4
MP:0008299 adrenal cortical hyperplasia,6
MP:0008307 short scala media,4
MP:0008317 abnormal paravertebral ganglion morphology,3
MP:0008320 absent adenohypophysis,3
MP:0008321 small adenohypophysis,11
MP:0008325 abnormal gonadotroph morphology,3
MP:0008327 abnormal corticotroph morphology,3
MP:0008329 decreased somatotroph cell number,11
MP:0008330 absent somatotrophs,4
MP:0008332 decreased lactotroph cell number,9
MP:0008333 absent lactotrophs,4
MP:0008335 decreased gonadotroph cell number,9
MP:0008337 increased thyrotroph cell number,5
MP:0008338 decreased thyrotroph cell number,5
MP:0008343 abnormal gamma-delta T cell morphology,4
MP:0008346 increased gamma-delta T cell number,23
MP:0008347 decreased gamma-delta T cell number,23
MP:0008348 absent gamma-delta T cells,3
MP:0008349 abnormal gamma-delta intraepithelial T cell morphology,3
MP:0008351 decreased gamma-delta intraepithelial T cell number,5
MP:0008356 abnormal gamma-delta T cell differentiation,7
MP:0008365 adenohypophysis hypoplasia,7
MP:0008380 abnormal gonial bone morphology,6
MP:0008381 absent gonial bone,4
MP:0008382 gonial bone hypoplasia,4
MP:0008387 hypochromic anemia,7
MP:0008388 hypochromic microcytic anemia,11
MP:0008390 abnormal primordial germ cell proliferation,8
MP:0008391 abnormal primordial germ cell morphology,6
MP:0008392 decreased primordial germ cell number,23
MP:0008393 absent primordial germ cells,5
MP:0008395 abnormal osteoblast differentiation,33
MP:0008396 abnormal osteoclast differentiation,72
MP:0008399 abnormal alpha-beta intraepithelial T cell morphology,4
"MP:0008401 abnormal CD8 positive, alpha-beta intraepithelial T cell morphology",4
MP:0008404 increased cellular sensitivity to methylmethanesulfonate,5
MP:0008406 increased cellular sensitivity to hydrogen peroxide,19
MP:0008410 increased cellular sensitivity to ultraviolet irradiation,19
MP:0008411 decreased cellular sensitivity to ultraviolet irradiation,10
MP:0008412 increased cellular sensitivity to oxidative stress,17
MP:0008414 abnormal spatial reference memory,28
MP:0008415 abnormal neurite morphology,28
MP:0008418 abnormal cutaneous elastic fiber morphology,5
MP:0008428 abnormal spatial working memory,54
MP:0008431 abnormal short term spatial reference memory,5
MP:0008432 abnormal long term spatial reference memory,15
MP:0008438 abnormal cutaneous collagen fibril morphology,20
MP:0008439 abnormal cortical plate morphology,12
MP:0008440 abnormal subplate morphology,4
MP:0008441 thin cortical plate,7
MP:0008444 retinal cone cell degeneration,17
MP:0008446 decreased retinal cone cell number,16
MP:0008449 abnormal retinal cone cell outer segment morphology,7
MP:0008450 retinal photoreceptor degeneration,52
MP:0008451 retinal rod cell degeneration,19
MP:0008453 decreased retinal rod cell number,4
MP:0008454 absent retinal rod cells,4
MP:0008456 abnormal retinal rod cell outer segment morphology,22
MP:0008457 abnormal cortical intermediate zone morphology,4
MP:0008458 abnormal cortical ventricular zone morphology,16
MP:0008461 left atrial isomerism,4
MP:0008462 abnormal medium spiny neuron morphology,3
MP:0008463 abnormal peripheral lymph node morphology,7
MP:0008464 absent peripheral lymph nodes,5
MP:0008465 absent mesenteric lymph nodes,8
MP:0008466 enlarged mesenteric lymph nodes,14
MP:0008469 abnormal protein level,11
MP:0008470 abnormal spleen B cell follicle morphology,42
MP:0008471 abnormal spleen primary B follicle morphology,6
MP:0008473 abnormal spleen follicular dendritic cell network,3
MP:0008474 absent spleen germinal center,21
MP:0008475 intermingled spleen red and white pulp,14
MP:0008476 increased spleen red pulp amount,43
MP:0008477 decreased spleen red pulp amount,10
MP:0008478 increased spleen white pulp amount,21
MP:0008479 decreased spleen white pulp amount,26
MP:0008480 absent eye pigmentation,4
MP:0008481 increased spleen germinal center number,18
MP:0008482 decreased spleen germinal center number,19
MP:0008483 increased spleen germinal center size,16
MP:0008484 decreased spleen germinal center size,18
MP:0008486 decreased muscle spindle number,3
MP:0008487 abnormal mesonephros morphology,9
MP:0008488 abnormal semicircular canal ampulla morphology,5
MP:0008489 slow postnatal weight gain,138
MP:0008493 alpha-synuclein inclusion body,4
MP:0008495 decreased IgG1 level,92
MP:0008496 decreased IgG2a level,57
MP:0008497 decreased IgG2b level,45
MP:0008498 decreased IgG3 level,64
MP:0008499 increased IgG1 level,65
MP:0008500 increased IgG2a level,54
MP:0008501 increased IgG2b level,34
MP:0008502 increased IgG3 level,23
MP:0008503 abnormal spinal cord grey matter morphology,5
MP:0008504 abnormal adrenal chromaffin cell morphology,4
MP:0008507 thin retinal ganglion layer,9
MP:0008509 disorganized retinal ganglion layer,4
MP:0008511 thin retinal inner nuclear layer,26
MP:0008512 disorganized retinal inner nuclear layer,9
MP:0008513 thin retinal inner plexiform layer,9
MP:0008515 thin retinal outer nuclear layer,74
MP:0008516 disorganized retinal outer nuclear layer,11
MP:0008518 retinal outer nuclear layer degeneration,30
MP:0008519 thin retinal outer plexiform layer,16
MP:0008520 disorganized retinal outer plexiform layer,4
MP:0008522 abnormal lymph node germinal center morphology,11
MP:0008523 absent lymph node germinal center,6
MP:0008524 increased plasmacytoid dendritic cell number,5
MP:0008525 decreased cranium height,26
MP:0008526 decreased cranium width,7
MP:0008528 polycystic kidney,45
MP:0008530 abnormal rostral-caudal patterning of the somites,8
MP:0008531 increased chemical nociceptive threshold,24
MP:0008532 decreased chemical nociceptive threshold,7
MP:0008533 abnormal anterior visceral endoderm morphology,11
MP:0008534 enlarged fourth ventricle,6
MP:0008535 enlarged lateral ventricles,54
MP:0008536 enlarged third ventricle,16
MP:0008537 increased susceptibility to induced colitis,61
MP:0008538 decreased zigzag hair amount,3
MP:0008539 decreased susceptibility to induced colitis,19
MP:0008540 abnormal cerebral hemisphere morphology,23
MP:0008542 enlarged cervical lymph nodes,5
MP:0008543 atrial fibrillation,7
MP:0008544 impaired olfaction,19
MP:0008545 absent sperm flagellum,12
MP:0008546 abnormal vesicle-mediated transport,15
MP:0008547 abnormal neocortex morphology,24
MP:0008552 abnormal circulating tumor necrosis factor level,5
MP:0008553 increased circulating tumor necrosis factor level,49
MP:0008554 decreased circulating tumor necrosis factor level,37
MP:0008555 abnormal interferon secretion,10
MP:0008556 abnormal tumor necrosis factor secretion,6
MP:0008559 abnormal interferon-gamma secretion,5
MP:0008560 increased tumor necrosis factor secretion,80
MP:0008561 decreased tumor necrosis factor secretion,86
MP:0008563 decreased interferon-alpha secretion,18
MP:0008565 decreased interferon-beta secretion,16
MP:0008566 increased interferon-gamma secretion,91
MP:0008567 decreased interferon-gamma secretion,110
MP:0008568 abnormal interleukin secretion,35
MP:0008570 lipidosis,6
MP:0008571 abnormal synaptic bouton morphology,8
MP:0008572 abnormal Purkinje cell dendrite morphology,41
MP:0008573 increased circulating interferon-alpha level,3
MP:0008574 decreased circulating interferon-alpha level,4
MP:0008575 increased circulating interferon-beta level,3
MP:0008576 decreased circulating interferon-beta level,4
MP:0008577 increased circulating interferon-gamma level,33
MP:0008578 decreased circulating interferon-gamma level,21
MP:0008579 abnormal Purkinje cell differentiation,4
MP:0008580 photoreceptor inner segment degeneration,5
MP:0008581 disorganized photoreceptor inner segment,5
MP:0008582 short photoreceptor inner segment,14
MP:0008583 absent photoreceptor inner segment,3
MP:0008584 photoreceptor outer segment degeneration,15
MP:0008585 absent photoreceptor outer segment,16
MP:0008586 disorganized photoreceptor outer segment,20
MP:0008587 short photoreceptor outer segment,35
MP:0008593 increased circulating interleukin-10 level,15
MP:0008594 decreased circulating interleukin-10 level,5
MP:0008596 increased circulating interleukin-6 level,58
MP:0008597 decreased circulating interleukin-6 level,33
MP:0008599 increased circulating interleukin-2 level,5
MP:0008600 decreased circulating interleukin-2 level,3
MP:0008602 increased circulating interleukin-4 level,10
MP:0008603 decreased circulating interleukin-4 level,10
MP:0008609 decreased circulating interleukin-13 level,3
MP:0008614 increased circulating interleukin-17 level,10
MP:0008617 increased circulating interleukin-12 level,14
MP:0008618 decreased circulating interleukin-12 level,5
MP:0008623 increased circulating interleukin-3 level,4
MP:0008626 increased circulating interleukin-5 level,5
MP:0008635 increased circulating interleukin-18 level,5
MP:0008636 decreased circulating interleukin-18 level,6
MP:0008638 increased circulating interleukin-1 alpha level,3
MP:0008639 decreased circulating interleukin-1 alpha level,3
MP:0008641 increased circulating interleukin-1 beta level,21
MP:0008642 decreased circulating interleukin-1 beta level,13
MP:0008647 increased circulating interleukin-12b level,7
MP:0008648 decreased circulating interleukin-12b level,6
MP:0008654 increased interleukin-1 alpha secretion,4
MP:0008655 decreased interleukin-1 alpha secretion,3
MP:0008656 abnormal interleukin-1 beta secretion,3
MP:0008657 increased interleukin-1 beta secretion,29
MP:0008658 decreased interleukin-1 beta secretion,23
MP:0008660 increased interleukin-10 secretion,25
MP:0008661 decreased interleukin-10 secretion,31
MP:0008663 increased interleukin-12 secretion,21
MP:0008664 decreased interleukin-12 secretion,23
MP:0008669 increased interleukin-12b secretion,6
MP:0008670 decreased interleukin-12b secretion,14
MP:0008672 increased interleukin-13 secretion,21
MP:0008673 decreased interleukin-13 secretion,19
MP:0008681 increased interleukin-17 secretion,29
MP:0008682 decreased interleukin-17 secretion,17
MP:0008687 increased interleukin-2 secretion,35
MP:0008688 decreased interleukin-2 secretion,46
MP:0008691 decreased interleukin-23 secretion,3
MP:0008698 abnormal interleukin-4 secretion,3
MP:0008699 increased interleukin-4 secretion,47
MP:0008700 decreased interleukin-4 secretion,50
MP:0008702 increased interleukin-5 secretion,21
MP:0008703 decreased interleukin-5 secretion,18
MP:0008704 abnormal interleukin-6 secretion,4
MP:0008705 increased interleukin-6 secretion,61
MP:0008706 decreased interleukin-6 secretion,68
MP:0008712 decreased interleukin-9 secretion,3
MP:0008713 abnormal cytokine level,55
MP:0008714 increased lung carcinoma incidence,15
MP:0008719 impaired neutrophil recruitment,40
MP:0008720 impaired neutrophil chemotaxis,35
MP:0008721 abnormal chemokine level,32
MP:0008722 abnormal chemokine secretion,45
MP:0008723 impaired eosinophil recruitment,14
MP:0008725 enlarged heart atrium,14
MP:0008727 enlarged heart right atrium,8
MP:0008729 decreased memory B cell number,3
MP:0008730 fused phalanges,13
MP:0008731 abnormal hair shaft melanin granule morphology,4
MP:0008734 decreased susceptibility to endotoxin shock,57
MP:0008735 increased susceptibility to endotoxin shock,48
MP:0008736 micromelia,4
MP:0008737 abnormal spleen physiology,6
MP:0008743 decreased liver iron level,7
MP:0008750 abnormal interferon level,20
MP:0008751 abnormal interleukin level,40
MP:0008752 abnormal tumor necrosis factor level,37
MP:0008753 abnormal osteocyte morphology,10
MP:0008754 abnormal T cell receptor V(D)J recombination,4
MP:0008755 abnormal immunoglobulin V(D)J recombination,4
MP:0008758 abnormal T cell receptor beta chain V(D)J recombination,5
MP:0008760 abnormal immunoglobulin heavy chain V(D)J recombination,6
MP:0008762 embryonic lethality,38
MP:0008764 increased mast cell degranulation,10
MP:0008765 decreased mast cell degranulation,15
MP:0008769 abnormal plasmacytoid dendritic cell physiology,5
MP:0008770 decreased survivor rate,160
MP:0008772 increased heart ventricle size,14
MP:0008778 abnormal lymphangiogenesis,9
MP:0008779 abnormal maternal behavior,8
MP:0008782 increased B cell apoptosis,21
MP:0008783 decreased B cell apoptosis,9
MP:0008784 craniorachischisis,10
MP:0008786 abnormal hindgut morphology,9
MP:0008788 abnormal fetal cardiomyocyte morphology,23
MP:0008789 abnormal olfactory epithelium morphology,25
MP:0008791 decreased NK cell degranulation,3
MP:0008797 facial cleft,11
MP:0008801 abnormal erythroid progenitor cell morphology,7
MP:0008803 abnormal placental labyrinth vasculature morphology,73
MP:0008805 decreased circulating amylase level,19
MP:0008806 increased circulating amylase level,10
MP:0008807 increased liver iron level,25
MP:0008808 decreased spleen iron level,15
MP:0008809 increased spleen iron level,19
MP:0008810 increased circulating iron level,32
MP:0008813 decreased common myeloid progenitor cell number,29
MP:0008814 decreased nerve conduction velocity,26
MP:0008816 petechiae,9
MP:0008817 hematoma,14
MP:0008818 abnormal interfrontal bone morphology,3
MP:0008821 increased blood uric acid level,15
MP:0008822 decreased blood uric acid level,4
MP:0008825 abnormal cardiac epithelial to mesenchymal transition,15
MP:0008826 abnormal splenic cell ratio,36
MP:0008827 abnormal thymus cell ratio,14
MP:0008828 abnormal lymph node cell ratio,17
MP:0008830 abnormal nucleolus morphology,3
MP:0008831 abnormal insulin-like growth factor I level,4
MP:0008837 increased transforming growth factor level,4
MP:0008838 decreased transforming growth factor level,4
MP:0008839 absent acrosome,4
MP:0008840 abnormal spike wave discharge,19
MP:0008841 ruptured lens capsule,11
MP:0008842 lipofuscinosis,11
MP:0008843 absent subcutaneous adipose tissue,17
MP:0008844 decreased subcutaneous adipose tissue amount,68
MP:0008845 abnormal paraventricular hypothalamic nucleus morphology,3
MP:0008846 abnormal supraoptic nucleus morphology,3
MP:0008847 abnormal suprachiasmatic nucleus morphology,3
MP:0008850 increased hemoglobin concentration distribution width,7
MP:0008852 retinal neovascularization,13
MP:0008853 decreased abdominal adipose tissue amount,15
MP:0008854 bleb,8
MP:0008856 fetal bleb,3
MP:0008858 abnormal hair cycle anagen phase,10
MP:0008859 abnormal hair cycle catagen phase,5
MP:0008861 abnormal hair shedding,3
MP:0008866 chromosomal instability,40
MP:0008868 abnormal granulosa cell morphology,11
MP:0008869 anovulation,17
MP:0008871 abnormal ovarian follicle number,13
MP:0008872 abnormal physiological response to xenobiotic,66
MP:0008873 increased physiological sensitivity to xenobiotic,89
MP:0008874 decreased physiological sensitivity to xenobiotic,131
MP:0008875 abnormal xenobiotic pharmacokinetics,24
MP:0008877 abnormal DNA methylation,27
MP:0008878 abnormal DNA methylation during gametogenesis,3
MP:0008879 submandibular gland inflammation,3
MP:0008880 lacrimal gland inflammation,12
MP:0008882 abnormal enterocyte physiology,7
MP:0008883 abnormal enterocyte proliferation,21
MP:0008884 abnormal enterocyte apoptosis,7
MP:0008885 increased enterocyte apoptosis,8
MP:0008891 decreased hepatocyte apoptosis,5
MP:0008892 abnormal sperm flagellum morphology,37
MP:0008893 detached sperm flagellum,8
MP:0008894 abnormal intraepithelial T cell morphology,3
MP:0008896 increased IgG2c level,6
MP:0008897 decreased IgG2c level,3
MP:0008898 abnormal acrosome morphology,21
MP:0008904 abnormal mammary fat pad morphology,4
MP:0008907 decreased total fat pad weight,14
MP:0008908 increased total fat pad weight,11
MP:0008911 induced hyperactivity,20
MP:0008913 weaving,3
MP:0008915 fused carpal bones,11
MP:0008916 abnormal astrocyte physiology,17
MP:0008917 abnormal oligodendrocyte physiology,8
MP:0008918 microgliosis,36
MP:0008919 fused tarsal bones,8
MP:0008924 decreased cerebellar granule cell number,5
MP:0008932 abnormal embryonic tissue physiology,6
MP:0008933 abnormal motile primary cilium physiology,4
MP:0008934 absent choroid plexus,3
MP:0008935 decreased mean platelet volume,12
MP:0008939 increased pituitary gland weight,3
MP:0008941 reticulocytopenia,5
MP:0008943 increased sensitivity to induced cell death,33
MP:0008944 decreased sensitivity to induced cell death,39
MP:0008947 increased neuron number,15
MP:0008948 decreased neuron number,35
MP:0008950 ventricular tachycardia,10
MP:0008956 decreased cellular hemoglobin content,7
MP:0008957 abnormal placenta junctional zone morphology,5
MP:0008959 abnormal spongiotrophoblast cell morphology,8
MP:0008960 abnormal axon pruning,7
MP:0008961 abnormal basal metabolism,5
MP:0008963 increased carbon dioxide production,20
MP:0008964 decreased carbon dioxide production,11
MP:0008965 increased basal metabolism,16
MP:0008966 abnormal chiasmata formation,8
MP:0008973 decreased erythroid progenitor cell number,43
MP:0008974 proportional dwarf,20
MP:0008975 delayed male fertility,6
MP:0008976 delayed female fertility,10
MP:0008985 hemimelia,3
MP:0008986 abnormal liver parenchyma morphology,7
MP:0008987 abnormal liver lobule morphology,3
MP:0008989 abnormal liver sinusoid morphology,6
MP:0008991 abnormal bile canaliculus morphology,3
MP:0008995 early reproductive senescence,18
MP:0008997 increased blood osmolality,12
MP:0008999 absent anus,4
MP:0009003 abnormal vibrissa number,7
MP:0009004 progressive hair loss,6
MP:0009006 prolonged estrous cycle,27
MP:0009007 short estrous cycle,4
MP:0009009 absent estrous cycle,31
MP:0009011 prolonged diestrus,18
MP:0009017 prolonged estrus,10
MP:0009018 short estrus,3
MP:0009020 prolonged metestrus,7
MP:0009021 absent estrus,6
MP:0009038 decreased inferior colliculus size,8
MP:0009039 absent inferior colliculus,3
MP:0009046 muscle twitch,4
MP:0009050 dilated proximal convoluted tubules,19
MP:0009051 dilated distal convoluted tubules,5
MP:0009073 absent Wolffian ducts,3
MP:0009078 adrenal gland hyperplasia,3
MP:0009081 thin uterus,7
MP:0009082 uterus cysts,8
MP:0009085 abnormal uterine horn morphology,4
MP:0009092 endometrium hyperplasia,11
MP:0009093 oocyte degeneration,6
MP:0009094 abnormal endometrial gland morphology,3
MP:0009096 decreased endometrial gland number,6
MP:0009097 absent endometrial glands,5
MP:0009108 increased pancreas weight,6
MP:0009109 decreased pancreas weight,5
MP:0009113 increased pancreatic beta cell mass,14
MP:0009114 decreased pancreatic beta cell mass,22
MP:0009115 abnormal fat cell morphology,33
MP:0009116 abnormal brown fat cell morphology,9
MP:0009117 abnormal white fat cell morphology,7
MP:0009118 increased white fat cell size,15
MP:0009122 decreased white fat cell lipid droplet size,3
MP:0009124 increased brown fat cell lipid droplet size,4
MP:0009125 decreased brown fat cell lipid droplet size,10
MP:0009130 increased white fat cell number,6
MP:0009131 decreased white fat cell number,10
MP:0009132 abnormal white fat cell size,3
MP:0009133 decreased white fat cell size,35
MP:0009136 decreased brown fat cell size,6
MP:0009137 decreased brown fat lipid droplet number,4
MP:0009140 dilated efferent ductules of testis,3
MP:0009141 increased prepulse inhibition,35
MP:0009142 decreased prepulse inhibition,118
MP:0009143 abnormal pancreatic duct morphology,3
MP:0009144 dilated pancreatic duct,6
MP:0009145 abnormal pancreatic acinus morphology,7
MP:0009146 abnormal pancreatic acinar cell morphology,18
MP:0009148 pancreas necrosis,5
MP:0009150 pancreatic acinar cell atrophy,3
MP:0009153 increased pancreas tumor incidence,6
MP:0009160 abnormal pancreatic acinar cell zymogen granule morphology,6
MP:0009161 pancreatic acinar cell zymogen granule accumulation,5
MP:0009165 abnormal endocrine pancreas morphology,3
MP:0009167 increased pancreatic islet number,9
MP:0009168 decreased pancreatic islet number,9
MP:0009171 enlarged pancreatic islets,13
MP:0009172 small pancreatic islets,38
MP:0009173 absent pancreatic islets,3
MP:0009174 absent pancreatic beta cells,7
MP:0009175 abnormal pancreatic beta cell differentiation,8
MP:0009176 increased pancreatic alpha cell number,17
MP:0009177 decreased pancreatic alpha cell number,9
MP:0009178 absent pancreatic alpha cells,6
MP:0009179 abnormal pancreatic alpha cell differentiation,3
MP:0009180 increased pancreatic delta cell number,3
MP:0009181 decreased pancreatic delta cell number,5
MP:0009199 abnormal external male genitalia morphology,5
MP:0009205 abnormal internal male genitalia morphology,4
MP:0009219 increased prostate intraepithelial neoplasia incidence,6
MP:0009222 increased uterus tumor incidence,5
MP:0009230 abnormal sperm head morphology,34
MP:0009231 detached acrosome,8
MP:0009232 abnormal sperm nucleus morphology,13
MP:0009233 enlarged sperm head,4
MP:0009234 absent sperm head,6
MP:0009237 kinked sperm flagellum,18
MP:0009238 coiled sperm flagellum,15
MP:0009239 short sperm flagellum,7
MP:0009243 hairpin sperm flagellum,13
MP:0009246 pale spleen,5
MP:0009247 meteorism,19
MP:0009248 small caput epididymis,3
MP:0009250 abnormal appendicular skeleton morphology,6
MP:0009251 enlarged endometrial glands,4
MP:0009254 disorganized pancreatic islets,12
MP:0009255 degranulated pancreatic beta cells,4
MP:0009257 dilated seminiferous tubules,5
MP:0009258 abnormal thymocyte apoptosis,3
MP:0009264 failure of eyelid fusion,16
MP:0009266 abnormal mesendoderm development,11
MP:0009267 abnormal cerebellum fissure morphology,5
MP:0009269 decreased fat cell size,18
MP:0009274 buphthalmos,3
MP:0009275 bruising,5
MP:0009277 increased brain tumor incidence,6
MP:0009278 abnormal bone marrow cell physiology,29
MP:0009280 reduced activated sperm motility,3
MP:0009282 reduced hyperactivated sperm motility,3
MP:0009283 decreased gonadal fat pad weight,32
MP:0009285 increased gonadal fat pad weight,23
MP:0009286 increased abdominal fat pad weight,7
MP:0009287 decreased abdominal fat pad weight,8
MP:0009288 increased epididymal fat pad weight,20
MP:0009289 decreased epididymal fat pad weight,44
MP:0009292 increased inguinal fat pad weight,13
MP:0009293 decreased inguinal fat pad weight,22
MP:0009294 increased interscapular fat pad weight,5
MP:0009295 decreased interscapular fat pad weight,10
MP:0009298 increased mesenteric fat pad weight,4
MP:0009299 decreased mesenteric fat pad weight,8
MP:0009300 increased parametrial fat pad weight,4
MP:0009302 increased renal fat pad weight,4
MP:0009303 decreased renal fat pad weight,6
MP:0009304 increased retroperitoneal fat pad weight,14
MP:0009305 decreased retroperitoneal fat pad weight,16
MP:0009308 increased adenocarcinoma incidence,10
MP:0009309 increased small intestine adenocarcinoma incidence,3
MP:0009310 increased large intestine adenocarcinoma incidence,3
MP:0009314 increased colon adenocarcinoma incidence,3
MP:0009317 increased follicular lymphoma incidence,3
MP:0009321 increased histiocytic sarcoma incidence,19
MP:0009322 increased splenocyte apoptosis,8
MP:0009323 abnormal spleen development,4
MP:0009325 necrospermia,6
MP:0009326 absent maternal crouching,3
MP:0009328 delayed heart looping,6
MP:0009331 absent primitive node,15
MP:0009333 abnormal splenocyte physiology,11
MP:0009335 decreased splenocyte proliferation,16
MP:0009336 increased splenocyte proliferation,12
MP:0009338 increased splenocyte number,16
MP:0009339 decreased splenocyte number,24
MP:0009341 decreased splenocyte apoptosis,5
MP:0009342 enlarged gallbladder,4
MP:0009343 dilated gallbladder,6
MP:0009346 decreased trabecular bone thickness,40
MP:0009347 increased trabecular bone thickness,30
MP:0009349 increased urine pH,11
MP:0009350 decreased urine pH,8
MP:0009351 thin hair shaft,5
MP:0009355 increased liver triglyceride level,62
MP:0009356 decreased liver triglyceride level,55
MP:0009357 abnormal seizure response to inducing agent,4
MP:0009358 environmentally induced seizures,18
MP:0009361 abnormal primordial ovarian follicle morphology,8
MP:0009362 abnormal primary ovarian follicle morphology,5
MP:0009363 abnormal secondary ovarian follicle morphology,12
MP:0009372 abnormal cumulus oophorus,4
MP:0009374 absent cumulus expansion,3
MP:0009375 thin zona pellucida,4
MP:0009378 abnormal endoplasmic reticulum morphology,14
MP:0009379 abnormal foot pigmentation,8
MP:0009381 abnormal prostate gland dorsolateral lobe morphology,4
MP:0009387 abnormal epidermal pigmentation,3
MP:0009392 retinal gliosis,6
MP:0009393 abnormal resting posture,7
MP:0009394 increased uterine NK cell number,5
MP:0009395 increased nucleated erythrocyte cell number,40
MP:0009397 increased trophoblast giant cell number,13
MP:0009399 increased skeletal muscle fiber size,16
MP:0009400 decreased skeletal muscle fiber size,31
MP:0009401 increased skeletal muscle fiber diameter,8
MP:0009402 decreased skeletal muscle fiber diameter,29
MP:0009403 increased variability of skeletal muscle fiber size,33
MP:0009404 centrally nucleated skeletal muscle fibers,62
MP:0009406 decreased skeletal muscle fiber number,13
MP:0009409 abnormal skeletal muscle fiber type ratio,30
MP:0009410 abnormal skeletal muscle satellite cell proliferation,4
MP:0009412 skeletal muscle fiber degeneration,9
MP:0009413 skeletal muscle fiber atrophy,20
MP:0009414 skeletal muscle fiber necrosis,13
MP:0009415 skeletal muscle degeneration,8
MP:0009417 skeletal muscle atrophy,18
MP:0009419 skeletal muscle fibrosis,9
MP:0009420 skeletal muscle endomysial fibrosis,5
MP:0009421 increased gastrocnemius weight,3
MP:0009422 decreased gastrocnemius weight,7
MP:0009426 decreased soleus weight,7
MP:0009428 decreased tibialis anterior weight,5
MP:0009429 decreased embryo weight,18
MP:0009431 decreased fetal weight,60
MP:0009432 increased fetal weight,4
MP:0009433 polyovular ovarian follicle,5
MP:0009434 paraparesis,24
MP:0009435 abnormal miniature inhibitory postsynaptic currents,29
MP:0009436 fragmentation of sleep/wake states,6
MP:0009441 delayed skin barrier formation,3
MP:0009444 ovarian follicular cyst,4
MP:0009445 osteomalacia,6
MP:0009446 abnormal platelet dense granule physiology,7
MP:0009450 abnormal axon fasciculation,16
MP:0009451 abnormal chromosome pairing during meiosis,10
MP:0009452 abnormal synaptonemal complex,18
MP:0009453 enhanced contextual conditioning behavior,19
MP:0009454 impaired contextual conditioning behavior,45
MP:0009455 enhanced cued conditioning behavior,9
MP:0009456 impaired cued conditioning behavior,30
MP:0009461 skeletal muscle hypertrophy,6
MP:0009476 enlarged cecum,4
MP:0009477 small cecum,3
MP:0009480 distended cecum,5
MP:0009481 cecum inflammation,7
MP:0009482 ileum inflammation,6
MP:0009485 distended ileum,5
MP:0009503 abnormal mammary gland duct morphology,14
MP:0009504 abnormal mammary gland epithelium morphology,17
MP:0009505 abnormal mammary gland lobule morphology,3
MP:0009506 abnormal mammary gland alveolus morphology,16
MP:0009511 distended stomach,6
MP:0009517 abnormal salivary gland duct morphology,5
MP:0009522 submandibular gland hypoplasia,4
MP:0009524 absent submandibular gland,6
MP:0009525 abnormal submandibular duct morphology,3
MP:0009538 abnormal synapse morphology,40
MP:0009541 increased thymocyte apoptosis,21
MP:0009542 decreased thymocyte apoptosis,14
MP:0009543 abnormal thymus corticomedullary boundary morphology,11
MP:0009544 abnormal thymus epithelium morphology,7
MP:0009545 abnormal dermis papillary layer morphology,4
MP:0009546 absent gastric milk in neonates,73
MP:0009548 abnormal platelet aggregation,9
MP:0009549 decreased platelet aggregation,46
MP:0009552 urinary bladder obstruction,4
MP:0009557 decreased platelet ADP level,3
MP:0009560 absent epidermis stratum granulosum,3
MP:0009570 abnormal right lung morphology,3
MP:0009577 abnormal developmental vascular remodeling,9
MP:0009580 increased keratinocyte apoptosis,6
MP:0009583 increased keratinocyte proliferation,20
MP:0009584 decreased keratinocyte proliferation,8
MP:0009586 increased platelet aggregation,9
MP:0009590 increased gonad tumor incidence,3
MP:0009591 increased liver adenocarcinoma incidence,3
MP:0009593 absent chorion,14
MP:0009594 abnormal corneocyte envelope morphology,5
MP:0009596 abnormal stratum corneum lipid matrix formation,4
MP:0009599 thick epidermis stratum granulosum,3
MP:0009600 hypergranulosis,5
MP:0009608 abnormal epidermal lamellar body morphology,7
MP:0009615 abnormal zinc homeostasis,4
MP:0009619 abnormal optokinetic reflex,4
MP:0009622 absent inguinal lymph nodes,9
MP:0009623 enlarged inguinal lymph nodes,6
MP:0009628 absent brachial lymph nodes,5
MP:0009630 absent axillary lymph nodes,9
MP:0009631 enlarged axillary lymph nodes,3
MP:0009633 absent cervical lymph nodes,8
MP:0009634 absent popliteal lymph nodes,6
MP:0009640 abnormal renal tubule epithelium morphology,26
MP:0009641 kidney degeneration,13
MP:0009642 abnormal blood homeostasis,108
MP:0009643 abnormal urine homeostasis,81
MP:0009644 uremia,6
MP:0009645 crystalluria,9
MP:0009646 urinary bladder inflammation,7
MP:0009647 decreased fertilization frequency,14
MP:0009648 abnormal superovulation,10
MP:0009651 abnormal eyelid development,5
MP:0009652 abnormal palatal rugae morphology,3
MP:0009653 abnormal palate development,9
MP:0009655 abnormal secondary palate development,15
MP:0009656 delayed chorioallantoic fusion,5
MP:0009657 failure of chorioallantoic fusion,54
MP:0009658 increased placenta apoptosis,4
MP:0009660 abnormal induced retinal neovascularization,18
MP:0009661 abnormal pregnancy,17
MP:0009671 abnormal uterus physiology,5
MP:0009674 decreased birth weight,92
MP:0009675 orthokeratosis,10
MP:0009676 abnormal hemostasis,3
MP:0009677 abnormal spinal cord dorsal column morphology,10
MP:0009681 abnormal pyramidal decussation morphology,3
MP:0009687 empty decidua capsularis,12
MP:0009688 abnormal spinal cord central canal morphology,4
MP:0009698 heart hemorrhage,6
MP:0009703 decreased birth body size,112
MP:0009705 abnormal midgut morphology,3
MP:0009709 hydrometra,10
MP:0009712 impaired conditioned place preference behavior,21
MP:0009713 enhanced conditioned place preference behavior,6
MP:0009719 reduced cerebellar foliation,10
MP:0009728 abnormal calcaneum morphology,4
MP:0009732 ventricular premature beat,7
MP:0009735 abnormal prostate gland development,3
MP:0009736 abnormal prostate gland branching morphogenesis,3
MP:0009742 increased corneal stroma thickness,4
MP:0009743 preaxial polydactyly,25
MP:0009744 postaxial polydactyly,7
MP:0009745 abnormal behavioral response to xenobiotic,17
MP:0009746 enhanced behavioral response to xenobiotic,17
MP:0009747 impaired behavioral response to xenobiotic,35
MP:0009748 abnormal behavioral response to addictive substance,10
MP:0009749 enhanced behavioral response to addictive substance,10
MP:0009750 impaired behavioral response to addictive substance,15
MP:0009751 enhanced behavioral response to alcohol,6
MP:0009753 enhanced behavioral response to morphine,3
MP:0009754 enhanced behavioral response to cocaine,16
MP:0009755 impaired behavioral response to alcohol,8
MP:0009757 impaired behavioral response to morphine,8
MP:0009758 impaired behavioral response to cocaine,11
MP:0009759 abnormal hair follicle bulge morphology,3
MP:0009760 abnormal mitotic spindle morphology,24
MP:0009761 abnormal meiotic spindle morphology,7
MP:0009762 abnormal mitotic spindle assembly checkpoint,5
MP:0009763 increased sensitivity to induced morbidity/mortality,171
MP:0009764 decreased sensitivity to induced morbidity/mortality,41
MP:0009766 increased sensitivity to xenobiotic induced morbidity/mortality,95
MP:0009767 decreased sensitivity to xenobiotic induced morbidity/mortality,30
MP:0009768 impaired somite development,15
MP:0009770 abnormal optic chiasm morphology,4
MP:0009772 abnormal retinal development,8
MP:0009776 decreased behavioral withdrawal response,5
MP:0009779 enhanced behavioral response to anesthetic,3
MP:0009780 abnormal chondrocyte physiology,22
MP:0009781 abnormal preimplantation embryo development,24
MP:0009783 abnormal melanoblast morphology,4
MP:0009787 increased susceptibility to infection induced morbidity/mortality,3
MP:0009788 increased susceptibility to bacterial infection induced morbidity/mortality,65
MP:0009789 decreased susceptibility to bacterial infection induced morbidity/mortality,25
MP:0009790 decreased susceptibility to viral infection induced morbidity/mortality,18
MP:0009791 increased susceptibility to viral infection induced morbidity/mortality,25
MP:0009796 abnormal base-excision repair,7
MP:0009797 abnormal mismatch repair,4
MP:0009801 abnormal hair cortex keratinization,3
MP:0009808 decreased oligodendrocyte number,12
MP:0009810 increased urine uric acid level,5
MP:0009811 abnormal prostaglandin level,5
MP:0009814 increased prostaglandin level,12
MP:0009815 decreased prostaglandin level,12
MP:0009817 decreased leukotriene level,4
MP:0009818 abnormal thromboxane level,5
MP:0009820 abnormal liver vasculature morphology,4
MP:0009823 abnormal sphingomyelin level,6
MP:0009828 increased tumor latency,4
MP:0009829 enlarged eye anterior chamber,5
MP:0009831 abnormal sperm midpiece morphology,19
MP:0009832 abnormal sperm mitochondrial sheath morphology,17
MP:0009833 absent sperm mitochondrial sheath,4
MP:0009834 abnormal sperm annulus morphology,7
MP:0009836 abnormal sperm principal piece morphology,7
MP:0009838 abnormal sperm axoneme morphology,12
MP:0009839 multiflagellated sperm,6
MP:0009843 decreased neural crest cell number,4
MP:0009845 abnormal neural crest cell morphology,5
MP:0009846 abnormal neural crest morphology,3
MP:0009850 embryonic lethality between implantation and placentation,3
MP:0009854 impaired gastric peristalsis,3
MP:0009856 failure of ejaculation,3
MP:0009858 abnormal cellular extravasation,22
MP:0009859 eye opacity,8
MP:0009862 abnormal aorta elastic tissue morphology,10
MP:0009865 abnormal aorta smooth muscle morphology,10
MP:0009866 abnormal aorta wall morphology,12
MP:0009867 abnormal ascending aorta morphology,4
MP:0009871 abnormal aorta tunica adventitia morphology,4
MP:0009873 abnormal aorta tunica media morphology,12
MP:0009874 abnormal interdigital cell death,3
MP:0009877 exostosis,5
MP:0009879 abnormal arcus anterior morphology,4
MP:0009880 microstomia,3
MP:0009882 absent palatal shelf,4
MP:0009883 palatal shelf hypoplasia,10
MP:0009884 palatal shelf fusion with tongue or mandible,5
MP:0009885 abnormal palatal shelf elevation,10
MP:0009886 failure of palatal shelf elevation,21
MP:0009887 abnormal palatal shelf fusion at midline,21
MP:0009888 palatal shelves fail to meet at midline,41
MP:0009890 cleft secondary palate,96
MP:0009895 decreased palatine bone horizontal plate size,9
MP:0009898 maxillary shelf hypoplasia,3
MP:0009901 abnormal frontonasal prominence morphology,7
MP:0009903 abnormal medial nasal prominence morphology,3
MP:0009905 absent tongue,3
MP:0009907 decreased tongue size,12
MP:0009908 protruding tongue,8
MP:0009913 abnormal hyoid bone greater horn morphology,3
MP:0009914 abnormal hyoid bone lesser horn morphology,8
MP:0009922 increased transitional stage T1 B cell number,5
MP:0009923 decreased transitional stage T1 B cell number,9
MP:0009926 decreased transitional stage T2 B cell number,11
MP:0009931 abnormal skin appearance,29
MP:0009932 skin fibrosis,7
MP:0009933 abnormal tail hair pigmentation,3
MP:0009936 abnormal dendritic spine morphology,40
MP:0009937 abnormal neuron differentiation,106
MP:0009938 abnormal hippocampus granule cell morphology,7
MP:0009939 abnormal hippocampus neuron morphology,8
MP:0009940 abnormal hippocampus pyramidal cell morphology,29
MP:0009945 abnormal accessory olfactory bulb morphology,3
MP:0009946 abnormal olfactory bulb layer morphology,4
MP:0009947 abnormal olfactory bulb external plexiform layer morphology,3
MP:0009948 abnormal olfactory bulb glomerular layer morphology,6
MP:0009949 abnormal olfactory bulb granule cell layer morphology,4
MP:0009951 abnormal olfactory bulb mitral cell layer morphology,6
MP:0009954 abnormal mitral cell morphology,3
MP:0009956 abnormal cerebellar layer morphology,10
MP:0009964 abnormal cerebellum lobule morphology,4
MP:0009967 abnormal neuron proliferation,19
MP:0009969 abnormal cerebral cortex pyramidal cell morphology,19
MP:0009971 decreased hippocampus pyramidal cell number,6
MP:0009974 decreased cerebral cortex pyramidal cell number,3
MP:0009977 abnormal cerebellar granule cell migration,10
MP:0009978 abnormal cerebellum white matter morphology,6
MP:0009979 abnormal cerebellum deep nucleus morphology,7
MP:0010011 ectopic hippocampus pyramidal cells,5
MP:0010016 variable depigmentation,4
MP:0010017 visceral vascular congestion,5
MP:0010018 pulmonary vascular congestion,20
MP:0010019 liver vascular congestion,13
MP:0010021 heart vascular congestion,3
MP:0010024 increased total body fat amount,120
MP:0010025 decreased total body fat amount,314
MP:0010026 decreased liver cholesterol level,15
MP:0010027 increased liver cholesterol level,20
MP:0010028 aciduria,4
MP:0010029 abnormal basicranium morphology,21
MP:0010030 abnormal orbit morphology,5
MP:0010031 abnormal cranium size,4
MP:0010035 increased erythrocyte clearance,9
MP:0010038 abnormal placenta physiology,3
MP:0010042 abnormal oval cell physiology,5
MP:0010047 axonal spheroids,8
MP:0010050 hypermyelination,3
MP:0010052 increased grip strength,78
MP:0010053 decreased grip strength,211
MP:0010055 abnormal sensory neuron physiology,5
MP:0010067 increased red blood cell distribution width,37
MP:0010068 decreased red blood cell distribution width,10
MP:0010069 increased serotonin level,8
MP:0010070 decreased serotonin level,6
MP:0010074 stomatocytosis,3
MP:0010080 abnormal hepatocyte physiology,20
MP:0010082 sternebra fusion,14
MP:0010087 increased circulating fructosamine level,10
MP:0010088 decreased circulating fructosamine level,24
MP:0010090 increased circulating creatine kinase level,19
MP:0010092 increased circulating magnesium level,16
MP:0010093 decreased circulating magnesium level,16
MP:0010096 abnormal incisor color,8
MP:0010097 abnormal retinal blood vessel morphology,31
MP:0010098 abnormal retinal blood vessel pattern,8
MP:0010099 abnormal thoracic cage shape,15
MP:0010101 increased sacral vertebrae number,57
MP:0010102 increased caudal vertebrae number,5
MP:0010103 small thoracic cage,19
MP:0010107 abnormal renal reabsorbtion,12
MP:0010108 abnormal renal water reabsorbtion,5
MP:0010109 abnormal renal sodium reabsorbtion,3
MP:0010111 abnormal renal calcium reabsorbtion,3
MP:0010116 abnormal primitive urogenital sinus morphology,4
MP:0010117 abnormal lateral plate mesoderm morphology,7
MP:0010119 abnormal bone mineral density,5
MP:0010123 increased bone mineral content,94
MP:0010124 decreased bone mineral content,190
MP:0010127 hypervolemia,3
MP:0010128 hypovolemia,3
MP:0010129 increased DN1 thymic pro-T cell number,3
MP:0010130 decreased DN1 thymic pro-T cell number,5
MP:0010132 decreased DN2 thymocyte number,5
MP:0010133 increased DN3 thymocyte number,7
MP:0010134 decreased DN3 thymocyte number,3
MP:0010136 decreased DN4 thymocyte number,4
MP:0010138 arteritis,6
MP:0010144 abnormal tumor vascularization,19
MP:0010146 umbilical hernia,10
MP:0010149 abnormal synaptic dopamine release,5
MP:0010152 abnormal brain ependyma morphology,8
MP:0010155 abnormal intestine physiology,28
MP:0010160 increased oligodendrocyte number,6
MP:0010161 decreased brain cholesterol level,6
MP:0010163 hemolysis,6
MP:0010166 increased response to stress-induced hyperthermia,4
MP:0010167 decreased response to stress-induced hyperthermia,3
"MP:0010168 increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number",10
"MP:0010169 decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number",21
MP:0010173 increased mammary gland epithelial cell proliferation,4
MP:0010174 decreased mammary gland epithelial cell proliferation,8
MP:0010175 leptocytosis,7
MP:0010177 acanthocytosis,11
MP:0010178 increased number of Howell-Jolly bodies,10
MP:0010179 rough coat,21
MP:0010180 increased susceptibility to weight loss,37
MP:0010181 decreased susceptibility to weight loss,6
MP:0010182 decreased susceptibility to weight gain,17
MP:0010186 increased T follicular helper cell number,3
MP:0010194 absent lymphatic vessels,3
MP:0010202 focal dorsal hair loss,5
MP:0010207 abnormal telomere morphology,5
MP:0010209 abnormal circulating chemokine level,17
MP:0010210 abnormal circulating cytokine level,15
MP:0010211 abnormal acute phase protein level,5
MP:0010214 abnormal circulating serum amyloid protein level,6
MP:0010219 increased T-helper 17 cell number,6
MP:0010220 decreased T-helper 17 cell number,4
MP:0010224 abnormal heart ventricle outflow tract morphology,5
MP:0010226 increased quadriceps weight,6
MP:0010227 decreased quadriceps weight,7
MP:0010234 abnormal vibrissa follicle morphology,10
MP:0010235 abnormal retina inner limiting membrane morphology,5
MP:0010238 increased skeletal muscle weight,3
MP:0010239 decreased skeletal muscle weight,14
MP:0010249 lactation failure,12
MP:0010252 anterior subcapsular cataracts,3
MP:0010254 nuclear cataracts,19
MP:0010259 anterior polar cataracts,3
MP:0010263 total cataracts,11
MP:0010264 increased hepatoma incidence,14
MP:0010266 decreased liver tumor incidence,3
MP:0010267 decreased lung tumor incidence,4
MP:0010279 increased gastrointestinal tumor incidence,17
MP:0010296 increased hemolymphoid system tumor incidence,4
MP:0010299 increased mammary gland tumor incidence,19
MP:0010300 increased skin tumor incidence,18
MP:0010301 increased stomach tumor incidence,11
MP:0010308 decreased tumor latency,14
MP:0010309 increased mesothelioma incidence,3
MP:0010316 increased thyroid tumor incidence,3
MP:0010320 increased pituitary gland tumor incidence,3
MP:0010323 retropulsion,8
MP:0010334 pleural effusion,7
MP:0010335 fused first pharyngeal arch,5
MP:0010346 increased thyroid carcinoma incidence,4
MP:0010355 abnormal first pharyngeal arch artery morphology,3
MP:0010356 abnormal second pharyngeal arch artery morphology,4
MP:0010360 decreased liver free fatty acids level,3
MP:0010363 increased fibrosarcoma incidence,11
MP:0010371 abnormal epiglottis morphology,5
MP:0010373 myeloid hyperplasia,33
MP:0010375 increased kidney iron level,13
MP:0010377 abnormal gut flora balance,11
MP:0010378 increased respiratory quotient,40
MP:0010379 decreased respiratory quotient,46
MP:0010380 abnormal inner cell mass apoptosis,25
"MP:0010382 abnormal dosage compensation, by inactivation of X chromosome",3
MP:0010383 increased adenoma incidence,19
MP:0010384 increased renal carcinoma incidence,5
MP:0010386 abnormal urinary bladder physiology,14
MP:0010392 prolonged QRS complex duration,24
MP:0010394 decreased QRS amplitude,3
MP:0010395 abnormal pharyngeal arch development,5
MP:0010398 decreased liver glycogen level,18
MP:0010399 decreased skeletal muscle glycogen level,5
MP:0010400 increased liver glycogen level,21
MP:0010401 increased skeletal muscle glycogen level,10
MP:0010402 ventricular septal defect,134
MP:0010403 atrial septal defect,44
MP:0010404 ostium primum atrial septal defect,13
MP:0010405 ostium secundum atrial septal defect,8
MP:0010406 common atrium,13
MP:0010412 atrioventricular septal defect,44
MP:0010413 complete atrioventricular septal defect,19
MP:0010418 perimembraneous ventricular septal defect,49
MP:0010419 inlet ventricular septal defect,3
MP:0010420 muscular ventricular septal defect,35
MP:0010422 heart right ventricle hypoplasia,9
MP:0010426 abnormal heart and great artery attachment,9
MP:0010428 abnormal heart right ventricle outflow tract morphology,4
MP:0010432 common ventricle,10
MP:0010439 abnormal hepatic vein morphology,3
MP:0010440 anomalous pulmonary venous connection,3
MP:0010449 heart right ventricle outflow tract stenosis,5
MP:0010451 kidney microaneurysm,5
MP:0010454 abnormal truncus arteriosus septation,24
MP:0010457 pulmonary artery stenosis,4
MP:0010460 pulmonary artery hypoplasia,8
MP:0010463 aorta stenosis,7
MP:0010464 abnormal aortic arch and aortic arch branch attachment,3
MP:0010465 aberrant origin of the right subclavian artery,10
MP:0010466 vascular ring,21
MP:0010476 coronary fistula,4
MP:0010484 bicuspid aortic valve,7
MP:0010485 aortic arch hypoplasia,3
MP:0010487 abnormal right subclavian artery morphology,4
MP:0010488 abnormal left subclavian artery morphology,9
MP:0010499 abnormal ventricle myocardium morphology,7
MP:0010500 myocardium hypoplasia,4
MP:0010502 ventricle myocardium hypoplasia,4
MP:0010503 myocardial trabeculae hypoplasia,9
MP:0010505 abnormal T wave,5
MP:0010506 prolonged RR interval,8
MP:0010507 shortened RR interval,17
MP:0010508 abnormal heart electrocardiography waveform feature,18
MP:0010511 shortened PR interval,8
MP:0010519 atrioventricular block,15
MP:0010520 sinoatrial block,5
MP:0010522 calcified aorta,3
MP:0010537 tumor regression,3
MP:0010540 long stride length,6
MP:0010541 aorta hypoplasia,4
MP:0010545 abnormal heart layer morphology,3
MP:0010551 abnormal coronary vessel morphology,14
MP:0010556 thin ventricle myocardium compact layer,10
MP:0010557 dilated pulmonary artery,3
MP:0010559 heart block,6
MP:0010563 increased heart right ventricle size,7
MP:0010570 prolonged ST segment,4
MP:0010571 shortened ST segment,9
MP:0010572 persistent right dorsal aorta,6
MP:0010574 aorta dilation,10
MP:0010579 increased heart left ventricle size,14
MP:0010580 decreased heart left ventricle size,3
MP:0010585 abnormal conotruncal ridge morphology,6
MP:0010591 enlarged aortic valve,5
MP:0010593 thick aortic valve cusps,9
MP:0010594 thick aortic valve,10
MP:0010600 enlarged pulmonary valve,3
MP:0010601 thick pulmonary valve,7
MP:0010605 thick pulmonary valve cusps,5
MP:0010607 common atrioventricular valve,11
MP:0010617 thick mitral valve cusps,6
MP:0010637 sinus bradycardia,9
MP:0010639 altered tumor pathology,7
MP:0010640 ventricular myocardium compact layer hypoplasia,3
MP:0010642 absent third pharyngeal arch,4
MP:0010656 thick myocardium,5
MP:0010662 abnormal intersomitic artery morphology,3
MP:0010668 abnormal hepatic portal vein morphology,3
MP:0010678 abnormal skin adnexa morphology,3
MP:0010681 abnormal hair follicle bulb morphology,3
MP:0010685 abnormal hair follicle inner root sheath morphology,12
MP:0010688 hair follicle outer rooth sheath hyperplasia,3
MP:0010695 abnormal blood pressure regulation,4
MP:0010698 abnormal impulsive behavior control,7
MP:0010701 fusion of atlas and odontoid process,9
MP:0010711 persistent hyperplastic primary vitreous,5
MP:0010713 corneal-lenticular stalk,3
MP:0010714 iris coloboma,7
MP:0010715 retina coloboma,3
MP:0010724 thick interventricular septum,24
MP:0010725 thin interventricular septum,16
MP:0010728 fusion of atlas and occipital bones,7
MP:0010729 absent arcus anterior,4
MP:0010732 abnormal node of Ranvier morphology,3
MP:0010734 abnormal paranode morphology,4
MP:0010736 abnormal extraembryonic ectoderm morphology,11
MP:0010738 abnormal internode morphology,3
MP:0010740 abnormal dendritic cell chemotaxis,9
MP:0010742 increased Schwann cell number,4
MP:0010743 delayed suture closure,8
MP:0010746 abnormal pre-Botzinger complex physiology,5
MP:0010748 abnormal visual evoked potential,8
MP:0010750 increased susceptibility to parasitic infection induced morbidity/mortality,7
MP:0010751 decreased susceptibility to parasitic infection induced morbidity/mortality,7
MP:0010752 impaired mucociliary clearance,4
MP:0010754 abnormal heart left ventricle pressure,8
MP:0010755 abnormal heart right ventricle pressure,7
MP:0010758 increased right ventricle systolic pressure,7
MP:0010760 abnormal macrophage chemotaxis,15
MP:0010762 abnormal microglial cell activation,11
MP:0010763 abnormal hematopoietic stem cell physiology,24
MP:0010766 abnormal NK cell physiology,46
MP:0010767 abnormal female meiosis I arrest,3
MP:0010769 abnormal survival,16
MP:0010770 preweaning lethality,4
MP:0010792 abnormal stomach mucosa morphology,22
MP:0010799 stomach mucosa hyperplasia,4
MP:0010802 abnormal intestinal enteroendocrine cell morphology,5
MP:0010803 abnormal stomach enteroendocrine cell morphology,4
MP:0010807 abnormal stomach position or orientation,7
MP:0010808 right-sided stomach,17
MP:0010809 abnormal Clara cell morphology,4
MP:0010810 increased type II pneumocyte number,12
MP:0010813 abnormal alveolar lamellar body morphology,3
MP:0010814 absent alveolar lamellar bodies,5
MP:0010815 enlarged alveolar lamellar bodies,3
MP:0010816 decreased type I pneumocyte number,3
MP:0010819 primary atelectasis,19
MP:0010825 abnormal lung saccule morphology,23
MP:0010827 small lung saccule,6
"MP:0010831 lethality, incomplete penetrance",41
"MP:0010835 increased CD4-positive, alpha-beta memory T cell number",3
"MP:0010836 decreased CD4-positive, alpha-beta memory T cell number",3
"MP:0010839 decreased CD8-positive, alpha-beta memory T cell number",3
"MP:0010844 increased effector memory CD4-positive, alpha-beta T cell number",16
"MP:0010845 decreased effector memory CD4-positive, alpha-beta T cell number",5
"MP:0010850 increased effector memory CD8-positive, alpha-beta T cell number",16
"MP:0010851 decreased effector memory CD8-positive, alpha-beta T cell number",16
MP:0010854 lung situs inversus,6
MP:0010856 dilated respiratory conducting tubes,14
MP:0010859 abnormal anterior commissure pars anterior morphology,3
MP:0010860 abnormal anterior commissure pars posterior morphology,8
MP:0010861 increased respiratory mucosa goblet cell number,4
MP:0010865 prenatal growth retardation,10
MP:0010867 abnormal bone trabecula morphology,26
MP:0010868 increased bone trabecula number,37
MP:0010869 decreased bone trabecula number,47
MP:0010870 absent bone trabeculae,4
MP:0010872 increased trabecular bone mass,14
MP:0010873 decreased trabecular bone mass,15
MP:0010875 increased bone volume,20
MP:0010876 decreased bone volume,36
MP:0010878 increased trabecular bone volume,34
MP:0010879 decreased trabecular bone volume,35
MP:0010883 trachea stenosis,4
MP:0010887 pale lung,4
MP:0010890 decreased alveolar lamellar body number,6
MP:0010891 increased alveolar lamellar body number,4
MP:0010894 pulmonary alveolar edema,4
MP:0010895 increased lung compliance,13
MP:0010896 decreased lung compliance,7
MP:0010897 abnormal bronchiole epithelium morphology,6
MP:0010898 abnormal pulmonary alveolus epithelium morphology,4
MP:0010899 abnormal pulmonary alveolar system morphology,9
MP:0010900 abnormal pulmonary interalveolar septum morphology,9
MP:0010901 abnormal pulmonary alveolar parenchyma morphology,8
MP:0010902 abnormal pulmonary alveolar sac morphology,10
MP:0010903 abnormal pulmonary alveolus wall morphology,17
MP:0010908 dilated pulmonary alveolar ducts,6
MP:0010909 pulmonary alveolar hemorrhage,12
MP:0010911 abnormal pulmonary acinus morphology,7
MP:0010912 herniated liver,3
MP:0010922 alveolitis,4
MP:0010924 abnormal osteoid morphology,5
MP:0010929 increased osteoid thickness,4
MP:0010932 increased trabecular bone connectivity density,4
MP:0010933 decreased trabecular bone connectivity density,8
MP:0010934 increased subcutaneous adipose tissue amount,8
MP:0010935 increased airway resistance,7
MP:0010936 decreased airway resistance,6
MP:0010937 increased total lung capacity,5
MP:0010939 abnormal mandibular prominence morphology,5
MP:0010940 abnormal maxillary prominence morphology,8
MP:0010941 abnormal foramen magnum morphology,7
MP:0010942 abnormal respiratory epithelium morphology,5
MP:0010943 abnormal bronchus epithelium morphology,7
MP:0010948 abnormal double-strand DNA break repair,32
MP:0010954 abnormal cellular respiration,26
MP:0010955 abnormal respiratory electron transport chain,28
MP:0010956 abnormal mitochondrial ATP synthesis coupled electron transport,28
MP:0010957 abnormal aerobic respiration,15
MP:0010958 abnormal tricarboxylic acid cycle,6
MP:0010959 abnormal oxidative phosphorylation,5
MP:0010961 increased compact bone mass,4
MP:0010962 decreased compact bone mass,5
MP:0010964 increased compact bone volume,6
MP:0010965 decreased compact bone volume,3
MP:0010967 increased compact bone area,8
MP:0010968 decreased compact bone area,12
MP:0010970 abnormal compact bone lamellar structure,3
MP:0010975 abnormal lung lobe morphology,10
MP:0010976 small lung lobe,6
MP:0010977 fused right lung lobes,4
MP:0010978 absent ureteric bud,7
MP:0010980 ectopic ureteric bud,5
MP:0010981 abnormal branching involved in ureteric bud morphogenesis,7
MP:0010982 abnormal ureteric bud elongation,4
MP:0010983 abnormal ureteric bud invasion,8
MP:0010984 abnormal metanephric mesenchyme morphology,18
MP:0010985 abnormal kidney mesenchyme morphology,6
MP:0010987 abnormal nephrogenic mesenchyme morphogenesis,4
MP:0010993 decreased surfactant secretion,7
MP:0010994 aerophagia,3
MP:0010995 abnormal lung alveolus development,3
MP:0010996 increased aorta wall thickness,6
MP:0010997 decreased aorta wall thickness,3
MP:0010998 pulmonary alveolar proteinosis,4
MP:0011003 reduced AMPA-mediated synaptic currents,6
MP:0011014 decreased core body temperature,7
MP:0011015 decreased body surface temperature,3
MP:0011016 increased core body temperature,7
MP:0011019 abnormal adaptive thermogenesis,9
MP:0011020 abnormal circadian temperature homeostasis,8
MP:0011021 abnormal circadian regulation of heart rate,4
MP:0011022 abnormal circadian regulation of systemic arterial blood pressure,4
MP:0011024 abnormal branching involved in lung morphogenesis,13
MP:0011028 impaired branching involved in bronchus morphogenesis,6
MP:0011032 impaired branching involved in terminal bronchiole morphogenesis,3
MP:0011045 decreased lung elastance,4
MP:0011049 impaired adaptive thermogenesis,29
MP:0011050 abnormal respiratory motile cilium morphology,7
MP:0011055 abnormal respiratory motile cilium physiology,10
MP:0011056 abnormal brain ependyma motile cilium morphology,11
MP:0011060 abnormal kinocilium morphology,3
MP:0011061 abnormal inner hair cell kinocilium morphology,3
MP:0011062 abnormal outer hair cell kinocilium morphology,5
MP:0011066 abnormal renal tubule epithelial cell primary cilium morphology,10
MP:0011069 abnormal brain ependyma motile cilium physiology,6
MP:0011075 abnormal macrophage activation involved in immune response,3
MP:0011076 increased macrophage nitric oxide production,3
MP:0011077 decreased macrophage nitric oxide production,4
MP:0011079 decreased macrophage cytokine production,8
MP:0011080 increased macrophage apoptosis,4
MP:0011081 decreased macrophage apoptosis,7
"MP:0011083 lethality at weaning, complete penetrance",45
"MP:0011084 lethality at weaning, incomplete penetrance",37
"MP:0011085 postnatal lethality, complete penetrance",384
"MP:0011086 postnatal lethality, incomplete penetrance",563
"MP:0011087 neonatal lethality, complete penetrance",462
"MP:0011088 neonatal lethality, incomplete penetrance",255
"MP:0011089 perinatal lethality, complete penetrance",217
"MP:0011090 perinatal lethality, incomplete penetrance",226
"MP:0011091 prenatal lethality, complete penetrance",272
"MP:0011092 embryonic lethality, complete penetrance",304
"MP:0011093 embryonic lethality at implantation, complete penetrance",20
"MP:0011094 embryonic lethality before implantation, complete penetrance",126
"MP:0011095 embryonic lethality between implantation and placentation, complete penetrance",40
"MP:0011096 embryonic lethality between implantation and somite formation, complete penetrance",250
"MP:0011097 embryonic lethality between somite formation and embryo turning, complete penetrance",71
"MP:0011098 embryonic lethality during organogenesis, complete penetrance",559
"MP:0011099 lethality throughout fetal growth and development, complete penetrance",196
"MP:0011100 preweaning lethality, complete penetrance",674
"MP:0011101 prenatal lethality, incomplete penetrance",293
"MP:0011102 embryonic lethality, incomplete penetrance",45
"MP:0011103 embryonic lethality at implantation, incomplete penetrance",5
"MP:0011104 embryonic lethality before implantation, incomplete penetrance",20
"MP:0011105 embryonic lethality between implantation and placentation, incomplete penetrance",11
"MP:0011106 embryonic lethality between implantation and somite formation, incomplete penetrance",21
"MP:0011107 embryonic lethality between somite formation and embryo turning, incomplete penetrance",16
"MP:0011108 embryonic lethality during organogenesis, incomplete penetrance",233
"MP:0011109 lethality throughout fetal growth and development, incomplete penetrance",170
"MP:0011110 preweaning lethality, incomplete penetrance",381
"MP:0011111 lethality during fetal growth through weaning, complete penetrance",8
"MP:0011112 lethality during fetal growth through weaning, incomplete penetrance",9
MP:0011121 decreased primordial ovarian follicle number,5
MP:0011125 decreased primary ovarian follicle number,6
MP:0011128 increased secondary ovarian follicle number,3
MP:0011129 decreased secondary ovarian follicle number,6
MP:0011143 thick lung-associated mesenchyme,17
MP:0011148 decreased mesenchymal cell proliferation involved in lung development,3
MP:0011160 dermal-epidermal separation,6
MP:0011165 abnormal tooth root development,5
MP:0011167 abnormal adipose tissue development,10
MP:0011168 abnormal fat cell differentiation,11
MP:0011169 abnormal white fat cell differentation,3
MP:0011171 increased number of Heinz bodies,5
MP:0011174 lipodystrophy,7
MP:0011176 abnormal erythroblast morphology,5
MP:0011178 increased erythroblast number,9
MP:0011179 decreased erythroblast number,6
MP:0011182 decreased hematopoietic cell number,4
MP:0011183 abnormal primitive endoderm morphology,7
MP:0011184 absent embryonic epiblast,9
MP:0011186 abnormal visceral endoderm morphology,44
MP:0011187 abnormal parietal endoderm morphology,8
MP:0011188 increased erythrocyte protoporphyrin level,7
MP:0011189 small embryonic epiblast,6
MP:0011190 thick embryonic epiblast,5
MP:0011191 increased embryonic epiblast cell apoptosis,8
MP:0011192 decreased embryonic epiblast cell proliferation,6
MP:0011197 abnormal proamniotic cavity morphology,8
MP:0011198 absent proamniotic cavity,10
MP:0011199 abnormal amniotic cavity morphology,8
MP:0011200 abnormal extraembryonic coelom morphology,10
MP:0011201 abnormal visceral yolk sac cavity morphology,3
MP:0011202 abnormal ectoplacental cavity morphology,4
MP:0011203 abnormal parietal yolk sac morphology,3
MP:0011204 abnormal visceral yolk sac blood island morphology,15
MP:0011205 excessive folding of visceral yolk sac,13
MP:0011207 absent ectoplacental cavity,6
MP:0011208 small proamniotic cavity,4
MP:0011210 abnormal temporomandibular joint morphology,3
MP:0011224 abnormal lymph node medullary cord morphology,3
MP:0011228 abnormal vitamin D level,13
MP:0011229 abnormal vitamin C level,5
MP:0011230 abnormal folic acid level,3
MP:0011232 abnormal vitamin A level,6
MP:0011233 abnormal vitamin A metabolism,6
MP:0011234 abnormal retinol level,9
MP:0011239 abnormal skin coloration,11
MP:0011243 decreased fetal derived definitive erythrocyte cell number,4
MP:0011246 abnormal fetal liver hematopoietic progenitor cell morphology,3
MP:0011249 abdominal situs inversus,4
MP:0011250 abdominal situs ambiguus,6
MP:0011252 situs inversus totalis,11
MP:0011253 situs inversus with levocardia,5
MP:0011255 abnormal anterior visceral endoderm cell migration,7
MP:0011256 abnormal neural fold morphology,5
MP:0011257 abnormal head fold morphology,9
MP:0011259 abnormal cephalic neural fold morphology,8
MP:0011260 abnormal head mesenchyme morphology,18
MP:0011261 abnormal limb mesenchyme morphology,5
MP:0011269 increased excitatory postsynaptic current amplitude,3
MP:0011270 decreased excitatory postsynaptic current amplitude,7
MP:0011275 abnormal behavioral response to light,46
MP:0011276 increased tail pigmentation,7
MP:0011277 decreased tail pigmentation,10
MP:0011278 increased ear pigmentation,5
MP:0011279 decreased ear pigmentation,5
MP:0011281 abnormal olfactory epithelium cilium morphology,4
MP:0011285 increased circulating erythropoietin level,6
MP:0011290 decreased nephron number,15
MP:0011294 renal glomerulus hypertrophy,16
MP:0011304 kidney papillary atrophy,7
MP:0011305 dilated kidney calyx,5
MP:0011307 kidney medulla cysts,9
MP:0011308 kidney corticomedullary cysts,4
MP:0011309 abnormal kidney arterial blood vessel morphology,6
MP:0011312 abnormal kidney afferent arteriole morphology,3
MP:0011316 abnormal kidney interlobular artery morphology,4
MP:0011320 abnormal glomerular capillary morphology,21
MP:0011321 abnormal peritubular capillary morphology,3
MP:0011331 abnormal papillary duct morphology,3
MP:0011333 abnormal kidney inner medulla morphology,4
MP:0011334 abnormal nephrogenic zone morphology,9
MP:0011338 abnormal mesangial matrix morphology,4
MP:0011339 abnormal glomerular mesangium morphology,11
MP:0011346 renal tubule atrophy,23
MP:0011348 abnormal renal glomerulus basement membrane morphology,20
MP:0011349 abnormal renal glomerulus basement membrane thickness,3
MP:0011352 proximal convoluted tubule brush border loss,9
MP:0011353 expanded mesangial matrix,31
MP:0011359 decreased glomerular capillary number,7
MP:0011360 kidney cortex hypoplasia,3
MP:0011363 renal glomerulus atrophy,7
MP:0011364 abnormal metanephros morphology,8
MP:0011365 small metanephros,3
MP:0011366 absent metanephros,7
MP:0011368 increased kidney apoptosis,22
MP:0011369 increased renal glomerulus apoptosis,6
MP:0011372 decreased renal tubule apoptosis,5
MP:0011376 abnormal kidney corticomedullary boundary morphology,9
MP:0011377 renal glomerulus fibrosis,8
MP:0011380 enlarged brain ventricles,42
MP:0011385 abnormal testosterone level,7
MP:0011386 increased metanephric mesenchyme apoptosis,13
MP:0011388 absent heart,9
MP:0011395 decreased fetal cardiomyocyte proliferation,8
MP:0011396 abnormal sleep behavior,64
"MP:0011400 lethality, complete penetrance",23
MP:0011402 renal cast,26
MP:0011403 pyelonephritis,4
MP:0011405 tubulointerstitial nephritis,17
MP:0011409 increased renal glomerulus basement membrane thickness,17
MP:0011413 colorless urine,4
MP:0011417 abnormal renal transport,6
MP:0011422 kidney medulla atrophy,9
MP:0011423 kidney cortex atrophy,13
MP:0011424 decreased urine uric acid level,7
MP:0011425 abnormal kidney interstitium morphology,7
MP:0011426 abnormal ureter smooth muscle morphology,4
MP:0011427 mesangial cell hyperplasia,22
MP:0011430 mesangiolysis,8
MP:0011431 increased urine flow rate,4
MP:0011432 decreased urine flow rate,3
MP:0011435 increased urine magnesium level,6
MP:0011437 glomerulus hemorrhage,4
MP:0011440 increased kidney cell proliferation,12
MP:0011441 decreased kidney cell proliferation,8
MP:0011442 abnormal renal sodium ion transport,3
MP:0011447 abnormal renal glucose reabsorption,3
MP:0011448 decreased dopaminergic neuron number,16
MP:0011451 increased susceptibility to dopaminergic neuron neurotoxicity,11
MP:0011452 decreased susceptibility to dopaminergic neuron neurotoxicity,11
MP:0011453 abnormal glomerular capillary endothelium morphology,12
MP:0011455 absent glomerular endothelium fenestra,3
MP:0011457 abnormal metanephric ureteric bud development,3
MP:0011459 increased urine chloride ion level,7
MP:0011460 decreased urine chloride ion level,7
MP:0011467 decreased urine urea nitrogen level,5
MP:0011468 abnormal urine amino acid level,5
MP:0011470 increased urine creatinine level,5
MP:0011471 decreased urine creatinine level,18
MP:0011473 increased urine glycosaminoglycan level,4
MP:0011478 abnormal urine catecholamine level,7
MP:0011481 anterior iris synechia,15
MP:0011493 double ureter,4
MP:0011495 abnormal head shape,30
MP:0011496 abnormal head size,3
MP:0011498 abnormal glomerular capsule parietal layer morphology,4
MP:0011501 increased glomerular capsule space,16
MP:0011504 abnormal limb long bone morphology,5
MP:0011505 camptomelia,4
MP:0011506 glomerular crescent,16
MP:0011508 glomerular capillary thrombosis,4
MP:0011509 dilated glomerular capillary,7
MP:0011514 skin hemorrhage,7
MP:0011521 decreased placental labyrinth size,16
MP:0011523 thin placenta labyrinth,9
MP:0011525 abnormal placenta intervillous maternal lacunae morphology,5
MP:0011526 abnormal placenta fetal blood space morphology,4
MP:0011527 disorganized placental labyrinth,5
MP:0011534 granular kidney,4
MP:0011535 increased urination frequency,3
MP:0011565 kidney papillary hypoplasia,4
MP:0011569 abnormal azygos vein morphology,3
MP:0011572 abnormal aorta bulb morphology,3
MP:0011584 increased alkaline phosphatase activity,7
MP:0011610 abnormal primordial germ cell apoptosis,5
MP:0011612 increased circulating ghrelin level,6
MP:0011617 abnormal habituation,5
MP:0011620 abnormal habituation to a new environment,4
MP:0011625 cystolithiasis,6
MP:0011628 increased mitochondria number,3
MP:0011629 decreased mitochondria number,4
MP:0011630 increased mitochondria size,15
MP:0011632 dilated mitochondria,5
MP:0011633 abnormal mitochondrial shape,8
MP:0011635 abnormal mitochondrial crista morphology,19
MP:0011636 disorganized mitochondrial cristae,6
MP:0011638 abnormal mitochondrial chromosome morphology,4
MP:0011639 decreased mitochondrial DNA content,9
MP:0011642 abnormal bone collagen fibril morphology,4
MP:0011643 abnormal tendon collagen fibril morphology,3
MP:0011649 immotile respiratory cilia,6
MP:0011665 d-loop transposition of the great arteries,6
"MP:0011666 double outlet right ventricle, ventricular defect committed to aorta",6
MP:0011667 double outlet right ventricle with atrioventricular septal defect,14
"MP:0011668 double outlet right ventricle, Taussig bing type",5
MP:0011679 abnormal vomeronasal sensory neuron morphology,3
MP:0011682 renal glomerulus cysts,16
MP:0011683 dual inferior vena cava,7
MP:0011697 vacuolated lens,16
MP:0011698 abnormal brown adipose tissue physiology,5
MP:0011699 abnormal brown adipose tissue thermogenesis,3
MP:0011703 increased fibroblast proliferation,36
MP:0011704 decreased fibroblast proliferation,78
MP:0011705 absent fibroblast proliferation,5
MP:0011707 impaired fibroblast cell migration,6
MP:0011708 decreased fibroblast cell migration,20
MP:0011711 impaired osteoblast differentiation,6
MP:0011723 ectopic neuron,5
MP:0011727 ectopic ovary,6
MP:0011731 decreased myelin sheath thickness,7
MP:0011732 decreased somite size,24
MP:0011733 fused somites,10
MP:0011743 abnormal Golgi apparatus morphology,3
MP:0011747 myelofibrosis,6
MP:0011750 abnormal seminiferous tubule epithelium morphology,29
MP:0011751 abnormal X-Y chromosome synapsis during male meiosis,3
MP:0011753 decreased podocyte number,3
MP:0011759 absent Rathke's pouch,7
MP:0011760 abnormal ureteric bud tip morphology,5
MP:0011772 genital tubercle hypoplasia,3
MP:0011774 abnormal urinary bladder detrusor smooth muscle morphology,3
MP:0011797 blind ureter,4
MP:0011799 increased urinary bladder weight,3
MP:0011816 decreased pre-pro B cell number,4
MP:0011819 increased pancreatic beta cell proliferation,10
MP:0011820 decreased pancreatic beta cell proliferation,6
MP:0011827 impaired neuron differentiation,7
MP:0011843 abnormal kidney collecting duct epithelium morphology,4
MP:0011854 cerebral edema,4
MP:0011856 abnormal glomerular filtration barrier function,3
MP:0011862 decreased cranium length,6
MP:0011868 podocyte microvillus transformation,3
MP:0011871 podocyte hypertrophy,5
MP:0011882 enlarged duodenum,3
MP:0011886 increased circulating lipase level,3
MP:0011890 increased circulating ferritin level,8
MP:0011896 increased circulating unsaturated transferrin level,3
MP:0011922 abnormal circulating osteocalcin level,3
MP:0011925 abnormal heart echocardiography feature,5
MP:0011932 abnormal endocrine pancreas development,4
MP:0011939 increased food intake,72
MP:0011940 decreased food intake,69
MP:0011941 increased fluid intake,43
MP:0011942 decreased fluid intake,16
MP:0011951 increased cardiac stroke volume,4
MP:0011952 decreased cardiac stroke volume,11
MP:0011953 prolonged PQ interval,7
MP:0011954 shortened PQ interval,5
MP:0011957 decreased compensatory feeding amount,8
MP:0011962 increased cornea thickness,7
MP:0011964 increased total retina thickness,5
MP:0011965 decreased total retina thickness,24
MP:0011966 abnormal auditory brainstem response waveform shape,30
MP:0011967 increased or absent threshold for auditory brainstem response,268
MP:0011968 decreased threshold for auditory brainstem response,33
MP:0011971 increased circulating lactate dehydrogenase level,3
MP:0011998 decreased embryonic cilium length,9
MP:0012000 abnormal limb position,3
MP:0012010 parturition failure,4
MP:0012014 abnormal olfactory neuron innervation pattern,5
MP:0012027 abnormal embryonic cilium location or orientation,3
MP:0012029 abnormal electroretinogram waveform feature,14
MP:0012051 spasticity,3
MP:0012055 abnormal phrenic nerve innervation pattern to diaphragm,9
MP:0012062 small tail bud,5
MP:0012075 impaired mammary gland growth during pregnancy,5
MP:0012078 abnormal tail ring morphology,4
MP:0012080 chylous ascites,12
MP:0012081 absent heart tube,6
MP:0012082 delayed heart development,15
MP:0012083 absent foregut,4
MP:0012085 midface hypoplasia,4
MP:0012087 absent midbrain,5
MP:0012089 decreased midbrain size,15
MP:0012090 midbrain hypoplasia,3
MP:0012091 increased midbrain size,3
MP:0012093 absent nodal flow,5
MP:0012095 increased Reichert's membrane thickness,3
MP:0012098 increased spongiotrophoblast size,7
MP:0012099 decreased spongiotrophoblast size,17
MP:0012100 absent spongiotrophoblast,3
MP:0012102 absent trophectoderm,7
MP:0012104 small amniotic cavity,6
MP:0012105 delayed gastrulation,3
MP:0012106 impaired exercise endurance,26
MP:0012107 enhanced exercise endurance,4
MP:0012109 decreased trophoblast glycogen cell number,4
MP:0012111 failure of morula compaction,5
MP:0012113 decreased inner cell mass proliferation,20
MP:0012114 absent inner cell mass proliferation,40
MP:0012119 increased trophectoderm apoptosis,3
MP:0012129 failure of blastocyst formation,4
MP:0012131 small visceral yolk sac,6
MP:0012132 abnormal midbrain-hindbrain boundary morphology,6
MP:0012133 absent midbrain-hindbrain boundary,3
MP:0012135 embryonic-extraembryonic boundary constriction,13
MP:0012136 absent forebrain,12
MP:0012138 decreased forebrain size,16
MP:0012143 decreased a wave amplitude,18
MP:0012144 decreased b wave amplitude,22
MP:0012156 rostral-caudal axis duplication,8
MP:0012157 rostral body truncation,18
MP:0012159 absent anterior visceral endoderm,4
MP:0012167 abnormal epigenetic regulation of gene expression,5
MP:0012172 abnormal amniotic fluid composition,6
MP:0012173 short rostral-caudal axis,13
MP:0012175 flat face,4
MP:0012176 abnormal head development,8
MP:0012182 abnormal presomitic mesoderm morphology,4
MP:0012183 decreased paraxial mesoderm size,9
MP:0012184 absent paraxial mesoderm,6
MP:0012232 abnormal ceramide level,12
MP:0012235 abnormal liver bud morphology,7
MP:0012246 abnormal hepatic cord morphology,3
MP:0012251 abnormal diaphragm development,10
MP:0012253 abnormal intersomitic vessel morphology,18
MP:0012254 absent intersomitic vessels,5
MP:0012260 encephalomeningocele,8
MP:0012261 increased hindbrain apoptosis,5
MP:0012263 decreased hindbrain size,6
MP:0012270 cardiac edema,7
MP:0012274 increased axial mesoderm size,3
MP:0012279 wide sternum,4
MP:0012283 decreased sternebra number,5
MP:0012284 increased sternebra number,6
MP:0012285 misaligned sternebrae,3
MP:0012288 abnormal paradoxical sleep pattern,5
MP:0012289 abnormal non-rapid eye movement sleep pattern,3
MP:0012306 enhanced spatial learning,4
MP:0012307 impaired spatial learning,25
MP:0012359 increased partial thromboplastin time,4
MP:0012431 increased lymphoma incidence,88
MP:0012468 decreased striatum area,15
MP:0012484 decreased corticospinal tract size,3
MP:0012490 abnormal cochlear VIII nucleus morphology,8
MP:0012493 absent pharyngeal arch arteries,3
MP:0012501 abnormal pericardial cavity morphology,11
MP:0012504 increased forebrain apoptosis,4
MP:0012505 increased neural tube apoptosis,7
MP:0012506 brain atrophy,4
MP:0012511 dilated aortic sac,3
MP:0012514 pectus excavatum,3
MP:0012515 abnormal heart apex morphology,5
MP:0012517 absent diencephalon,4
MP:0012531 delayed limb development,3
MP:0012535 abnormal optic fissure closure,5
MP:0012536 delayed optic fissure closure,4
MP:0012538 persistent hyaloid artery,3
MP:0012547 spina bifida cystica,4
MP:0012556 increased cell death,8
MP:0012671 retinal spots,7
MP:0012675 enlarged floor plate,4
MP:0012676 dilated brain ventricles,17
MP:0012685 abnormal primitive streak elongation,10
MP:0012686 everted embryonic neuroepithelium,4
MP:0012701 increased embryonic neuroepithelium apoptosis,16
MP:0012702 increased embryonic neuroepithelium thickness,6
MP:0012703 decreased embryonic neuroepithelium thickness,14
MP:0012706 decreased embryonic neuroepithelial cell proliferation,7
MP:0012707 incomplete caudal neuropore closure,8
MP:0012725 small sebaceous gland,6
MP:0012728 abnormal somite border morphology,4
MP:0012729 abnormal common carotid artery morphology,9
MP:0012730 abnormal internal carotid artery morphology,4
MP:0012732 abnormal perineural vascular plexus morphology,4
MP:0012737 abnormal primary polar body morphology,3
MP:0012739 abnormal anterior primitive streak morphology,5
MP:0012740 abnormal posterior primitive streak morphology,3
MP:0012757 abnormal cranial neural crest cell migration,4
MP:0012764 increased alpha-beta T cell number,5
MP:0012765 decreased alpha-beta T cell number,8
MP:0012767 increased KLRG1-positive NK cell number,7
MP:0012768 decreased KLRG1-positive NK cell number,6
MP:0012796 abnormal rhombomere 4 morphology,3
MP:0012800 abnormal rhombomere 5 morphology,3
MP:0013022 increased Ly6C high monocyte number,9
MP:0013023 decreased Ly6C high monocyte number,7
MP:0013025 increased Ly6C low monocyte number,4
MP:0013026 decreased Ly6C low monocyte number,15
MP:0013155 decreased KLRG1+ CD8 alpha beta T cell number,7
MP:0013164 abnormal forelimb bud morphology,6
MP:0013166 small forelimb buds,4
MP:0013168 absent hindlimb buds,4
MP:0013176 abnormal tail position or orientation,6
MP:0013178 tail necrosis,3
MP:0013179 wavy tail,3
MP:0013182 increased spinal cord apoptosis,4
MP:0013203 abnormal primary cilium morphology,4
MP:0013207 absent endoderm,3
MP:0013219 abnormal substantia nigra pars compacta morphology,5
MP:0013236 ovary degeneration,4
MP:0013237 abnormal skeletal muscle regeneration,8
MP:0013239 impaired skeletal muscle regeneration,9
MP:0013241 embryo tissue necrosis,35
MP:0013245 abnormal lipid metabolism,5
MP:0013258 abnormal extracellular matrix morphology,6
MP:0013264 tongue ankylosis,3
MP:0013278 decreased fasted circulating glucose level,56
MP:0013279 increased fasted circulating glucose level,66
MP:0013283 failure of ventral body wall closure,3
MP:0013292 embryonic lethality prior to organogenesis,133
MP:0013293 embryonic lethality prior to tooth bud stage,158
MP:0013294 prenatal lethality prior to heart atrial septation,45
MP:0013307 increased adrenal gland weight,4
MP:0013317 abnormal seminal vesicle development,5
MP:0013318 abnormal branching involved in seminal vesicle morphogenesis,3
MP:0013320 dilated seminal vesicles,3
MP:0013337 abnormal adenohypophysis development,5
MP:0013342 bifurcated Rathke's pouch,3
MP:0013349 small Rathke's pouch,3
MP:0013351 abnormal Rathke's pouch development,9
MP:0013352 abnormal Rathke's pouch apoptosis,5
MP:0013375 abnormal sebocyte morphology,3
MP:0013400 abnormal endometrial gland development,3
MP:0013404 decreased circulating lactate level,9
MP:0013405 increased circulating lactate level,6
"MP:0013435 decreased CD8-positive, naive alpha-beta T cell number",6
MP:0013438 dysmyelination,4
MP:0013486 decreased Paneth cell number,3
MP:0013501 increased fibroblast apoptosis,26
MP:0013502 decreased fibroblast apoptosis,14
MP:0013504 increased embryonic tissue cell apoptosis,79
MP:0013511 increased CD4-negative NK T cell number,3
MP:0013513 decreased memory-marker CD4-negative NK T cell number,3
MP:0013519 decreased CD4-positive NK T cell number,3
MP:0013522 decreased memory-marker CD4-positive NK T cell number,3
MP:0013538 increased Harderian gland adenoma incidence,3
MP:0013558 abnormal exocrine gland morphology,3
MP:0013566 dilated gastric glands,4
MP:0013580 abnormal nasal gland morphology,3
MP:0013582 abnormal lateral nasal gland morphology,3
MP:0013585 thymus cortex atrophy,5
MP:0013587 absent thymus medulla,3
MP:0013588 small thymus medulla,8
MP:0013593 enlarged thymus cortex,3
MP:0013595 absent vomeronasal organ,3
MP:0013600 testis degeneration,12
MP:0013601 increased testis apoptosis,4
MP:0013603 abnormal fetal Leydig cell differentiation,3
MP:0013616 decreased volumetric bone mineral density,6
MP:0013618 decreased areal bone mineral density,4
MP:0013624 decreased femur compact bone thickness,4
MP:0013630 increased bone trabecular spacing,5
MP:0013631 decreased bone trabecular spacing,6
MP:0013639 decreased bone stiffness,3
MP:0013648 increased CD11b-high dendritic cell number,4
MP:0013649 decreased CD11b-high dendritic cell number,3
MP:0013655 decreased CD103-positive CD11b-low dendritic cell number,3
MP:0013663 increased myeloid cell number,6
MP:0013675 decreased Ly6C-positive mature NK cell number,3
MP:0013691 decreased CD5-positive Ly6C-positive T cell number,3
MP:0013716 hypolactation,10
MP:0013718 galactostasis,3
MP:0013741 absent thymus corticomedullary boundary,4
MP:0013743 ciliary body hypoplasia,5
MP:0013745 abnormal eyelid margin morphology,4
MP:0013771 decreased effector memory T-helper cell number,3
MP:0013772 increased effector memory T-helper cell number,3
MP:0013785 abnormal mammary gland bud morphology,4
MP:0013787 photophobia,3
MP:0013795 abnormal colon goblet cell morphology,10
MP:0013906 absent embryonic telencephalon,5
MP:0013956 decreased colon length,9
MP:0013962 absent Hensen stripe,3
MP:0014046 abnormal mitophagy,3
MP:0014071 increased cardiac muscle glycogen level,5
MP:0014082 decreased small intestinal villus height,4
MP:0014091 abnormal tectorial membrane striated-sheet matrix morphology,6
MP:0014117 increased pancreatic beta cell apoptosis,5
MP:0014121 increased pancreatic islet cell apoptosis,5
MP:0014126 increased mammary gland apoptosis,6
MP:0014130 thymus cysts,3
MP:0014142 increased body fat mass,4
MP:0014143 decreased body fat mass,13
MP:0014146 decreased white adipose tissue mass,7
MP:0014164 abnormal ciliary process morphology,4
MP:0014166 ectopic cranial bone,3
MP:0014167 ectopic bone,5
MP:0014169 decreased brown adipose tissue mass,12
MP:0014171 increased fatty acid oxidation,7
MP:0014172 decreased fatty acid oxidation,6
MP:0014174 decreased fatty acid beta-oxidation,3
MP:0014178 increased brain apoptosis,3
MP:0014185 cerebellum atrophy,9
MP:0014198 absent pituitary infundibular stalk,3
MP:0020001 decreased response to antigen,13
MP:0020010 decreased bone mineral density of femur,6
MP:0020039 increased bone ossification,16
MP:0020040 decreased bone ossification,23
MP:0020080 increased bone mineralization,7
MP:0020137 decreased bone mineralization,32
MP:0020138 delayed bone mineralization,3
MP:0020154 impaired humoral immune response,20
MP:0020220 decreased tear production,5
MP:0020234 decreased basal metabolism,8
MP:0020254 decreased collagen level,6
MP:0020316 decreased vascular endothelial cell proliferation,6
MP:0020321 increased vascular endothelial cell apoptosis,3
MP:0020329 decreased capillary density,5
MP:0020332 impaired leukocyte tethering or rolling,18
MP:0020333 enhanced leukocyte tethering or rolling,7
MP:0020340 abnormal inhibitory learning,6
MP:0020351 decreased vocalization,20
MP:0020354 increased endoplasmic reticulum stress,7
MP:0020357 abnormal excitatory synapse morphology,4
MP:0020367 increased heart iron level,4
MP:0020378 abnormal cell cytoskeleton morphology,17
MP:0020386 adipose tissue inflammation,9
MP:0020409 abnormal cardiac thrombosis,5
MP:0020411 increased abdominal adipose tissue amount,5
MP:0020416 decreased fibroblast chemotaxis,4
